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Summary 
 
Mycotoxins, toxic secondary metabolites of various fungi, are frequent contaminants of crops 
worldwide. Prominent examples are aflatoxin B1, ochratoxin A, fumonisins, deoxynivalenol 
and zearalenone, found at variable levels in diverse geographical regions. These mycotoxins 
are of concern, since their ingestion can cause disorders and severe diseases in animals and 
humans. Most developed countries enforce strict regulations to minimize dietary exposure of 
consumers. But, in developing countries as Bangladesh there is no regular surveillance for 
contaminants, and data on mycotoxins in food and feed is scarce or absent. As biomonitoring 
(analysis of parent compounds and metabolites in human samples) covers intake from all 
dietary sources, this approach was used to systematically investigate mycotoxin exposure in 
inhabitants of Bangladesh and compare it with the situation in other countries. 
Determining urinary biomarkers of exposure by means of an LC-MS/MS based multi-
mycotoxin method served to select major mycotoxins of interest, namely aflatoxin B1 (AFB1, 
hepatocarcinogen), ochratoxin A, citrinin (OTA, CIT; nephrotoxic), and deoxynivalenol 
(DON, emetogen, immunotoxic). Then an in-depth analysis by sensitive specific methods was 
conducted for AFM1 (metabolite of AFB1), OTA, CIT and its main metabolite dihydrocitrinon 
(HO-CIT), or for DON and its metabolites, to determine the concentration ranges in samples 
(urines) collected from several Bangladeshi cohorts and in those from a German cohort. 
To gain insight into the range of mycotoxin exposure among the Bangladeshi population, 
urine samples were collected from cohorts in two districts of the country, and from residents 
of rural and urban areas with presumably some differences in food habits. Bangladesh has a 
subtropical monsoon climate, characterized by seasonal variations in rainfall, temperature and 
humidity, conditions that favour the growth of certain fungal species on crops and stored food 
commodities. Thus, urines were collected from cohorts in summer and winter season for 
mycotoxin biomarker analysis. 
My thesis is based on seven original publications in peer-reviewed journals on the occurrence 
and ranges of suitable biomarkers of exposure for AFB1, CIT, OTA, and DON in the 
Bangladeshi cohorts (Ali et al. 2014; Ali et al. 2015a,b,c,d,e; Gerding et al. 2015). The 
included publications provide more details on study cohorts, sample collection, analytical 
methods and their validation, full sets of biomarker data and an in-depth interpretation of all 
results. The thesis presents also unpublished data on AFM1 and DON biomarker analysis in 
Bangladeshi and German cohorts, and an overview of the literature on urinary biomarker data 
from other countries. Main findings of this first systematic biomonitoring study in the 
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Bangladeshi population and a German ‘reference’ cohort are briefly summarized below along 
with comments regarding possible risks associated with an exposure to these mycotoxins. 
Aflatoxin B1: In the organism AFB1 is partly converted to the hydroxylated metabolite AFM1 
and excreted with urine (and milk). AFM1 was not detected by HPLC-FD analysis (LOD 1.7 
pg/mL) in any of the urine samples from German adults (n=50). But, AFM1 was detected in 
>40% of urines from Bangladeshi cohorts in one district (n=62), and in 31% of urines from 
pregnant women (n=54) in another district. The latter samples contained similar or slightly 
lower AFM1 levels (mean 13.9, max 142 pg/mL) than those found in the other cohort during 
two sampling seasons (mean 13.6, max 140 pg/mL in summer, and mean 27.7, max 190 
pg/mL in winter). These novel biomarker results indicate frequent exposure to the potent 
hepatotoxic mycotoxin AFB1 in the Bangladeshi population, and at levels which should raise 
concerns. As AFB1 is a potent mutagenic carcinogen, no “safe” intake values can be defined, 
and the exposure should be kept as low as possible (ALARA principle).  
Ochratoxin A and Citrinin: Both compounds are known nephrotoxins, with OTA being more 
potent than CIT. Absorbed OTA has a long half-life in blood of humans, since only a small 
fraction of circulating OTA is excreted in urine. In principle, OTA biomarker analysis can use 
either blood or urine samples, although non-invasive sampling is often preferred. CIT is 
converted to the less toxic metabolite dihydrocitrinon (HO-CIT), the major urinary metabolite 
in humans. Thus, the sum of both (‘total CIT’) served as biomarker of exposure.  
The mean OTA plasma concentration (0.85 ng/mL) in Bangladeshi students (n=64) only 
slightly exceeds an ‘overall mean world OTA serum level’ of 0.7 ng/mL in apparently healthy 
populations. Dietary intake of OTA (mean 11.7, max 91.4 ng/kg b.w/week) calculated on the 
basis of plasma levels in Bangladeshi students is lower than the tolerable weekly OTA intake 
(120 ng/kg body weight) set by European Food Safety Agency (EFSA). This first data 
indicated low risks in the student group, yet further studies in other Bangladeshi cohorts were 
indicated, also to assess concomitant exposure to CIT. 
Biomarkers for OTA and CIT exposure were present in most of the urines collected from our 
Bangladeshi cohorts. In residents of two areas in Rajshahi district, no regional difference was 
observed in urinary OTA levels, whereas sampling season had a clear impact, with higher 
OTA mean levels found in winter (mean 0.19, max 1.75 ng/mL urine) than in summer (mean 
0.06, max 0.55 ng/mL). For CIT biomarkers more pronounced regional and seasonal 
variations were found among these cohorts. Their mean level of total CIT (CIT plus HO-CIT) 
was significantly higher in winter (mean 3.77, max 48.12 ng/mL urine) than in summer (mean 
0.51, max 5.70 ng/mL) season. In both seasons, total CIT biomarker concentrations were 
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significantly higher in the rural than in the urban cohort. Determination of urinary OTA 
concentrations (mean 0.10, max 0.84 ng/mL) for pregnant women cohorts from Dhaka district 
and CIT biomarker analysis (total mean 0.73, max 9.40 ng/mL) confirmed a frequent 
concomitant exposure to these mycotoxins in the Bangladeshi population. In German adults, 
the urinary OTA concentration (mean 0.21, max 1.82 ng/mL) was similar to that found in the 
Bangladeshi adult cohorts in winter season. However, CIT biomarker levels in German urines 
(total mean 0.14, max 0.58 ng/mL) were clearly lower than those in all Bangladeshi samples.  
The novel biomarker results for CIT and a urinary excretion rate of 36% per day were used 
for calculating probable daily CIT intake in all cohorts and compare these values to the 
preliminary tolerable daily intake (TDI) of 0.2 µg/kg bw set by EFSA. The TDI for CIT 
exposure was not exceeded in the German cohort, but in up to 24% of the Bangladeshi cohort. 
Estimates of OTA exposure from urine data are hampered by its low excretion rate (< 3%).  
Deoxynivalenol: DON is mainly metabolized to glucuronides and about 70% of an ingested 
dose is excreted in urine within a day. Overall, biomonitoring results for all Bangladeshi 
cohorts reveal low DON exposure, with some regional but no marked seasonal variation. The 
urinary DON level in pregnant women from Dhaka district (mean 0.86, max 7.16 ng/mL) was 
higher than in the Rajshahi cohorts (mean 0.17, max 1.78 ng/mL in summer, mean 0.16; max 
1.21 ng/mL in winter). Urinary DON concentrations (mean 9.02, max 38.44 ng/mL) in 
German adults are significantly higher (p<0.0001) than in any of the Bangladeshi cohorts. 
However, the probable daily DON intakes for all participants in both countries were below the 
TDI of 1 µg/kg/d set by WHO, thereby indicating that present DON exposures are not of 
concern.  
Conclusions: The frequent detection of AFM1 in Bangladeshi urines clearly indicates 
aflatoxin exposures of concern. To minimize this health risk, further studies to identify major 
sources of AFB1 intake are recommended. Exposure to CIT an OTA should be further 
monitored, including susceptible groups in the population (especially children), and in light of 
possible combined effects.  
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Zusammenfassung 
Mykotoxine, toxische Sekundärmetaboliten verschiedener Schimmelpilzarten, treten weltweit 
als Kontaminanten in Getreide und anderem pflanzlichen Erntegut auf. Bekannte Beispiele 
sind Aflatoxin B1, Ochratoxin A, Fumonisine, Deoxynivalenol and Zearalenon. Man findet sie 
in verschiedenen geographischen Regionen der Erde in unterschiedlicher Häufigkeit und 
Menge. Diese Mykotoxine geben Grund zur Besorgnis, weil ihre Aufnahme die Gesundheit 
von Mensch und Tieren beeinträchtigen und zu schweren Erkrankungen führen kann. 
Entwickelte Länder haben daher strikte Regelungen für Mykotoxine und Kontrollstrukturen 
etabliert, um eine nahrungsbedingte Aufnahme (Exposition) zu minimieren. In Entwicklungs-
ländern wie Bangladesh gibt es noch keine solchen Maßnahmen zum Schutz der Verbraucher. 
Daten zur Kontamination von Lebens- und Futtermitteln mit Mykotoxinen sind daher rar oder 
fehlen ganz. Das Humanbiomonitoring (die Analyse von Fremdstoffen und deren Metaboliten 
in Körper-flüssigkeiten) spiegelt eine Aufnahme aus allen Nahrungsquellen wider. Es wurde 
nun genutzt, um erstmals systematisch die Mykotoxin-Exposition in der Bevölkerung in 
Bangladesh zu untersuchen und deren Belastung mit der in anderen Ländern zu vergleichen. 
Die Analyse sog. ‘biomarker of exposure’ in Urinproben mit Hilfe einer LC-MS/MS basierten 
Multi-Mykotoxin-Methode erlaubte es, eine Auswahl wichtiger Mykotoxine zu treffen, 
nämlich Aflatoxin B1 (AFB1, hepatotoxisch und kanzerogen), Ochratoxin A, Citrinin (OTA, 
CIT; nephrotoxisch) und Deoxynivalenol (DON, emetogen, immunotoxisch). Selektive 
Methoden - mit Anreicherung der Analyten AFM1 (Metabolit von AFB1), OTA, CIT und 
Dihydrocitrinon (HO-CIT Metabolit von CIT) sowie DON und seine Metaboliten - wurden 
dann zur Bestimmung der Konzentrationen in Humanproben (Urinen) von mehreren 
Personengruppen in Bangladesh und in einer deutschen Kohorte eingesetzt. 
Zwecks Charakterisierung der Mykotoxin-Exposition in der Bevölkerung von Bangladesh, 
wurden dort Urine von Kohorten in zwei Distrikten gesammelt und von Bewohnern ländlicher 
und städtischer Regionen mit vermutlich unterschiedlichen Nahrungsgewohnheiten. 
Bangladesh hat ein subtropisches (Monsun-)Klima mit saisonalen Schwankungen in Nieder-
schlag, Temperatur und Luftfeuchte. Die Bedingungen sind förderlich für das Wachstum von 
Schimmelpilzen auf Erntegut und eingelagerten Produkten. Daher wurden in den Kohorten 
jeweils im Sommer und im Winter Urinproben für das Mykotoxin-Biomonitoring gesammelt. 
Meine Dissertation zur biomarker-basierten Ermittlung der Exposition gegen AFB1, CIT, 
OTA und DON in Bewohnern von Bangladesh stützt sich auf 7 Originalarbeiten in referierten 
Fachzeitschriften (Ali et al. 2014; Ali et al. 2015a,b,c,d,e; Gerding et al. 2015), mit detail-
lierten Angaben zu Studien-Kohorten, Probensammlung, Analysenmethoden und Validierung, 
kompletten Biomarker-Datensets und vertieften Diskussionen aller Befunde. Die vorliegende 
Schrift enthält ferner bislang unpublizierte Daten zu AFM1- und DON-Analysen in Kohorten 
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aus Bangladesh und Deutschland sowie Übersichten zu publizierten Mykotoxin-Daten aus 
anderen Ländern. Wesentliche Befunde der ersten systematischen Biomonitoring-Studie in 
der Bevölkerung in Bangladesh und einer deutschen Vergleichs-Kohorte werden nachfolgend 
kurz zusammengefasst und mögliche Risiken der Mykotoxin-Expositionen diskutiert. 
Aflatoxin B1: AFB1 wird im Organismus u.a. in den hydroxylierten Metaboliten AFM1 umge-
wandelt, der in Urin (und Milch) ausgeschieden wird. AFM1 war mit sensitiver Analytik in 
keiner deutschen Urinprobe (n=50) nachweisbar (LOD 1,7 pg/mL). Dagegen wurde AFM1 in 
>40% der Urine (n=62) von Bewohnern eines Distrikts in Bangladesh detektiert und in 31% 
der Proben von Schwangeren (n=54) aus einer anderen Region. Deren Urine hatten ähnliche 
bzw. etwas geringere AFM1 Konzentrationen (Mittelwert, MW 13,9; max. 142 pg/mL) als die 
zu zwei Zeiten gesammelten Urine der anderen Kohorte (MW 13,6; max. 140 pg/mL im 
Sommer und MW 27,7; max. 190 pg/mL im Winter). Die neuen Biomarker-Daten belegen die 
häufige Exposition der Bevölkerung in Bangladesh gegenüber dem hepatotoxischen 
Mykotoxin AFB1 und zwar in einer Höhe, die als bedenklich anzusehen ist. Da AFB1 ein 
potentes mutagenes Kanzerogen ist, können keine ‘safe intake’ Werte definiert werden, und 
die Exposition mit der Nahrung sollte so gering wie möglich sein (sog. ALARA Prinzip).  
Ochratoxin A und Citrinin: Beide Substanzen wirken primär nierentoxisch, OTA ist dabei 
potenter als CIT. Aufgenommenes OTA zirkuliert relativ lang im Blut des Menschen, weil 
täglich nur ein kleiner Anteil davon im Urin ausgeschieden wird. OTA kann in Blut oder Urin 
analysiert werden, wobei nicht-invasive Probenahme oft vorzuziehen ist. CIT wird in das 
geringer toxische Dihydrocitrinon (HO-CIT) umgewandelt, ein Hauptmetabolit im Urin von 
Menschen. Die Summe beider Analyten (‘total CIT’) dient daher als ‘biomarker of exposure’.  
In Bangladesh bei Studenten (n=64) gemessene OTA Blutplasma Werte (MW 0.85 ng/mL) 
liegen nur gering über dem ‘overall mean world OTA serum level’ von 0,7 ng/mL in anderen 
gesunden Personengruppen. Die auf Basis der OTA Blutspiegel berechnete Aufnahmemenge 
der Studenten (MW 11,7, max. 91.4 ng/kg KG/Woche) ist geringer als eine von der European 
Food Safety Agency (EFSA) abgeleitete unschädliche Exposition für OTA, der sog. ‘tolerable 
weekly intake’ von 120 ng/kg KG. Die Daten sprachen zwar für geringe OTA Belastungen in 
der Gruppe der Studenten, dennoch waren Studien in anderen Bangladesh-Kohorten 
angezeigt, auch um begleitende Expositionen gegenüber CIT zu ermitteln. 
Biomarker für OTA- und CIT-Exposition waren in fast allen Urinen der Bangladesh Kohorten 
nachweisbar. Bei Bewohnern zweier Gebiete in Rajshahi fanden sich keine regionalen Unter-
schiede in den OTA-Urinspiegeln, aber deutliche saisonale Einflüsse, mit höheren Werten im 
Winter (MW 0,19; max. 1,75 ng/mL) als im Sommer (MW 0,06; max. 0.55 ng/mL). Die CIT- 
Biomarker Analysen dieser Kohorten zeigten ausgeprägtere regionale und saisonale Unter-
schiede, nämlich signifikant höhere Gesamt-CIT (CIT+HO-CIT) Konzentrationen im Winter 
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(MW 3,77; max. 48.12 ng/mL Urin) als im Sommer (MW 0,51; max 5.70 ng/mL) sowie in 
beiden Sammelperioden signifikant höhere Spiegel in der ländlichen als in der städtischen 
Bevölkerung. Die in Urinen einer Kohorte von Schwangeren im Dhaka Distrikt gefundene 
OTA-Konzentration (MW 0,10; max. 0.84 ng/mL) und CIT-Biomarker Analysen (MW ‘total’ 
0,73; max. 9.40 ng/mL) bestätigen eine häufige und gleichzeitig bestehende Exposition der 
Einwohner in Bangladesh gegen beide Mykotoxine. In der deutschen Kohorte gefundene 
OTA Konzentrationen (MW 0,21; max. 1.82 ng/mL Urin) ähneln denen der Bangladesh-
Kohorte im Winter. Dagegen liegen CIT-Biomarker-Werte in deutschen Urinen (MW ‘total’ 
0,14; max. 0.58 ng/mL) deutlich unter den Werten aller Proben aus Bangladesh.  
Auf Basis der CIT-Biomarker-Daten und einer Exkretionsrate von 35% im Urin wurde für 
alle Kohorten deren tägliche CIT-Aufnahme berechnet und die Werte dann mit dem von der 
EFSA abgeleiteten vorläufigen ‘tolerable daily intake’ (TDI) von 0,2 µg/kg KG verglichen. In 
der deutschen Kohorte wurde der TDI für CIT Exposition nicht überschritten, aber in bis zu 
24% der Individuen der Bangladesh-Kohorten. Eine Abschätzung der OTA Exposition aus 
Urin-Daten ist wegen der geringen Exkretionsrate (< 3%) zu unsicher und nicht sinnvoll.  
Deoxynivalenol: DON wird überwiegend zu Glucuroniden metabolisiert, und etwa 70% einer 
aufgenommenen Dosis werden am Tag im Urin ausgeschieden. Insgesamt belegen die 
Biomonitoring-Befunde eine niedrige DON Exposition aller Bangladesh-Kohorten, zwar mit 
regionalen Unterschieden, doch ohne klare saisonale Einflüsse: Urinspiegel in Schwangeren 
im Dhaka Distrikt (DON MW 0,86; max. 7.16 ng/mL) sind höher als in den Rajshahi 
Kohorten (MW 0,17; max. 1.78 ng/mL im Sommer, MW 0,16; max. 1.21 ng/mL im Winter). 
DON Konzentrationen (MW 9,02; max. 38.44 ng/mL) in der deutschen Kohorte sind signify-
kant höher als in den Urinen aus Bangladesh. Die berechnete tägliche DON-Aufnahme aller 
Teilnehmer aus beiden Ländern lag unter dem TDI der WHO von 1 µg/kg KG. Die gegen-
wärtigen DON Expositionen geben somit keinen Anlass zur Besorgnis.  
Schlussfolgerungen: Der häufige Nachweis des Biomarkers AFM1 in Urinproben aus 
Bangladesh ist ein klares Indiz für Aflatoxin-Expositionen, die als bedenklich angesehen 
werden. Um gesundheitliche Risiken der Bevölkerung künftig minimieren zu können, werden 
Folgestudien (Nahrungsmittelanalysen) empfohlen mit dem Ziel, die Hauptquellen einer 
AFB1 Aufnahme zu identifizieren. Biomonitoring für CIT- und OTA-Exposition sollte 
fortgesetzt und auf empfindliche Gruppen der Bevölkerung (Kinder) ausgedehnt werden, auch 
in Hinblick auf mögliche Kombinationseffekte.   
 
 
 
 
 
x 
 
Table of contents 
 
Acknowledgement…………………………………………………………………………..ii 
Citation of publications in this dissertation.…….……………………………………......iii 
Summary……………………………………………………………………………………iv 
Zusammenfassung…………………………………………………………………………vii 
List of  figures……………………………………….……………………………………..xii 
List of tables……………………………………………………………………...………..xiii 
List of abbreviations………………………………………………………………………xiv 
1 Introduction…………………………………………..……………………………………1 
1.1 General information on mycotoxins…………...……………………………....…....…….1 
1.2 Estimation of human exposure to mycotoxins……………………………………………1 
1.3 Background on mycotoxin occurrence in Bangladesh…………………………….…...…3 
1.4 Background on four major mycotoxins (AFB1, OTA, CIT and DON) …………………..4 
1.4.1 Aflatoxin B1……………………………………………………………………………..4 
1.4.1.1 Physiochemical properties of AFB1…………………………………..…...………4 
1.4.1.2 Toxicity and kinetics of AFB1……………………………….…………………....4 
1.4.1.3 Human exposure to AFB1………………………………..………………………..6 
1.4.2 Ochratoxin A…………………………………………………………………………….7 
1.4.2.1 Physiochemical properties of  OTA……………………………………………….7 
1.4.2.2 Toxicity and kinetics of OTA……………………………………………………..7 
1.4.2.3 Human exposure to OTA………………………………………………………….9 
1.4.3 Citrinin…………………………………………………………………………………10 
1.4.3.1 Physiochemical properties of CIT……………………………………………….10 
1.4.3.2 Toxicity and kinetics of CIT……………………………………………………..10 
1.4.3.3 Human exposure to CIT………………………………………………………….11 
1.4.4 Deoxynivalenol………………………………………………………………………...11 
1.4.4.1 Physiochemical properties of DON………………………………………...……11 
1.4.4.2 Toxicity and kinetics of DON……………………………………………………11 
1.4.4.3 Human exposure to DON………………………………………………………...13 
1.4 Scope and aims of this work……………………………………………………………..13 
2 Materials and methods………………………...…………………………………………14 
2.1 Standards, chemicals and reagents………………………………………………..……..14 
2.2 Study populations and sampling areas………………………………………….……….14 
2.3 Demographic information of the study populations …………………………………….16 
2.4 Biomarkers analysis……………………………………………………………………...16 
2.4.1 Aflatoxin M1…………………………………………………………………………...17 
xi 
 
2.4.1.1 AFM1 determination by ELISA………………………………………………….17 
2.4.1.2 AFM1 determination by HPLC-FD ……………………………………………...18 
2.4.2 Ochratoxin A…………………………………………………………………………...20 
2.4.3 Citrinin…………………………………………………………………………………21 
2.4.4 Deoxynivalenol ………………………………………………………………………..21 
2.4.5 Food consumption data………………………………………………………………...21 
2.4.6 Statistical analysis……………………………………………………………………...22 
3 Results……………………………………………………………………………………..23 
3.1 Aflatoxin M1 as biomarker of AFB1 exposure…………………………………………...23 
3.1.1 Comparison of ELISA and HPLC-FD in AFM1 analysis……………………………...23 
3.1.2 Bangladesh…………………………………………………………………………24 
3.1.3 Germany……………………………………………………………………………27 
3.2 Ochratoxin A biomarker analysis………………………………………………………..28 
3.2.1 Bangladesh…………………………………………………………………………28 
3.2.2 Germany……………………………………………………………………………29 
3.3 Citrinin biomarker analysis………………………………………………………………29 
3.3.1 Bangladesh…………………………………………………………………………29 
3.3.2 Germany……………………………………………………………………………31 
3.4 Deoxynivalenol biomarker analysis……………………………………………………...31 
3.4.1 Bangladesh…………………………………………………………………………31 
3.4.2 Germany……………………………………………………………………………32 
3.5 Correlation between food consumption pattern and urinary biomarker levels…………..33 
4 Discussion………………………………………………………………………………….34 
4.1 Aflatoxin M1, as a urinary biomarker of AFB1……………………………………...34 
4.2 Ochratoxin A biomarker……………………………………………………………..38 
4.3 Citrinin biomarker……………………………………………………………………43 
4.4 Deoxynivalenol biomarker…………………………………………………………...45 
4.5 Biomarker-based exposure estimates and TDI values……………………………….49 
4.6 Possible sources of dietary mycotoxin intake………………………………………..50 
5 Conclusions… …………………………………………………………………………….52 
6 References………………………………………………………………………………....53 
7 Curriculum vitae………………………………………………………………………….63 
8 Appendices………………………………………………………………………………...65 
Appendix 1: Informed consent in Bangla……………………………………………………65 
Appendix 2: Participant information and food frequency questionnaire (FFQ) …………….66 
Appendix 3: Informed consent in German…………………………………………………...68 
9 Reprint of original publications and contribution statement………………………….69 
xii 
 
List of figures 
 
Fig. 1 An illustration of two approaches used to estimate human exposure to undesirable 
compounds - such as mycotoxins…………………………………………………..3
Fig. 2 Aflatoxin B1 metabolism and biomarkers………………………………………….5 
Fig. 3 Proposed metabolic pathways of ochratoxin A in animals and humans…………...8 
Fig. 4 Structures of citrinin and its metabolite dihydrocitrinone ………………………..10
Fig. 5 Structure of DON, its metabolite DOM-1 and glucuronide isomers……………..12 
Fig. 6 Map of Bangladesh and selected sampling sites in Rajshahi and Dhaka district…15
Fig. 7 HPLC chromatograms of a blank, spiked and AFM1 contaminated urine………..19 
Fig. 8 Comparison of ELISA and HPLC-FD measurements of urinary 
AFM1 concentartion………………………………………………………….…..23 
Fig. 9 Urinary level of AFM1 in the rural and urban cohorts of Rajshahi district in 
summer and winter season………………………………………………………..24 
Fig. 10 Urinary level of AFM1 in pregnant women from Dhaka district…………………27 
Fig. 11 Mean reported OTA serum levels (52 datasets) from healthy populations 
in different countries of the world with new data from the Bangladeshi 
student cohort……………………………………………………………………..38 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xiii 
 
List of tables 
 
Table 1 Overview on mechanism of action and toxic properties of some 
major mycotoxins……………………………………………………………...2 
Table 2 Recovery of AFM1 using two types of IAC columns in human urine………..20 
Table 3 Intra-day and inter-day assay repeatability for AFM1 in urine using two 
types of IAC columns…………………………………………………………20 
Table 4 Urinary levels of AFM1 in rural and urban adult cohorts in Rajshahi district 
of Bangladesh…………………………………………………………………25 
Table 5 Correlation between urinary AFM1 levels and last two days of food 
consumption…………………………………………………………………..26 
Table 6 Urinary AFM1 biomarker levels (pg/mL) and last two days of rice 
Consumption…………………………………………………………………..26
Table 7 Urinary levels of AFM1 in pregnant women from Dhaka district of 
Bangladesh…………………………………………………………………….27
Table 8 Levels of OTA and its metabolite OTα in urines from German adults……….29 
Table 9 Provisional daily intake (PDI) of citrinin (µg/kg b.w.) calculated from urine 
biomarker concentrations……………………………………………………..30 
Table 10 Occurrence of DON and DOM-1 in urines from Bangladesh and Germany…32 
Table 11 Provisional daily intake (PDI) of DON (ng/kg b.w.)* among the participants 
in Bangladesh and Germany………………………………………………….32 
Table 12 Occurrence of AFM1 in urines from cohorts in different countries…………..36 
Table 13 Occurrence of OTA and its metabolite in urines from cohorts in different 
countries………………………………………………………………………40 
Table 14 Occurrence of CIT and its metabolite in urines from cohorts in different 
countries…………………………………………………………………...….44 
Table 15 Occurrence of DON and its metabolite DOM-1 in urines from cohorts in 
different countries…………………………………………………………….47 
 
 
 
 
 
 
 
 
xiv 
 
 
 
List of abbreviations 
 
ADME Absorption, distribution, metabolism and excretion
AFB1 Aflatoxin B1
AFB2 Aflatoxin B2
AFG1 Aflatoxin G1
AFG2 Aflatoxin G2
AFM1 Aflatoxin M1
AFP1 Aflatoxin P1
AFQ1 Aflatoxin Q1 
ALARA As low as reasonably achievable
BEN  Balkan endemic nephropathy 
B.W/W Body weight/week 
BMI Body mass index 
CYP  Cytochrome P450 
CIT Citrinin 
HO-CIT Dihydrocitrinone 
DNA Deoxyribonucleic acid
DON Deoxynivalenol 
DOM-1 De-epoxy metabolite 1 
EC  European Community 
EFSA  European Food Safety Authority 
ELISA  Enzyme-linked immunosorbent assay 
ESI  Electrospray ionization 
FAO  Food and Agriculture Organization 
FB1 Fumonisin B1
FFQ Food frequency questionnaire 
HPLC  High performance liquid chromatography 
FD  Fluorescence detection 
IAC  Immunoaffinity column 
IARC  International Agency for Research on Cancer 
xv 
 
JECFA Joint FAO/WHO Expert Committee on Food Additives 
LC-MS/MS Liquid chromatography - tandem mass spectrometric detection 
LLE Liquid-liquid extraction 
LOD Limit of detection 
LOQ Limit of quantification 
m/z mass-to-charge ratio 
MW Molecular weight 
NOEL No observed effect level 
OTA Ochratoxin A 
OTα Ochratoxin alpha 
PTDI provisional tolerable daily intake 
Q1 / Q3 Quadrupole 1 / Quadrupole 3 
RP Reverse phase 
RSD Relative standard deviation 
SCF Scientific Committee on Food 
SD Standard deviation 
SGT Glutathione S-transferase 
S/N Signal-to-noise ratio 
SPE Solid phase extraction 
SRM Selected reaction monitoring mode 
STs Sulfotransferases 
UV  Ultraviolet 
TDI Tolerable daily intake 
WHO World health organization 
β -Gluc/ArylS β-Glucuronidase/Arylsulfatase 
ZEN Zearalenone 
1 
 
1. Introduction 
 
1.1 General information on mycotoxins  
Mycotoxins are toxic secondary metabolites produced by filamentous fungi that grow under a 
wide range of climatic conditions on agricultural commodities in the field and during storage 
(CAST 2003; Zöllner and Mayer-Helm 2006). Their frequent occurrence in food and feed has 
raised concern, since ingestion of mycotoxins can cause disorders and severe diseases in 
animals and humans (Bennett & Klich 2003; Fung & Clark 2004; Marin et al. 2013; Richard 
2007; Rocha et al. 2014). Prominent examples of mycotoxins are aflatoxin B1, ochratoxin A, 
fumonisins, deoxynivalenol and zearalenone. Several studies have demonstrated their 
nephrotoxic, hepatotoxic, carcinogenic, teratogenic, immunotoxic and mutagenic 
characteristics in animal and human. An overview on toxic properties and mechanism of 
action of some major mycotoxins is given in Table 1.   
 
1.2 Estimation of human exposure to mycotoxins  
Human exposure to undesirable compounds, e.g. mycotoxins, can be estimated by two 
complementary approaches (Fig. 1): For the ‘Top-down approach’ an analysis of mycotoxin 
contaminants is conducted, usually for the most important (not all!) food commodities. Then 
data on frequency of detection and contaminant levels are combined with information on food 
consumption in the general population to estimate the intake. But, dietary intake for certain 
subgroups (vegetarians, children etc.) can differ. Thus, uncertainties remain whether all 
sources are covered, and the data do not allow to judge (extreme) exposures of individuals. 
The ‘Bottom-up approach’ is based on an analysis of parent compound and/or metabolites of 
the contaminant of interest in body fluids of individuals in a given cohort. The blood or urine 
levels of the analytes (or biomarkers) reflect exposure from all sources, but depend also on the 
kinetics of the mycotoxin, i.e. its fate in the organism (ADME). Thus, validation studies are 
important that have demonstrated a good correlation between the dietary mycotoxin intake 
and the concentration of a chosen biomarker of exposure.  
In short, biomonitoring i.e. analysis of mycotoxin biomarker in human body fluids provides 
the best approach as it covers mycotoxin intake from all dietary sources and exposure by 
various routes (Degen 2011). In developing countries like Bangladesh, where food 
contaminant data is scarce or unavailable, human biomonitoring is especially useful to 
investigate the human exposure to mycotoxins. 
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Table 1 Overview on mechanism of action and toxic properties of some major mycotoxins, frequently found as food and feed 
contaminants (modified table from Šegvić Klarić et al. 2012) 
  
Mycotoxins Fungal species Primary events at the cellular level Toxic properties 
Aflatoxin B1 A. flavus, 
A. parasiticus 
Metabolic activation → AFB1-8,9-epoxide 
→ modification of major cell 
macromolecules 
Hepatotoxic, immunosuppressive, 
carcinogenic (group 1, IARC), 
teratogenic, mutagenic 
Citrinin P. citrinum 
A. ochraceus 
M. purpureus 
 
Affects mitochondrial  permeability 
transition, calcium flux, and cytochrome c 
release from mitochondria, inhibits  
macromolecule biosynthesis → cell death 
Nephrotoxic, hepatotoxic, genotoxic 
(group 3, IARC), teratogenic, 
immunotoxic 
Deoxynivalenol F. culmorum, 
F. graminearum 
Inhibition of protein synthesis → cell death, 
disruption of cytokine regulation 
Causes nausea, food refusal, vomiting, 
diarrhoea, immunotoxic, IARC group 3 
Diacetoxyscirpenol 
and T2-toxin 
F. sporotrichioides 
F. poae 
F. graminearum 
Inhibition of protein synthesis → cell Death, 
T-2 → erythrocyte lysis, induction of lipid 
peroxidation, apoptosis,  inhibition of 
mitochondrial electron transport 
Alimentary toxic aleukia (inflammation of 
the skin, vomiting, damage to 
hematopoietic tissues, haemorrhagia), 
IARC group 3 
Fumonisin B1 F. proliferatum, 
F. verticillioides 
Inhibition of ceramide synthase → changes 
in sphingolipid metabolism, → protein 
kinase activity, oxidative stress → oxidative 
damage of cell macromoleculs 
Equine leukoencephalomalacia, porcine 
pulmonary oedema, hepatotoxic, 
nephrotoxic, immunosuppressive, 
carcinogenic (group 2B, IARC) 
Ochratoxin A A. ochraceus, 
P. verrucosum 
P. cyclopium 
Competition with phenylalanine and 
inhibition of Phe-dependent enzymes, 
inhibition of protein and DNA synthesis, 
mitochondrial transport system and transport 
of organic anions and cations, oxidative 
stress, DNA damage, affects glucose 
metabolism and Ca2+  homeostasis 
Nephrotoxic, neurotoxic, hepatotoxic, 
affects blood coagulation, immunotoxic 
carcinogenic (group 2B, IARC), 
teratogenic 
Zearalenone F. culmorum 
F. graminearum 
Resembles 17β-oestradiol → binds to 
oestrogen receptors in mammalian target 
cells 
Disruption of hormonal control, IARC 
group 3 
A: Aspergillus; F: Fusarium; M: Monuscus; P: Penicillium. 
  Frequency & Levels in various items 
 Food consumption  
 Food habits 
 Subgroups? 
EXPOSURE
Contaminant analysis in 
food commodities 
Top-Down  
 
 
 
 
  Inter/Intra-individual Levels!  
 Kinetics? 
 Validation? 
Analysis of ‘biomarkers’ in 
Body fluids (eg. blood, urine)  Bottom-Up 
 
Fig. 1 An illustration of two approaches used to estimate human exposure to undesirable 
compounds - such as mycotoxins. 
 
Human biomonitoring studies may require the sampling of blood for subsequent biomarker 
analysis. Analysis of blood plasma or serum provides useful data on internal circulating 
biomarker levels, but blood sampling is invasive and requires medical personal. Non-invasive 
sampling of body fluids (e.g. urine, breast milk or saliva) is easier to perform in field studies 
and often better accepted by the participants. Breast milk can be obtained only from nursing 
mothers, yet is of interest with respect to infant exposure to mycotoxins. Urine is the most 
widely chosen option for mycotoxin biomarker analysis as sampling is non-invasive and can 
be used for biomonitoring in all groups of the population. Suitable methods have become 
available to determine the presence of important mycotoxins and their metabolites in human 
biological fluids (Cano-Sancho et al. 2011; Turner 2012; Wild & Gong 2010).  
 
1.3 Background on mycotoxin occurrence in Bangladesh 
Bangladesh has a subtropical monsoon climate, characterized by seasonal variations in 
rainfall, temperature and humidity (http://en.wikipedia.org/wiki/Geography_of_Bangladesh). 
Three seasons are usually recognized: a hot, humid summer (32-40oC) from March to June; a 
humid rainy monsoon season (28-35oC) from Juli to October; and a warm, dry winter (15-
25oC) from November to February. Agriculture in Bangladesh is heavily dependent on the 
weather and crops are mainly produced in summer and in winter. Food stored in one season 
(e.g. summer) is largely consumed in the next season until new seasonal (e.g. winter) crops 
become available (Ali et al. 2015d). Humidity at harvest and in storage can favour the growth 
of a variety of mycotoxin producing moulds on agricultural products. 
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Various food commodities, including those consumed by the local population, such as rice 
and wheat as staple food, pulses, oilseeds, tuber and root crops, are susceptible to 
contamination by fungi and mycotoxins. Surveys in Bangladesh document the presence of 
aflatoxins, ochratoxin A, deoxynivalenol, fumonisin B1 and zearalenone in plant derived food 
(maize, cereals, groundnuts) and feed (Dawlatana et al. 2002; Dawlatana et al. 2008). In 
addition to these key commodities, also consumption of eggs, meat and milk can contribute to 
human mycotoxin exposure when livestock has been fed with contaminated materials. With 
regard to the latter, reports indicate variable mycotoxin contaminations of dairy feed and 
forages from Bangladesh (Phillips et al. 1996; Al-Mamun et al. 2002). This contamination can 
result in carry-over to animal products. A more recent investigation in Bangladesh reported 
the presence of AFB1 in some food commodities and in poultry feed, at levels above EU 
regulatory limits (Roy et al. 2013). Overall, this data inform on an occurrence of certain 
mycotoxins, but do not allow to conclude on the extent of human exposure (see section 1.2). 
 
1.4 Background on four major mycotoxins (AFB1, OTA, CIT and DON)  
1.4.1 Aflatoxin B1
1.4.1.1 Physiochemical properties of AFB1
Aflatoxin B1 (C17H1206, MW 312) is crystalline compound, soluble in moderately polar 
solvents such as methanol, chloroform, methanol and dimethylsulfoxide, and dissolve in 
water to the extent of 10-20 mg/litre. AFB1 fluoresce under UV radiation. The crystalline 
form of AFB1 is stable in absence of light and particularly UV radiation, even at temperature 
over 100oC. Chemically AFB1 is a highly substituted coumarin structure with a fused 
dihydrofurofuran moiety (Kensler et al. 2011). Aflatoxin M1 (C17H1207, MW 328), one of the 
hydroxylated metabolites of AFB1, is found in milk of mammals that ingested AFB1 and also 
excreted in urine. Chemical structures of AFB1 and its metabolites are depicted in Fig. 2 (p.5) 
 
1.4.1.2 Toxicity and kinetics of AFB1 
Toxicity: Aflatoxin B1 (AFB1) is the most prevalent aflatoxin and a potent liver carcinogen in 
various species, including humans (IARC group 1). AFB1 exerts serious toxic effects with a 
range of consequences: i) large doses lead to acute toxicity and death ii) chronic subletal 
doses induce tumors, and also impair growth and immunologic functions (EFSA 2007). Acute 
toxicity of AFB1 has been well demonstrated in experimental animals: The most susceptible 
species are rabbits, and ducks while chickens and rats have greater tolerance (EFSA 2007). 
AFM1 the metabolite of AFB1, has lower potency, but is also a genotoxic agent (FAO/WHO 
2001). The degree of AFB1 toxicity depends on age (young animals being more sensitive than 
adults), as well as sex and nutritional status.  
 
Kinetics: Absorption of AFB1 in the rat small intestine is a rapid process that follows first-
order kinetics, with an absorption rate constant [k(a)] of 5.84 ± 0.05 h-1 (EFSA 2007). 
Absorbed AFB1 reaches the liver through the portal system and is metabolised by cytochrome 
P450 (CYP)-dependent mono-oxygenases in reactions involving the incorporation of an atom 
of molecular oxygen into the substrate (EFSA 2007).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IA2 
IA2 and 
3A4 (3A5) 
3A4 
(3A5) IA2 
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Fig. 2 Aflatoxin B1 metabolism and biomarkers. Me, methyl; GST, glutathione S-transferase; SG, 
glutathione; MA, mercapturic acid; → epoxide-related toxicity pathways; ····>, non-epoxide-related 
toxicity pathways; - - -> excretion or blood routes (Turner et al. 2012). 
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The major CYP enzymes involved in human AFB1 metabolism in liver are CYP3A4, 3A5 and 
1A2 (Wild and Turner 2002), while the lipoxygenases and prostaglandin H synthase appear to 
be important in its biotransformation in lung (Dohnal et al. 2014). Generally, there is some 
diversity in the metabolism of AFB1 among different animal species (Wu et al. 2009). AFB1 
metabolism involves several pathways that are depicted in Fig. 2.  
The most critical reaction is bioactivation to (endo-, exo-) AFB1-8,9-epoxide, highly reactive 
metabolite which covalently binds to DNA and induces mutations or forms adducts with 
proteins. The GST-catalyzed conjugation of AFB1-8,9-epoxide is an important detoxication 
reaction (Degen and Neumann 1981; Hengstler et al. 1999). Other reactions are O-
dealkylation to AFP1, hydroxylation to AFM1 and AFQ1, or ketoreduction to AFL. Aflatoxin 
B1 metabolites can serve as biomarkers of human exposure to this mycotoxin: AFM1, AFQ1 
and AFP1 have been detected in human urines as well as AFB1-N7-guanine, the depurination 
product of the DNA adduct. Moreover, the AFB1-albumin adduct in blood or AFB1-lysin 
(Groopman et al. 2014; Kensler et al. 2011) are useful biomarkers of exposure (Fig. 2).  
 
1.4.1.3 Human exposure to AFB1
Humans are exposed to AFB1 by consumption of contaminated dietary staples, including 
maize and groundnuts. AFB1 contaminated commodities are a major problem in developing 
countries where hot and humid climate favours fungal growth and where food storage 
conditions are poor (Groopman et al. 2008; Williams et al. 2004; Wild and Turner 2002). 
Aflatoxin B1 the most prevalent aflatoxin, is a major cause of human disease in several parts 
of the world including, Asia and Sub-Saharan Africa (Williams et al. 2004; Wild and Gong 
2010; Kensler et al. 2011). The population in low-income countries often cannot afford to 
discard even visibly spoiled food or they use it as animal feed. Then, the transfer of AFB1 and 
its similarly toxic metabolite AFM1 into milk of lactating animals and in human breast milk 
will add to the risk of exposure for the youngest and most susceptible part of the population 
(Degen et al. 2013).  
Several epidemiological studies investigated urinary aflatoxin M1, aflatoxin-N7-guanine and 
serum aflatoxin-albumin/lysin adduct as biomarkers of AFB1 exposure in human populations 
with an increased risk of hepatocellular carcinoma (Wogan et al. 2012; Turner et al. 2012). 
More recent study showed dose-response relationships between early (pre- and postnatal) 
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aflatoxin exposure and growth retardation of infants in Gambia, Benin and Togo (Turner 
2013). In many biomonitoring studies, urinary AFM1 has also served as a biomarker of AFB1 
exposure in human population in different countries (see discussion section Table 12). 
 
1.4.2 Ochratoxin A 
1.4.2.1 Physiochemical properties of OTA 
Ochratoxin A (C20H18O6NCl, MW 403) is a weak organic acid (pKa 4.4 for the carboxylic 
acid group, and pKa 7.3 for the phenolic group). At acidic and neutral pH, OTA is soluble in 
polar organic solvents (acetone, methanol, chloroform), slightly soluble in water and insoluble 
in petroleum ethers and saturated hydrocarbons. OTA is soluble in aqueous sodium 
bicarbonate solution and other alkaline solutions. In acidic and alkaline solutions, OTA shows 
green and blue fluorescence, respectively. The absorption maxima in ethanol (95%) are 332 
nm and 212 nm; the extinction coefficient at 332 nm is 5500 M-1 cm-1 in methanol (Kuiper-
Goodman & Scott 1989). The metabolite OTα (C11H9CIO5, MW 256) is more polar than 
OTA; thus, it elutes earlier than OTA in reverse phase HPLC. Due to the dihydroiso-coumarin 
structure, OTα shows also fluorescence (highest at 450 nm). A pKa value for OTα is not 
available in the published literature; based on a structural similarity to 2-hydroxy-benzoic acid 
(with pKa 3.0) OTα is expected to have more acidic properties than OTA. The structure of 
OTA and its major metabolites are depicted in Fig. 3 (p.8). 
 
1.4.2.2 Toxicity and kinetics of OTA 
Toxicity: Kidney is the most susceptible target organ of OTA toxicity in all tested animals 
(Kuiper-Goodman and Scott 1989; Mally and Dekant 2009). Studies have demonstrated its 
carcinogenic (IARC group 2B), hepatotoxic, immunotoxic, and teratogenic effects in animals. 
OTA is considered as hazard for human health, and long-term human exposure to OTA may 
be involved in Balkan endemic nephropathy (Castegnaro et al. 2006). OTA inhibits protein 
synthesis indirectly, through impairing the activity of phosphophenolpyruvate carboxykinase 
(PEPCK). Studies in eukaryotic cell cultures and in vivo suggest that OTA competitively 
inhibits the Phe-tRNA synthase, which is the primary cause of OTA toxicity at cellular level 
(Creppy et al. 1979, 1980).  
 
Kinetics: In most animal species, OTA is passively absorbed from stomach and particularly, 
from the proximal jejunum (Ringot et al. 2006). The absorption of OTA varies among the 
species: 66% in pigs, 56% in rats and rabbits and 40% in chicken (Galtier et al. 1981). Once it 
reaches the bloodstream, OTA (as dianion form) is bound to serum albumin, which partly 
explains its long-half life in human body (Il’ichev et al. 2002). The half-life of OTA in human 
blood is about 35.5 days, in pigs 72-120 hours and in rats 55-120 hours (Studer-Rohr et al. 
2000; WHO 2001a). OTA in blood is distributed to different tissues (Kidney > liver > muscle 
> fat), and reabsorption, as a consequence of enterohepatic recirculation, plays an important 
role (Roth et al. 1988). In all species, both renal and faecal excretion play important role in 
plasma clearance of OTA (WHO 2001a). In kidney, OTA is mainly eliminated through 
tubular filtration in kidney, and faecal excretion is mainly due to biliary excretion (Ringot et 
al. 2006). In mammals including humans, OTA is also excreted through breast milk, and this 
is of importance because the milk is consumed by the young (Degen et al. 2013).   
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Fig. 3 Proposed metabolic pathways of ochratoxin A in animals and humans (adapted from Wu et al. 
2011)  
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In mammalian species, OTA metabolism comprises phase I and phase II reactions (Fig. 3). 
Hydrolysis is the major metabolic pathway whereby a much less toxic compound OTα is 
produced by the cleavage of the peptide bond in OTA.  Ochratoxin A hydrolysis to OTα is 
mediated by gastrointestinal tract enzymes (e.g. carboxypeptidase A, trypsin) and intestinal 
microflora (Madhyastha et al. 1992). A small fraction of absorbed OTA is converted, mainly 
in the liver, into 4(R/S)-hydroxy-OTA and 10-hydroxy-OTA by P450 enzymes; their toxicity 
is lower than that of OTA (Ringot et al. 2006). Bioactivation of OTA catalysed by 
cytochrome P450, prostaglandin synthase and lipooxygenase has been proposed to play a role 
(Pfohl-Leszkowicz and Manderville 2007), however, data supporting this view are scarce or 
lacking (Degen et al. 2007; Mally and Dekant 2009). Published information about phase II 
metabolism of OTA is limited: Glucuronide conjugates have been detected in bile of pigs and 
mice exposed to OTA (Roth et al. 1988, Kühn et al. 1995), whilst no conjugates were found in 
vitro with human and rat hepatocytes (Gross-Steinmeyer et al. 2002). Published information 
on formation of OTA conjugates in humans is contradictory: Pena et al. (2006) report indirect 
evidence for OTA glucuronide in human urines, but this was not confirmed in another study 
(Vatinno et al. 2007). More recent findings in urines of highly OTA exposed infants indicate 
that OTA glucuronidation can occur (Muñoz 2012). It is worth noting that the major human 
metabolite OTα is largely excreted in urine as conjugate (Coronel et al. 2011; Muñoz et al. 
2010; Klapec et al. 2012)  
 
1.4.2.3 Human exposure to OTA 
Human are exposed through consumption of OTA contaminated foodstuffs of plant and 
animal origin, including cereals, pulses, raisins, spices, coffee, cacao, beer, wine, meat, meat 
products, or edible offal (EFSA 2006; Ostry et al. 2013). Along with OTA also citrinin, 
another nephrotoxic mycotoxin, has been found in various foods and in animal feed and their 
co-occurrence has raised concerns on possible risks for human and animal health (Peraica et 
al. 2008). Several biomonitoring studies have been conducted to investigate human exposure 
to OTA (reviewed by Scott et al. 2005; Märtlbauer et al. 2009; Duarte et al. 2011), and 
indicate worldwide occurrence of this mycotoxin contaminant. The occurrence and levels of 
OTA in biological matrices (serum/plasma and urine) of various human populations has been 
summarized in the discussion section (see Fig. 11 and Table 13) along with new data from the 
studies in Bangladeshi cohorts and a German cohort. 
 1.4.3 Citrinin 
1.4.3.1 Physiochemical properties of CIT 
Citrinin (C13H14O5; MW 250) in solution shows fluorescence under UV light and absorption 
peaks at 250 nm and 333 nm (in methanol). CIT forms lemon-yellow crystals, melting point at 
172oC (Xu et al. 2006). CIT is sparingly soluble in water but soluble in sodium carbonate or 
sodium acetate, diluted sodium hydroxide, in acetonitril, methanol, ethanol and other polar 
organic solvents (Deshpande 2002). Solutions of CIT should be protected from light and high 
temperatures to avoid degradation. 
 
 
 
Metabolism  
 
 
 Citrinin Dihydrocitrinone
 
Fig. 4 Structures of citrinin and its metabolite dihydrocitrinone 
 
 
1.4.3.2 Toxicity and kinetics of CIT 
Toxicity: In animal studies, CIT has similar toxic properties as OTA, with kidney being also 
the primary target organ of CIT toxicity (Frank 1992). In animal studies, high doses of CIT 
can exert genotoxic, teratogenic, tumorigenic and immunotoxic effects (Frank 1992; EFSA 
2012). The mycotoxin OTA is carcinogenic to rodents and has been classified as group 2B 
human carcinogen, whereas CIT is in group 3 due to limited evidence for carcinogenicity in 
experimental animals (IARC 1986, 1993).  
 
Kinetics: Information on CIT kinetics is limited. In animal studies, after i.v. administration of 
3 mg/kg body weight in rats, CIT was found in liver (15%) and kidney (6%); about 74% of 
the ingested dose was excreted in 24 h urine (Phillips et al. 1979). CIT was detected in serum 
after oral application to rats (Frank 1992), and there is new evidence that CIT binds to serum 
albumin (Poór et al. 2015). Dihydrocitrinone (HO-CIT) was first identified as minor 
metabolite of CIT in urines of rats (Dunn et al. 1983). In a recent study with a human 
volunteer who ingested a small CIT dose (45 ng/kg b.w.) about 12% of CIT was excreted in 
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24h urine as parent compound, but 24% as metabolite HO-CIT (Ali et al. 2015f). This 
observation is of interest since formation of the metabolite HO-CIT is considered as 
detoxication reaction (Föllmann et al. 2014). It is presently unknown which enzymes catalyze 
this reaction, and the ability to convert CIT to HO-CIT may vary among individuals. Thus, 
the sum of both analytes (‘total CIT’) should be considered as biomarker of exposure in 
human biomonitoring studies. 
 
1.4.3.3 Human exposure to CIT 
Human are exposed to CIT through mycotoxin contaminated food. Since CIT has been 
detected along with OTA in food and feed, their co-occurrence has raised concerns with 
regards to possible combined adverse effects on health of humans and animals (EFSA 2006; 
EFSA 2012; Ostry et al. 2013). CIT was suspected to be involved together with OTA in 
Balkan endemic nephropathy (Castegnaro et al. 2006; Peraica et al. 2008; Pfohl-Leszkowicz 
2009). In contrast to OTA, only few biomonitoring studies have been carried out to assess 
CIT exposure in human populations. This is partly due to the fact that first sensitive methods 
for CIT biomarker analysis have been established only recently (Blaszkewicz et al. 2013). 
Data on CIT biomarker analyses in human urines are summarized in discussion  (Table 14).  
 
1.4.4 Deoxynivalenol 
1.4.4.1 Physiochemical properties of DON 
Chemically DON (C15H20O6; MW 296.3 g/mol) is a type B trichothecene. DON crystallizes as 
colourless needles, has a high temperature tolerance (stable at 120ºC, moderately stable at 
180ºC) and is soluble in water and in some polar solvents, including aqueous methanol, 
acetonitril, and ethyl acetate (EFSA 2004). The structure of DON and its metabolite DOM-1 
are depicted in Fig. 5 (p. 12). 
 
1.4.4.2 Toxicity and kinetics of DON 
Toxicity: Consumption of DON contaminated feed has been associated with a number of 
adverse effects in animals, including feed refusal, vomiting (thus the synonym ‘vomitoxin’, 
diarrhea, dizziness and fever, (Rotter et al. 1996). Chronic exposure to DON can lead to 
growth faltering, immunological and neurological dysfunction (Pestka and Smolinski 2005). 
Susceptibility of animals to DON can be ranked as follows: swine > mice > rats > poultry ≈ 
ruminants (Pestka and Smolinski 2005). The acute effects of DON in humans are similar to 
those seen in animals and chronic dietary DON exposure in animals’ causes altered nutritional 
efficiency (EFSA 2013), whilst long term effects in humans were not established so far. 
Toxicity of DON involves inhibition of protein synthesis, and it activates a signaling pathway 
known as ribotoxic stress response in cells and induces apoptosis (Pestka and Smolinski 
2005). Moreover, effects include altered neuroendocrine signaling, impaired gut integrity and 
immune function (Pestka 2010).  
 
Kinetics: DON is rapidly absorbed and oral bioavailability is estimated to reach 55 % in pigs 
(Rotter et al. 1996). Organ distribution was measured in pigs only following a single 
intravenous injection of DON (1 mg/kg b.w.) and revealed high initial concentrations in 
plasma, kidney and liver (EFSA 2004). The plasma elimination half-life of DON was found to 
vary between 1.2 and 3.9 hours in pigs from various studies (EFSA 2004).  
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 DON-15-β-D-O-glucuronide 
 
Fig. 5 Structure of DON, its metabolite DOM-1 and glucuronide isomers (modified from Warth et al. 
2012) 
 
DOM-1 is the primary metabolite (phase I metabolism) of DON found in urine and feces of 
DON exposed animals (Pestka and Smolinski 2005). DON is conjugated with glucuronic acid 
(phase II metabolism) in liver and its metabolites (DON-3ß-Glu and DON-15ß-Glu) can be 
found in human urine (Fig. 5). After DON intake about 68-72 % of these DON biomarkers 
(aglycone and conjugates) are excreted in urine within a day (Warth et al. 2013, Turner et al. 
2010b). DOM-1 is also excreted as glucuronide, but only at rather low levels in human urine.   
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1.4.4.3 Human exposure to DON 
DON is the most frequently detected mycotoxin contaminant of maize, wheat and barley in 
temperate regions of the world (WHO 2001b; EFSA 2013). Human are exposed to DON 
through consumption of various contaminated food commodities. DON biomarker occurrence 
and levels have been analyzed in urines from the general population of some Asian, European, 
African and American countries (see discussion section Table 15).  
 
1.5 Scope and aims of this work  
To protect consumers, developed countries have established regulations and limit values for 
the most important mycotoxins in food and feed in order to minimize dietary exposure. 
However, in developing countries like Bangladesh there is no regular surveillance for 
contaminants, although there is now awareness of this deficit (Islam & Hoque 2013). Data 
available from small surveys indicate the presence of some mycotoxins in certain crops and in 
animal feed in Bangladesh (Dawlatana et al. 2002; Dawlatana et al. 2008; Roy et al. 2013), 
but are insufficient to assess mycotoxin exposure in the population. As biomonitoring 
(analysis of parent compounds and/or metabolites in human samples) covers intake from all 
dietary sources, this approach was used to investigate mycotoxin exposure in inhabitants of 
Bangladesh and compare it with the situation in Germany and other countries. 
My thesis project on biomonitoring was designed and conducted with specific aims. These 
aims were accomplished by a stepwise strategy: An initial determination of analyte patterns 
(‘screening’) in urines by means of an LC-MS/MS based multi-mycotoxin method for 
biomarkers of exposure served to select four major mycotoxins of interest, namely aflatoxin 
B1 (hepatocarcinogen), ochratoxin A and citrinin (nephrotoxins), and deoxynivalenol 
(emetogen, immunotoxic). Then an in-depth analysis by more sensitive tailored methods was 
conducted for AFM1 (metabolite of AFB1), OTA and metabolite OTα, CIT and metabolite 
HO-CIT, and DON and its metabolites, to determine the concentration ranges in samples 
(urines) collected from Bangladeshi cohorts and in those from a German cohort.  
Another aim of this study was to gain insight into the variability of mycotoxin exposure 
among the Bangladeshi population. Therefore, urines were collected from cohorts in two 
districts of the country, and residents of rural and urban areas with presumably some 
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differences in food habits. Moreover, Bangladesh has a subtropical monsoon climate, 
characterized by clear seasonal variations in rainfall, temperature and humidity, conditions 
which favour the growth of certain fungal species on crops and stored food commodities. 
Thus, urines were collected from two cohorts in summer and winter season for mycotoxin 
biomarker analysis. Finally, biomarker-based estimates of mycotoxin exposure ranges in 
Bangladeshi and German cohorts were compared in a broader context with data reported for 
other populations of the world and also discussed with regard to possible risks associated with 
an exposure to the mycotoxins examined. 
 
2. Materials and methods 
2.1 Standards, chemicals and reagents 
Chloroform, Methanol (HPLC grade), isopropanol, acetic acid (96%), sodium hydrogen 
carbonate (NaHCO3) and phosphoric acid (85%) were purchased from Merck (Darmstadt, 
Germany). Acetonitrile and methanol (LC-MS grade) were from Promochem (Wesel, 
Germany). OTA (purity >98%) was obtained from Sigma–Aldrich (Taufkirchen, Germany), 
and OTα standard (purity 98.9%) from Biopure (Tulln, Austria). CIT standard material (purity 
>98%) was purchased from Sigma-Aldrich (Taufkirchen, Germany). The CIT metabolite 
dihydrocitrinone HO-CIT (purity 98.9%) was from AnalytiCon Discovery GmbH (Potsdam, 
Germany). AFB1, AFB2, AFG1, AFG2 and AFM1 standard solution was from Sigma-Aldrich 
Chemie (Taufkirchen, Germany). The β-glucuronidase/arylsulfatase (β-Gluc/ArylS) enzyme 
from Helix pomatia was purchased from Roche (Mannheim, Germany). The aflatoxin M1 
ELISA kits were purchased from Helica Biosystems Inc., Santa Ana, CA 92704, USA. IAC 
columns i.e. AflaTest® WBSR, AflaM1 HPLC, CitriTest® and DON Test WB HPLC were 
purchased from Ruttmann, Hamburg, Germany.  
  
 
2.2 Study populations and sampling areas  
Bangladesh: In total 164 adult urines were collected (n = 69 in summer May 2013, n = 95 in 
winter February 2014) from residents of a rural (Mongol Para, Puthia) and an urban area 
(Rajshahi University region) of Rajshahi district in Bangladesh, among which there were 62 
participants enrolled in both sampling periods (Ali et al. 2015b). In between February to 
March 2014 (winter) urine samples were also collected from pregnant women (n = 54) of a 
rural and a suburban area of Savar region in the Dhaka district of Bangladesh (Ali et al. 
2015e). In June 2013, blood samples (n = 64) were collected from healthy bachelor students 
at Gonoshasthaya Samaj Vittik Medical College and Hospital, Savar, Dhaka-1344, 
Bangladesh (Ali et al. 2014). The sampling sites are indicated in Fig. 6. All the participants 
were informed about the study and a written consent was obtained from them prior to 
inclusion in the study. The participants were of good health and they were asked to fill a short 
questionnaire for anthropometric information (age, gender, height, and weight), occupation 
and daily, weekly and normal food habits. Foods consumed by the study subjects two days 
prior of sample collection were also recorded in the questionnaire. 
 
  
Urban area (Rajshahi 
university region)  
Urines were collected from 
adults in both areas (summer: 
May 2013; winter: Feb 2014) 
 
Urines were collected from 
pregnant women in rural and 
suburban area, Savar, Dhaka 
(winter: Feb-Mar 2014) 
Blood plasma from students of 
Gonoshasthaya Samaj Vittik 
Medical College, Savar, Dhaka 
(June 2013) 
 
 
 
 
Rural area  
(Puthia, Rajshahi)  
 
 
 
 
 
 
Fig. 6 Map of Bangladesh and selected sampling sites in Rajshahi and Dhaka district.  
Source: https://www.google.de/search?q=map+of+bangladesh 
 
 
Approximately 50 mL first morning urine samples were collected into a non-sterile disposable 
container and blood samples (5-7 ml) were from each individual by venipuncture into EDTA 
containing tubes. The collected samples were first stored at -20oC at Rajshahi University and 
sent on dry ice to IfADo, Dortmund for subsequent biomarkers analysis. Urinary creatinine 
was determined by a modified Jaffe method (Blaszkewicz and Liesenhoff 2012) to control the 
differences of urine dilution between individual spot urines. This study was approved by the 
Institute of Biological Sciences of Rajshahi University, Rajshahi-6205, Ethics Committee of 
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Gonoshasthaya Samaj Vittik Medical College, Dhaka-1344, Bangladesh and by the 
Institutional Internal Review Board of IfADo, Dortmund, Germany. 
 
Germany: In 2013 (July-August) IfADo employees (n = 50) who participated gave their 
written consent before inclusion in the study. First morning urine samples were collected into 
a non-sterile disposable container (approximately 80 mL) and immediately stored at -20oC 
until biomarkers analysis. All the volunteers were asked to fill a short questionnaire for their 
baseline anthropometric information (age, gender, height, weight and occupation). 
 
2.3 Demographic information of the study populations 
Bangladesh: Among the rural and urban adult cohorts in Rajshahi district, the number of male 
and female participants were equal. The mean age of our volunteers was 39 ± 11 years (range 
22–60 years) with no significant difference in gender or regions. The average body mass 
index (BMI) of the urban cohort was significantly higher (23.8 ± 3.2 kg/m2) than that of the 
rural (21.4 ± 2.6 kg/m2) cohort (Ali et al. 2015b). The mean age of the pregnant women 
cohort in Dhaka district was 25 ± 5 years ranging from 18 to 36 years with no significant 
difference between rural and suburban residents. The average BMI for all subjects was 20.1 ± 
3.0 kg/m2. Volunteers of the rural cohort had significantly higher BMI (21.2 ± 2.3 kg/m2) than 
those in the sub-urban (18.6 ± 3.2 kg/m2) cohort (Ali et al. 2015e). For student cohort in 
Dhaka, the mean age was 20.2 ± 0.8 years and mean BMI was 22.0 ± 3.3 kg/m2 (Ali et al. 
2014). All the participants consumed typical Bangladeshi food. Details on baseline 
characteristics of all cohorts are given in above publications.  
 
Germany: Among 50 volunteers, 54% were female, and 46% were male participants. The 
mean age of all participants was 38.5 years, with no significant difference between females 
and males. The average BMI for all subjects was 25.2 ± 3.8 kg/m2. The participants consumed 
typical mixed German food. They are all employees at IfADo (scientists, technicians, office 
workers, etc.) residing in Dortmund or nearby urban settlements. Details on basic 
anthropometric characteristics of this cohort are given in Ali et al. 2015c. 
 
2.4 Biomarker analysis 
An LC-MS/MS based multi-mycotoxin method suited to detect 23 analytes was applied for an 
initial determination of patterns of biomarkers in urines collected from cohorts living in three 
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different continents (Gerding et al. 2015). Based on occurrence of certain mycotoxin 
biomarkers, i.e. AFM1, OTA, CIT and DON metabolites in urines from a Bangladeshi and/or 
a German cohort, then ‘tailored’ methods were used to determine biomarker occurrence and 
concentration ranges in all study cohorts from Bangladesh and a German ‘reference’ cohort. 
Analysis by ‘tailored’ methods involves sample clean-up to enrich urinary analytes and in 
some cases also enzymatic hydrolysis of glucuronide/sulfate metabolites. It is thus more 
labor-intensive than the ‘dilute-and-shoot’ approach applied for the initial screening, but also 
more sensitive thereby resulting in higher frequencies of ‘positive detects’ which facilitates 
subsequent statistical analysis, e.g. for group comparisons. 
 
2.4.1 Aflatoxin M1
2.4.1.1 AFM1 determination by ELISA 
Aflatoxin M1 (AFM1) levels in urine were determined using enzyme-linked immunosorbent 
assay (ELISA) according to the procedure specified in the method protocol. In brief, both the 
AFM1 standards (provided in the kit) and the urine samples were diluted with distilled water 
(1:20 or 1:5); 100 µL of each were mixed with 200 µL assay buffer. Then 100 µL of this 
mixture was transferred to antibody coated microtiter well, and the plate incubated at RT for 1 
hour. An automated microplate washer (Tecan Hydro Flex, Salzburg, Austria) was then used 
for washing the plate with washing solution (supplied with the kit). AFM1 conjugate (100 µL) 
was added to each well and incubated at RT for 15 min; then the plate was washed again with 
washing solution to remove the unbound conjugate.  Substrate reagent (100 µL) was added to 
each well and the colour reaction was allowed to proceed in the dark for 15 min at RT. Then 
stop solution (100 µL) was added to the wells to terminate the enzyme reaction, and within 15 
min the absorbance was measured at 450 nm by a microplate reader (Tecan Genios®, 
Salzburg, Austria). The absorption intensity is inversely proportional to AFM1 concentration 
in the samples. The AFM1 level in the samples was calculated from concurrent standard 
curves using AFM1 standard solution for each plate. All urine samples were analyzed in 
duplicate at two different dilutions (1:5 and 1:20) and average values were calculated. For 
method validation, blank urines (from Germany) were spiked with different concentrations 
(20 to 60 pg/mL) of AFM1 standard; the recovery rate was in the range of 85 to 115%, and the 
method detection limit (MDL) was determined to be 30 pg/mL. More details have been 
described in Ali et al. 2015a. 
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2.4.1.2 AFM1 determination by HPLC-FD  
Sample preparation: Immunoaffinity column (AflaTest® WBSR and AflaM1 HPLC: Vicam® 
from Ruttmann, Hamburg, Germany) were used for urine clean-up and enrichment of the 
analyte. In brief, urine samples were thawed and centrifuged at 3500 g for 10 min at 20oC. 
Then 10 mL of urine was adjusted with 1 N hydrochloric acid or 1 M sodium hydroxide to pH 
between 5.5 to 7.0, followed by a centrifugation step as described above. The sample was then 
loaded on AflaTest® WBSR or AflaM1 HPLC at a flow rate of 1 drop/s. Columns were washed 
twice with 10 mL distilled H2O, then AFM1 was eluted (flow rate 1 drop/s) with 2 mL of 
methanol. The eluate was evaporated to dryness under a stream of nitrogen at 45oC, and the 
residue was dissolved in 500 µL of acetonitrile/water (25:75), vortexed and centrifuged at 
12000 rpm for 3 min prior to HPLC-FD analysis. Thus the enrichment factor was 20.  
 
HPLC–FD analysis: AFM1 analyses were carried out with a HPLC Shimadzu system 
consisting of two LC-10AS pumps, RF-10Axl fluorescence detector, SIL-10AD Vp auto 
injector, CBM-20A communication module, and Shimadzu LC solution software. A 
Microsorb-MV 100 C18 column (150mm×4.6mm, 5 µm; R0086200D5, Agilent Technologies, 
76337 Waldbronn, Germany) fitted with a C18 metaguard column (10x4.6 mm, Microsorb 
A104MG) was used for separation of the analytes at a column temperature of 25°C.  
Chromatographic separation was obtained by an isocratic system with a mobile phase of 25% 
acetonitrile and 75% water. The flow rate was 1 mL/min and the injection volume was 80 µL. 
The fluorescence detector was set at 360 nm excitation and 440 nm emission wavelengths. 
The retention time for AFM1 was 7.9. 
 
Validation of parameters: The calibration curve with pure standards in mobile phase showed 
linearity in the range of 50-5000 pg/mL for the analyte with coefficient of determination (R2) 
of 0.9998. Analysis of AFM1 spiked urine yielded similar data for linearity in the range of 
LOD–1000 pg/mL. The limit of detection (LOD) and limit of quantification (LOQ) were 
determined based on the lowest quantity of analyte that can be clearly distinguished from the 
background (LOD; S/N = 3) or quantified (LOQ; S/N ≥ 10). For AFM1, the LOD was 1.7 
pg/mL and LOQ was 5 pg/mL. Recovery assays were performed in urine with no measurable 
background of AFM1. Recovery of analyte was assessed at three concentration levels in 
spiked samples (n = 4) with mean value of 90% for AflaTest® WBSR and 88% for AflaM1 
HPLC columns (Table 2). The intra-day and inter-day repeatability at a spike concentration of 
50 pg/mL (n = 10) were determined using also the mycotoxin-free urine, and showed 
acceptable precisions for the measurements (Table 3). Chromatograms of spiked urine with 
AFM1 standard and a natural AFM1 contaminated urine sample are presented in Fig. 7. 
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Fig. 7 HPLC chromatograms of (A) a blank urine (B) a urine spiked urine with AFM1 
standard at 50 pg/mL (C) a naturally AFM1-contaminated urine sample (56 pg/mL) from rural 
male volunteer. 
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Table 2 Recovery of AFM1 using two types of IAC columns in human urine 
 
Table 3 Intra-day and inter-day assay repeatability for AFM1 in urine using two types of 
IAC column 
AflaTest(R) WBSR AflaM1 HPLC Spike level (pg/mL) 
 
 
Mean ± SD 
(pg/mL) 
Recovery  
(%) 
RSD  
(%) 
Mean ± SD 
(pg/mL) 
Recovery  
(%) 
RSD  
(%) 
Intra-day (50) 
n = 10 
0.46 ± 0.02 92 4.3 0.43 ± 0.03 86 6.9 
Inter-day (50) 
n = 10 
0.44 ± 0.03 88 6.8 0.45 ± 0.02 90 4.4 
Spike level (pg/mL) AflaTest(R) WBSR  AflaM1 HPLC  
 Recovery (%) RSD (%) Recovery (%) RSD (%) 
10 (n = 4) 92 4.2 88 6.2 
20 (n = 4) 88 5.2 86 4.8 
100 (n = 4) 90 3.4 90 4.2 
 
 
2.4.2 Ochratoxin A 
OTA and its metabolite OTα were measured by a validated method (Muñoz et al. 2010) which 
involves liquid–liquid extraction (LLE). Briefly, 3 mL urine or 0.5 mL plasma sample was 
enzymatically treated by adding 250 µL or 100 µL hydrolysis buffer (pH 5.0) and 40 µL and 
10 µL of β-Gluc/ArylS and incubation at 37oC overnight, respectively. Then, the hydrolyzed 
urine or plasma sample was mixed with 3 mL of 1% NaHCO3, and pH was adjusted to 2.8-3.0 
with 1M H3PO4. Then 3 mL or 2 mL chloroform/isopropanol (97:3) mixture was added to 
hydrolyzed urine and plasma samples respectively, and kept on a rotary mixer for 20 min, 
followed by centrifugation at 4500 rpm for 20 min at 20oC. The aqueous upper layer was 
discarded and 2 mL (for urine) or 1 mL (for plasma) of the organic layer was transferred with 
a pipette to a vial and evaporated to dryness under a stream of nitrogen at 45oC. The residue 
was dissolved in 500 µL or 250 µL of methanol/water (1:1) respectively. The vial was 
vortexed, centrifuged and the extract was filtered through a 0.45 µm pore size Teflon syringe 
filter (WICOM, Germany) before HPLC-FD analysis. Then analysis of OTA and its 
metabolite OTα was carried out by high performance liquid chromatography with 
fluorescence detection (Ali et al. 2014; Ali et al. 2015b). 
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2.4.3 Citrinin 
Urinary citrinin and its metabolite dihydrocitrinon (HO-CIT) were measured after 
immunoaffinity column (IAC) cleanup for enrichment of analytes according to Blaszkewicz et 
al. (2013): Five mL of urine was diluted with 5 mL of 1 mM acetic acid in water and mixed 
for 15 min on a rotary shaker. The sample was then loaded on a CitriTest® column at a flow 
rate of 1 drop/s. The column was washed twice with 5 mL distilled water, then CIT and its 
metabolite HO-CIT were eluted (flow rate 1 drop/s) using 4 mL of methanol. The eluate was 
evaporated to dryness under a stream of nitrogen at 40oC, and the residue was dissolved in 
500 µL methanols, vortexed and filtered through a 0.45 µm pore size Teflon syringe filter 
(WICOM GmbH, Germany). The urine extract was then measured by a validated LC/MS-MS 
method as described elsewhere in more detail (Blaszkewicz et al. 2013; Ali et al. 2015b,c). 
 
2.4.4 Deoxynivalenol  
Urine samples were hydrolyzed as described above (section 2.4.2) to convert glucuronides of 
DON and DOM-1 to their aglycone form. Then clean-up and enrichment of analytes was 
performed by immunoaffinity column (IAC) extraction with DONTest™ (Ali et al. 2015e). 
Briefly, the column was rinsed with 1 mL of water and then the entire hydrolyzed urine 
sample was loaded on a DON Test™ column at a flow rate of 1 drop/sec. The column was 
washed with 5 mL distilled water, then DON was eluted (flow rate 1 drop/sec) from the 
column using 2 mL of methanol. The elute was evaporated to dryness under a stream of 
nitrogen at 45oC; the residue was dissolved in 500 µL water/methanol (90:10), vortexed and 
filtered through a 0.45 µm pore size Teflon syringe filter. Thus, the enrichment factor was 6. 
Then, DON and its metabolite DOM-1 were measured in urine extracts by a validated 
LC/MS-MS method as described elsewhere in more detail (Ali et al. 2015e). 
 
 
2.4.5 Food consumption data 
All Bangladeshi participants were asked to fill out a food frequency questionnaire (FFQ) (see 
Appendix) to record their daily, weekly and normal food habits and two days of food 
consumption prior to urine sample collection. The FFQ asked for intake of typical food 
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consumed by Bangladeshi people: staple food, mainly cereals such as rice, wheat, maize, and 
lentils as the major pulse. Chicken meat, eggs, milk and milk-based products were also 
included, as well as coffee and beverages. Among all foodstuffs only rice is regularly 
consumed by the participants one to three times in a day. Beer and wine, items of relevance 
for OTA intake in Europe (EC/SCOOP 2002), are usually not consumed in Bangladesh and 
coffee is generally consumed only by a few urban people. Assessment of food consumption 
was done using the score 1–4 (1 = do not consume at all, 2 = 1 time daily, 3 = 2 times daily 
and 4 = 3 times daily).  
 
2.4.6 Statistical analysis 
All the data was analyzed using the software IBM SPSS Statistics version 22. Descriptive 
analysis was used to determine mean, median and interquartile ranges of the analytes. 
Differences of the analytes’ concentrations between the male-female cohorts, regions and 
seasons were analyzed by independent sample t-test. Spearman correlation coefficient (two-
tailed) was used to assess the correlation of analytes with food consumption, age, gender and 
body mass index (BMI). One-way ANOVA was used to compare analyte concentrations in 
the rice consumption groups. Box plots were used to describe analyte concentration by region 
and season. A level of alpha 0.05 was assigned for statistical significance. More details on 
statistical analysis have been described in my publications (Ali et al. 2014, Ali et al. 
2015a,b,c). 
 
3. Results 
3. 1 Aflatoxin M1 as biomarker of AFB1 exposure 
3.1.1 Comparison of ELISA and HPLC-FD in AFM1 analysis 
The collected urines have been analyzed by both, an ELISA assay (MDL 30 pg/mL) and an 
HPLC-FD (LOD 1.7 pg/mL; LOQ 5.0 pg/mL) method. An initial analysis of 95 samples by 
ELISA indicated the frequent detection (46%) of AFM1 in urines (range LOD–348 pg/mL) 
from rural and urban residents in Bangladesh (Ali et al. 2015a). When subsequently analysed 
by HPLC-FD, the detection frequency for AFM1 was similar (42%), although the mean and 
maximal concentrations (Table 4) were somewhat lower in all urines than those found by 
ELISA. Notably, there were several urines in which AFM1 was not detectable by ELISA, but 
detected by HPLC-FD analysis or vice versa. A good correlation (p<0.01) was found between 
the two methods when a number of urines (n = 62) were analyzed by both methods (Fig. 8). 
Apparently, our ELISA analysis overestimates the AFM1 biomarker concentration; this can be 
due to cross reactivity with other aflatoxins present and/or possible matrix effects. 
 
 
 
 
 
 
 
 
 
 
 
 
r = 0.57 
p < 0.01 
Fig. 8 Comparison of ELISA and HPLC measurements of urinary AFM1 concentration. Spearman 
correlation coefficient (two-tailed) was used to assess the correlation between the two measurements.  
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ELISA is the most widely used screening method for measuring AFM1 (as biomarker for 
human AFB1 exposure). But, we consider HPLC-FD analysis more reliable as this method 
consists of a sample clean-up by IAC to enrich the analyte and provides better (more precise) 
quantification. Therefore, here only the more reliable HPLC-FD data are presented and in 
results and discussion section. 
 
3.1.2 Bangladesh 
Rural and urban adult cohort (Rajshahi): AFM1 was detected in 40% of all urine samples at a 
range of 1.7–104 pg/mL in summer and 42% of samples at a range of 1.8–190 pg/mL in 
winter season (Table 4). The mean level of urinary AFM1 was higher in winter (27.7 ± 42.6 
pg/mL) than in summer (13.5 ± 21.2 pg/mL) season, and a significant difference (p<0.05) was 
observed at the mean AFM1 level between the rural (40.4 ± 48.3 pg/mL) and the urban (3.6 ± 
1.2 pg/mL) cohort (Table 4 and Fig. 9).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 9 Urinary level of AFM1 in the rural and urban cohorts of Rajshahi district in summer and winter 
season. Only positive samples (≥ LOD) were considered for box plot preparation. ap<0.05 when 
compared to urban cohort in winter season, p-value obtained from independent sample t-test.  
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     Cohorts Gender n Summer Winter
   
Positive 
n (%) 
Mean ± SD 
(pg/mL) 
Median (range) 
(pg/mL) 
Mean ± SD 
(pg/mg crea) 
Positive 
n (%) 
Mean ± SD 
(pg/mL) 
Median (range) 
(pg/mL) 
Mean ± SD 
(pg/mg crea) 
Rural Men 15 5 (33) 2.6 ± 0.9 2.6 (1.7–4.0) 9.3 ± 5.0 10 (67) 46.3 ±  60.2 19.5 (1.9–189.9) 49.4 ± 44.6 
 Women 15 2 (13) 6.6 ± 4.5 6.6 (3.4–9.8) 42.7 ± 38.6 7 (47) 32.0 ± 25.8 28.2 (3.1–70.8) 45.1 ± 38.1 
 All 30 7 (23) 3.7 ± 2.8 2.9 (1.7–9.8) 18.8 ± 23.0 17 (57) 40.4 ± 48.3a 21.4 (1.9–189.9) 47.6 ± 40.8b
          
          
 
Urban  Men 16 9 (56) 26.1 ± 32.0 11.4 (2.9–104.0) 41.2 ± 28.6 2 (12) 4.5 ± 1.3 4.5 (3.6–5.4) 6.6 ± 0.7 
 Women 16 9 (56) 8.4 ± 5.6 7.2 (2.0–19.4) 31.9 ± 21.6 7 (44) 3.4 ± 1.1 3.4 (1.8–5.4) 5.2 ± 2.5 
 All 32 18 (56) 17.2 ± 24.1 10.6 (2.0–104.0) 36.5 ± 25.0 9 (28) 3.6 ± 1.2 3.6 (1.8–5.4) 5.5 ± 2.3 
 
Men 31 14 (45) 17.7 ± 27.7 7.9 (1.7–104.0) 29.8 ± 27.6 12 (39) 39.4 ± 56.8 13.5 (1.9–189.9) 42.2 ± 43.6 Both- 
cohorts Women 31 11 (35) 8.1 ± 5.2 7.2 (2.0–19.4) 33.9 ± 23.2 14 (45) 17.7 ± 23.0 4.5 (1.8–70.8) 25.2 ± 33.2 
 All 62 25 (40) 13.5 ± 21.2 7.2 (1.7–104.0) 31.6 ± 25.4 26 (42) 27.7 ± 42.6 8.0 (1.8–189.9) 33.1 ± 38.5 
Positive sample refer to urines containing the analyte ≥ limit of detection (LOD: 1.7 pg/mL). Only positive samples were considered during calculation of mean 
and median values. ap<0.05,  bp<0.05 when compared to urban cohort in winter season, p- value obtained from independent sample t-test. 
Table 4 Urinary levels of AFM1 in rural and urban adult cohorts in Rajshahi district of Bangladesh  
 
 
 
 
 
 
 
 
 
Urinary AFM1 levels did not show significant associations with consumption of certain types 
of food by the participants (Table 5). When the major food item rice was categorized into 
three groups and compared by one-way ANOVA, the higher mean AFM1 biomarker levels 
were observed in the high rice consumption group only in winter season (Table 6). 
 
Table 5 Correlation between urinary AFM1 levels and last two days of food consumption 
Food items Summer  Winter  
 Correlation (r) p-value Correlation (r) p-value 
Rice  0.051 0.808 0.341 0.088 
Wheat/maize 0.338 0.090 0.056 0.635 
Lentil -0.245 0.239 -0.128 0.389 
Milk and Milk products -0.198 0.344 -0.123 0.549 
Chicken meat 0.201 0.336 -0.153 0.454 
Groundnut 0.082 0.697 -0.114 0.325 
Food consumption assessment was done using the score 1 – 4 (1 = do not consume at all, 2 = 1 time 
daily, 3 = 2 times daily and 4 = 3 times daily. Positive samples (≥LOD) were considered for 
correlation analysis.  P-value obtained from Spearman’s correlation coefficient (two-tailed). 
 
 
 
 
Table 6 Urinary AFM1 biomarker levels (pg/mL) and last two days of rice consumption  
 
Group  Summer   Winter   
 n Mean ± SD Range n Mean ± SD Range 
Low 3 10.1 ± 6.1 1.7–16.2 2 3.6 ± 1.8 1.7–5.40 
Medium  12 15.1 ± 24.4 1.8–104.0 11 23.4 ± 16.4 1.8–51.8 
High 10 12.6 ± 8.7 1.7–28.3 13 34.8 ± 56.6 1.9–189.9 
 
Low = 1 time/day, Medium = 2 times/day and High = 3 times/day rice consumption. Positive samples 
(≥ LOD) were considered for calculation. One way ANOVA used for analysis of biomarker level 
among the groups. 
 
Pregnant women cohort (Dhaka): AFM1 was detected in 31% of these urine samples, at a 
range of 1.7–141.5 pg/mL (Table 7). The mean level of urinary AFM1 was higher in the 
suburban (30.2 ± 54.7 pg/mL) than in the rural (13.9 ± 33.3 pg/mL) participants (Table 7 and 
Fig. 10) The mean AFM1 concentration (13.9 ± 33.3 pg/mL) was similar with the level found 
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in adult cohorts of Rajshahi district in summer season. Urinary AFM1 levels did not show 
significant associations with consumption of certain types of food by the participants. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 10. Urinary level of AFM1 in pregnant women from Dhaka district of Bangladesh. Only positive 
samples (≥ LOD) were considered for box plot preparation. 
 
 
Table 7 Urinary levels of AFM1 among pregnant women in Dhaka district of Bangladesh 
 Cohorts n Positive 
n (%) 
Mean ± SD 
pg/mL 
Median (range) 
pg/mL 
Mean ± SD 
pg/mg crea 
Rural 32 11 (34) 5.0 ± 5.1 3.4 (1.7–19.6) 6.6 ± 4.7 
Suburban 22 6 (27) 30.2 ± 54.7 9.3 (1.8–141.5) 70.4 ± 143.3 
Both cohorts 54 17 (31) 13.9 ± 33.3 4.8 (1.7–141.5) 29.1 ± 86.1 
 
 
 
Positive sample refer to urines containing the analyte ≥ limit of detection (LOD 1.7 pg/mL). Only positive 
samples were considered during calculation of mean and median values .  
 
 
3.1.3 Germany 
AFM1 was not detected in any of the urine samples from the German cohort. This was 
expected, since the food consumed by the German population is usually free from AFB1 
contamination.  
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3.2 Ochratoxin A biomarker analysis 
3.2.1 Bangladesh 
Student cohort (Dhaka): OTA and its metabolite OTα were detected in 64 (100%) and 61 
(95%) of all plasma samples collected from adult students of Gonoshasthaya Samaj Vittik 
Medical College and Hospital, Dhaka, Bangladesh (Ali et al. 2014). The average levels of 
OTA and OTα were 0.85 ± 1.05 ng/mL (range: 0.20–6.63 ng/mL) and 0.28 ± 0.15 ng/mL 
(range: LOD–0.79 ng/mL), respectively. A slightly higher OTA plasma level (0.92 ± 1.09 
ng/mL) was found in male than in female students (0.78 ± 1.02 ng/mL). Also OTα mean 
levels were higher in male (0.33 ± 0.16 ng/mL) than female (0.23 ± 0.13 ng/mL) students. 
Based on OTA plasma concentrations, the dietary OTA intake was calculated by means of the 
Klaassen equation (conversion factor 1.97). The mean daily dietary intake of OTA for the 
Bangladeshi students was 11.7 ng/kg bw per week (Ali et al. 2014) which was markedly 
lower than the tolerable intake value of 120 ng/kg bw/week proposed by EFSA (2006). 
 
Rural and urban adult cohort (Rajshahi): In summer OTA and OTα were in 71% and 53% in 
summer and in winter 98% and 62%, respectively (Ali et al. 2015b). No significant difference 
was found at the mean level of OTA between the rural and urban cohorts in summer. 
However, in rural cohort a significant difference (p<0.05) was found for the mean OTA level 
between the summer (0.05 ± 0.08 ng/mL) and winter (0.28 ± 0.52 ng/mL) season. The mean 
level of OTA for all participants (both cohorts) was significantly higher (p<0.01) in winter 
(0.19 ± 0.38 ng/mL) than summer (0.06 ± 0.10 ng/mL) season (Ali et al. 2015b). The 
metabolite OTα was present in summer urine at about 4-fold higher levels than OTA and 2-
fold lower than the parent compound in winter. The ratio of OTA to OTα in the male and 
female subgroups of both cohorts varied considerably. The rural cohort with higher urinary 
levels of parent compound OTA apparently excreted also more of the non-toxic metabolite.  
 
Pregnant women cohort (Dhaka): The OTA and OTα detection frequency were 91% and 41% 
in the rural and 95% and 45% in the suburban participants, respectively (Ali et al. 2016a). A 
significant difference (p<0.05) was found at the mean level of OTA between the rural (0.06 ± 
0.07 ng/mL) and suburban (0.15 ± 0.19 ng/mL) cohorts (Ali et al. 2016a), whilst the mean 
level of OTα was quite similar between the cohorts. The ratio of OTA to OTα in both cohorts 
varied between individuals.  
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3.2.2 Germany 
The OTA and OTα detection frequency were 100% and 78% in all urine samples, 
respectively. The mean level of OTA was slightly higher in male (0.24 ± 0.37) than female 
(0.18 ± 0.26) participants (Table 8). For OTα, a significant difference (p<0.05) was found 
between male (2.16 ± 3.60) and female (0.62 ± 0.97) volunteers (Table 8). The ratio of parent 
compound to it metabolite was quite variable between male female cohorts. In German adults, 
the urinary OTA concentration (mean 0.21, max 1.82 ng/mL) was similar to that found in the 
Bangladeshi adult cohorts in winter season.  
 
Table 8 Levels of OTA and its metabolite OTα in urines from German adults 
 
 
n 
 
Positive  
n (%) 
Mean ± SD 
(ng/mL) 
Median (range) 
(ng/mL) 
Mean ± SD 
(ng/mg creatinine) 
OTA          
Men 23 23 (100) 0.24 ± 0.37 0.14 (0.04–1.82) 0.15 ± 0.14 
Women 27 27 (100) 0.18 ± 0.26 0.11 (0.02–1.42) 0.18 ± 0.27 
All 50 50 (100) 0.21 ± 0.31 0.12 (0.02–1.82) 0.17 ± 0.22 
OTα       
Men 23 21 (91) 2.16 ± 3.60a 0.97 (nd–14.25) 1.18 ± 1.78 
Women 27 18 (67) 0.62 ± 0.97 0.16 (nd–3.65) 0.87 ± 2.10 
All 50 39 (78) 1.33 ± 2.63 0.21 (nd–14.25) 1.01 ± 1.94 
 
Positive sample refer to urines containing the analyte ≥ LOD; nd: level below LOD. For calculation of mean and 
median values, those samples that contained analyte concentration below LOD were assigned a value of one-half 
the detection limit. ap<0.05 when compared to women, p-value obtained from independent sample t-test.  
 
3.3 Citrinin biomarker analysis 
3.3.1 Bangladesh 
Rural and urban adult cohort (Rajshahi): The detection frequency for CIT and HO-CIT in 
summer samples was 95% and 71%, and in winter 92% and 97%, respectively (Ali et al 
2015b). A significant difference (p<0.05 and p<0.01) was found at the mean level of CIT and 
HO-CIT between the rural (0.14 ± 0.22 ng/mL, 0.78 ± 1.33 ng/mL) and the urban (0.06 ± 0.08 
ng/mL, 0.08 ± 0.08 ng/mL) cohort. In winter season, only the mean level of HO-CIT showed 
a significant difference (p<0.001) between the rural (5.95 ± 1.63 ng/mL) and the urban (0.60 
± 1.02 ng/mL) cohort. Regarding seasonal differences, in both cohorts a significant difference 
(p<0.05) was found for CIT and HO-CIT levels between summer and winter season (Ali et al 
2015b). The metabolite HO-CIT was present at about 5-fold higher levels than the parent 
compound in both seasons, indicative of HO-CIT as useful additional biomarker of citrinin 
 30  
exposure. The ratio of CIT to HO-CIT in the male and female subgroups of both cohorts 
varied considerably. Total citrinin (CIT + HO-CIT) varies by region, being significantly 
higher in the rural than in the urban cohort, and a significant difference between summer 
(mean 0.51, max 5.70 ng/mL) and winter (mean 3.77, max 48.12 ng/mL urine) also indicates 
a different exposure by season (Ali et al 2015b). A provisional daily intake for CIT was 
calculated, and exceeded a preliminary TDI value set by EFSA 2012 (0.2 µg/kg/d) in 10% 
and 24% of participants in summer and winter, respectively (Table 9).  
 
 
Table 9 Provisional daily intake (PDI) of citrinin (µg/kg b.w.) calculated from urine 
biomarker concentrations (see Methods section in Ali et al. 2015b)
 
Cohort and season n Mean ± SD 
µg/kg b.w 
Median 
µg/kg b.w 
Range 
µg/kg b.w 
Exceeding 
TDIc, n (%) 
Bangladesh         
Adults (Rajshahi)      
  Summer 62 0.043 ± 0.099 0.014 0.002–0.506 3 (10) 
  Winter 62 0.304 ± 0.776 0.043 0.002–4.663 15 (24) 
Pregnant women 
(Dhaka) 
54 0.102 ± 0.216a 0.041 0.004–1.088 3 (6) 
      
Germany, adults 50 0.023 ± 0.017b 0.020 0.010–0.100 0 (0) 
 
ap<0.05 when compared to adult cohort in winter season,  bp<0.001 when compared to adult cohort in winter 
season and pregnant women cohort . P-value obtained from independent sample t-test. 
cPreliminary TDI ‘no concern for nephrotoxicity in humans’ at 0.2 µg/kg b.w. per day (EFSA 2012). 
 
Pregnant women cohort (Dhaka): The detection frequencies for CIT and HO-CIT were 84% 
and 84% in the rural and 91% and 86% in the suburban participants, respectively (Ali et al. 
2016a, submitted). The mean levels of CIT and HO-CIT were about 2-fold higher in the rural 
(0.42 ± 1.20 ng/mL, 0.55 ± 1.04 ng/mL, respectively) than the suburban residents (0.15 ± 0.13 
ng/mL, 0.23 ± 0.18 ng/mL, respectively). The ratio of CIT to HO-CIT in both groups varied 
between individuals. By and large, the HO-CIT metabolite concentration was about 1.5-fold 
higher than that of the parent compound CIT in the Dhaka cohort (Ali et al. 2016a, 
submitted). The mean concentration of total CIT biomarker (mean 0.73, max 9.40 ng/mL) is 
similar to the level found in adult cohorts of Rajshahi district in summer season. The 
preliminary TDI value was exceeded in 6 % of these study participants which is lower than 
that observed in rural and urban adult cohorts of Rajshahi district in winter season (Table 9).  
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3.3.2 Germany 
CIT and its metabolite HO-CIT were detected in 82% and 84% of the urine samples (Ali et al. 
2015c). A significant difference (p<0.05) was found in the mean CIT urine concentration 
between the male (0.04 ± 0.02 ng/mL) and female (0.03±0.02) subgroup whereas no 
significant difference was observed for the metabolite HO-CIT or total CIT (Ali et al. 2015c). 
The level of HO-CIT was about 3-fold higher than that of the parent compound indicating that 
this metabolite is a useful (additional) biomarker of citrinin exposure in human biomonitoring 
studies. The mean urine concentration for total CIT (mean 0.14, max 0.58 ng/mL) in the 
German cohort was clearly lower than in any of the Bangladeshi cohorts. The provisional 
daily CIT intake among the German adults was much lower than in all Bangladeshi cohorts 
and no individual exceeded the preliminary TDI value set by EFSA 2012. 
 
3.4 Deoxynivalenol biomarker analysis 
 
3.4.1 Bangladesh 
Rural and urban adult cohorts (Rajshahi): DOM-1 was not detected in any of the urines whilst 
DON was detectable in 27% of urines collected in summer and in 31% of urines in winter 
season (Ali et al. 2016b; manuscript in preparation). There was no significant difference at the 
mean urinary level of DON (Table 10) between summer (0.17 ± 0.25 ng/mL) and winter (0.16 
± 0.18 ng/mL) season. A regional difference between the rural and urban residents was also 
not significant. The biomarker-based estimated daily DON intake was 6.3 ± 9.1 ng/kg bw in 
summer and 6.0 ± 6.1 ng/kg bw in winter season; the highest DON intake was 65.4 ng/kg bw 
(Table 11). All individuals had an estimated daily DON intake far below the tolerable daily 
intake (TDI) value of 1000 ng/kg bw/day (WHO 2001b). 
 
Pregnant women cohort (Dhaka): DOM-1 was not detected in any of the samples whilst DON 
was detectable in 52% of the urines, at concentrations ranging from 0.18 to 7.16 ng/mL (Ali et 
al. 2015e). The average urinary DON level (0.86 ± 1.57 ng/mL) in the Dhaka cohort was 
significantly higher (p<0.01) than that in the Rajshahi district cohorts (Table 10). Accordingly, 
also the provisional daily DON intake (mean 52.5 ± 94.4, maximum 461 ng/kg bw) was 
significantly higher (p<0.01) than that of our cohorts in Rajshahi district (Table 11). Yet, all 
of the pregnant women participants had an estimated daily DON intake clearly below the 
tolerable daily intake (TDI) of 1000 ng/kg bw/day (WHO 2001b). 
 3.4.2 Germany 
DON and its metabolite DOM-1 were detected in 100% and 40% of all urine samples, 
respectively (Ali et al. 2016b, manuscript in preparation). The mean level of urinary DON and 
DOM-1 was slightly higher in men (9.71 ± 7.82 ng/mL; 0.22 ± 0.20 ng/mL, respectively) than 
women (8.44 ± 5.97 ng/mL; 0.19 ± 0.22 ng/mL, respectively) participants, but this difference 
did not reach statistical significance. Overall, the mean level of urinary DON was 
significantly higher (p<0.0001) among German adults than the Bangladeshi adults (Table 10).  
 
Table 10 Occurrence of DON and DOM-1 in urines from Bangladesh and Germany 
(Excerpted from Table 1 and 2; Ali et al. 2016b, manuscript in preparation and Ali et al. 
2015e) 
 
Cohort and season n DON DOM-1 
 
 
 Positive 
n (%) 
Mean ± SD 
(ng/mL) 
Range 
(ng/mL) 
Positive 
n (%) 
Mean ± SD 
(ng/mL) 
Range 
(ng/mL) 
Bangladesh           
Adults (Rajshahi)*        
  Summer 62 17 (27) 0.17 ± 0.25 nd–1.78 0 nd nd 
  Winter 62 19 (31) 0.16 ± 0.18 nd–1.21 0 nd nd 
Pregnant women 
(Dhaka) 
54 28 (52) 0.86 ± 1.57a nd–7.16 0 nd nd 
        
Germany, adults 50 50 (100) 9.02 ± 6.84b 1.06–38.44 20 (40) 0.21 ± 0.21 nd–0.73 
 
*Rural and urban residents. Positive refer to urines containing the analyte ≥ LOD, nd: level below LOD.  
ap<0.01 when compared to the Rajshahi cohort and bp<0.0001 when compared to all cohorts in Bangladesh.  
 
 
 
Table 11 Provisional daily intake (PDI) of DON (ng/kg b.w.)* among the participants in 
Bangladesh and Germany (Excerpted from table 3 and 4; Ali et al. 2016b and Ali et al. 2015e) 
 
Cohort and season n Mean ± SD 
ng/kg b.w. 
Median 
ng/kg b.w. 
Range 
ng/kg b.w. 
Bangladesh        
Adults (Rajshahi)     
  Summer 62 6.3 ± 9.1 3.4  2.3–65.4 
  Winter 62 6.0 ± 6.1 3.5 2.3–39.8 
Pregnant women 
(Dhaka) 
54 52.5 ± 94.4a 11.2 3.1 – 460.8 
     
Germany, adults 50 267.6 ± 199.0b 211.5 36.0–975.0 
 
*Dietary DON intake was calculated based on urinary DON concentrations, adjusted for 24 h urine volume, 
assuming a 68% clearance rate and individual body weights (details in experimental section Ali et al. 2015e). 
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ap<0.01 when compared to adult cohorts of Rajshahi and bp<0.0001 when compared to all cohorts in 
Bangladesh.  
 
The biomarker-based estimated daily DON intake (267.6 ± 199.0; maximum 975 ng/kg bw) in 
the German cohort was significantly higher (p<0.0001) than in all cohorts from Bangladesh 
(Table 11). Nevertheless, no German individual had an estimated daily DON intake above the 
tolerable daily intake (TDI) of 1000 ng/kg bw/day (WHO 2001b). 
 
 
3.5 Correlation between food consumption pattern and urinary biomarker levels  
Based on FFQ information, possible correlations were analyzed between food consumption in 
the Bangladeshi cohorts and their urinary biomarker levels for AFM1, OTA, CIT and DON. 
Intake of certain Bangladeshi food items rice, wheat/maize, lentil soup, chicken meat, milk 
and milk based products and coffee did not show significant associations with the urinary 
biomarker levels. However, the higher mean level of AFM1, OTA and total CIT biomarker 
levels were observed in the more rice consumption group compared to medium and low rice 
consumption group (Table 6 and Ali et al. 2015b).  
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4. Discussion 
In Bangladesh, data on food contaminants are scarce, as there is no surveillance on the 
occurrence of mycotoxins in food commodities (Islam and Hoque 2013). In such a situation, 
the analysis of mycotoxin biomarkers in human samples (e.g. urines) is a valuable approach to 
gain more insights into human exposure to certain mycotoxins. Human biomonitoring is the 
best strategy to investigate exposure from all sources, either in the general population or in 
specific population groups (Cano-Sancho et al. 2010; Degen 2011; Turner et al. 2012). Our  
initial studies screened by ELISA for the presence of AFM1 in urines of Bangladeshi adults 
(Ali et al. 2015a) and an LC-MS/MS multibiomarker method revealed the frequent exposure 
to other mycotoxins (OTA, CIT and DON) in the Bangladeshi and German population 
(Gerding et al. 2015). Based on these findings sensitive tailored methods with enrichment of 
analytes were then used to quantify mycotoxin biomarker concentrations in urines collected 
from the Bangladeshi population and a German ‘reference’ cohort.   
This is the first systematic investigation on biomarkers for four major mycotoxins in rural, 
suburban and urban residents of two different districts (Rajshahi and Dhaka) in Bangladesh 
along with regional and seasonal variations and/or possible gender differences in exposure. 
Moreover, mycotoxin biomarker levels and ranges for the Bangladeshi population were 
compared with those determined in a German cohort. The new biomarker data are discussed 
here in a broader context, first with regard to some variables (gender, region and season) and 
possible sources of dietary mycotoxin intake among the Bangladeshi cohorts. Secondly, 
urinary biomarker levels are compared with published data from other parts of the world. 
Finally, biomarker-based estimates of exposure are discussed with regard to possible risks for 
humans, by comparing them to ‘tolerable intake values’ derived by competent authorities on 
the basis of toxicities for a given mycotoxin.  
 
4.1 Aflatoxin M1 as biomarker of AFB1 exposure 
Effects of variables (gender, region and season) on biomarker levels 
In rural and urban adult cohorts of Rajshahi district (North-West part of Bangladesh) male 
participants had often higher mean level of urinary AFM1 than female participants (Table 4). 
Yet, as biomarker levels varied considerably among the individuals, statistical data analysis 
did not show significant gender differences. In a regional comparison, the mean AFM1 levels 
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were higher in the urban than in the rural residents in summer season, but the reverse situation 
was observed in winter season (Fig. 9). There was no difference in detection frequency; yet, 
the mean AFM1 level of both cohorts was about two fold higher in winter (27.7 ± 42.6 pg/mL) 
than in summer (13.5 ± 21.2 pg/mL) season (Table 4).  AFM1 was also frequently detected in 
urines of pregnant women residents from a rural or suburban area in Dhaka district (Central 
part). Their mean concentration (13.9 ± 33.3 pg/mL, Table 7) is similar to the AFM1 levels 
observed in the Rajshahi cohorts in summer season. On the other hand, the suburban residents 
in Dhaka have AFM1 urine levels resembling those seen in Rajshahi cohorts in winter. Some 
variability in urinary AFM1 levels among the cohorts by region and season, may be related to 
differences in eating habits and/or the well known fact that aflatoxin contamination of crops 
can be quite heterogenous and vary with environmental conditions (Ali et al. 2015a).  
Overall, our biomarker data indicate a frequent exposure to AFB1 in the Bangladeshi 
population. A recent study with analysis of the AFB1-lysine adduct in human blood serum 
also showed rather high AFB1 exposure in the population of this country (Groopman et al. 
2014). Due to few data on aflatoxin food contamination (Roy et al. 2013), it is as yet unclear 
which food commodities are main contributors to mycotoxin exposure in Bangladesh. In 
Asian countries, likely sources of AFB1 intake are rice and spices for preparing curries and 
groundnuts, as discussed previously in more detail (Ali et al. 2015a).  
In contrast to the data from Bangladesh, AFM1 was not detected in any of the urines from the 
German cohort. This result is expected as food consumed by the German population is usually 
free from AFB1 contamination due to strict regulations for this carcinogenic mycotoxin and 
regular controls in food commodities.  
 
Comparison of AFM1 biomarker data with other countries 
In several studies of human populations on different continents, urinary AFM1 served as 
biomarker of exposure to AFB1. Although different methods for urinary AFM1 analysis were 
used with different limits of detection, the reported mean concentrations and ranges provide 
an orientation for aflatoxin exposure in Asian, African, European and South American 
populations. Details on the occurrence and levels of urinary AFM1 in different populations are 
summarized in Table 12. 
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  Country, cohort Positive 
n (%) 
Mean (range)  
pg/mL 
 
pg/mg creatinine 
Method LOD/LOQ
(pg/mL) 
Reference 
Asia       
Bangladesh, adults 
Summer 
Winter 
 
25/62 (40) 
26/62 (42) 
 
13.5 (1.7–104) 
27.7 (1.8–190) 
 
31.6 
33.1 
 
HPLC-FD 
 
1.7/5.0 
 
Ali et al. 2016 unpub. 
 
Bangladesh  
Pregnant women 
 
 17/54 (31) 
 
13.9 (1.7–142) 
 
29 
 
HPLC-FD 
 
1.7/5.0 
 
Ali et al. 2016 unpub. 
Bangladesh, adults 44/95 (46) 40 (31–348) 130 ELISA 30/NS Ali et al. 2015a 
China  
Pregnant women 
Adults male 
 
430/512 (64) 
14/ (16) 
 
51.5 (<LOD–4900) gm
50.3 (<LOD–3500) gm
 
na 
 
ELISA 
 
10/NS 
 
Lei et al. 2013 
 
China, adults 142/300 (47) 40 (10–330)  na HPLC-FD 5/NS Mykkänen et al. 2005 
China, adults 78/145 (54) 9.6 (LOD–243) na HPLC 3.6/NS Sun et al. 1999 
China, adults 18/49 (37) 
 
NS(170–5200) na HPLC 70 (all AFs) Qian et al. 1994 
China, adults 
 
NS NS (0–3200)   
   
  
      
na ELISA
HPLC 
10/NS 
NS/NS 
Zhu et al. 1987 
 
Malaysia, adults 22/22 (100) 42.1 (28.9–154.7)   na ELISA 24/NS Sabran et al. 2012a 
Malaysia, adults 98/160 (61) 
 
23.4 (<LOD–74.7)  
 
na ELISA 11/NS Sabran  et al. 2012b 
 Europe 
Czech Republic, adults 
(1997-1998) 
118/205 (58) 
 
Na   0.39 (0.02–19.22) 
 
ELISA 0.125 pg/mL Ostry et al. 2005 
Germany, adults 0/50 (0) nd nd HPLC-FD 1.7/5.0 Ali et al. 2016 unpub. 
Italy, adults and children 3/52 (6) 
 
68 (20–0.146) 
 
na LC-MS/MSb NS/20 Solfrizzo et al. 2014 
 Africa  
Egypt, pregnant women 44/93 (47) na 5.48 (4.12–7.28)gm
19.7 (14.8–26.3)gp
HPLC-FD 4/NS Piekkola et al 2012  
 
Egypt, children 
 
4/50 (8) 5.5 (5.0–6.2)  
2.7gm 
na HPLC-FD  5/NS Polychronaki et al. 2008 
 
Ghana, adults 83/91 (91) na 1800 (<LOD–11562) HPLC-FD 10/NS Jolly et al. 2006 
Guinea, children 
 
32/50 (64) 97 (8.0–801)  
16.3gm 
na HPLC-FD  5/NS Polychronaki et al. 2008 
 
Ivory Coast, adults 40/99 (40) na (nd–14.10) na LC-MS/MSb 0.06/NS Kouadio et al. 2014  
Nigeria, adults, adolescent 
and children 
17/120 (14) 300 (LOD–1500) na LC-MS/MSb
 
50/150 Ezekiel et al. 2014.  
America 
Brazil, adults 39/64 (61) na 1.2 (0.19–12.7) UPLC-MS 0.07/0.25 Jager et. 2014 
Brazil, adults 45/69 (65) 5.9 (LOD–39.9)  na HPLC-FD 0.6/1.8 Romero et al. 2010 
Haiti, adults and children 11/142 (8) 60 (<LOD–140) 60 LC-MS/MSb 2.5/10 Gerding et al. 2015 
 na: not available, nd: not detected, NS: not stated, gm:geometric mean, gp: geometric mean for positive samples, bmulti-biomarker approach
Table 12 Occurrence of AFM1 in urines from cohorts in different countries 
In Asia, AFM1 has been detected quite frequently in urines from China and Malaysia. The 
mean level and range of urinary AFM1 (mean 23 and 42 pg/mL, range 11–155 pg/mL) in two 
Malaysian cohorts (Sabran et al. 2012a,b) was close to the levels observed among the 
Bangladeshi cohorts (Table 12). In China, many studies have been conducted, often in regions 
with widespread dietary aflatoxin exposure. Early studies reported only the ranges but no 
mean values for urinary AFM1, namely Zhu et al. 1987 (LOD–3200 pg/mL) and Qian et al. 
1994 (170–5200 pg/mL). Clearly lower AFM1 levels were reported in two other studies, with 
a mean of 9.6 (LOD–243) pg/mL (Sun et al. 1999) or 40 (range 10–330) pg/mL (Mykkänen et 
al. 2005). Two more recent studies in China found again a wider range of urinary AFM1 
levels: Lei et al. (2013) reported a mean of 51.5 (range LOD–4900) pg/mL) in a male cohort 
and a mean of 50.3 (range LOD-3500) pg/mL in pregnant women in China. By and large, the 
average aflatoxin exposure in the Bangladeshi population appears to be of a similar magnitude 
as that found in studies in Malaysia (Sabran et al. 2012a,b) and some studies in China (Sun et 
al. 1999; Mykkänen et al. 2005), although maximal AFM1 biomarker levels in Bangladeshi 
adults were lower than in several Chinese cohorts. 
In Africa, the highest urinary AFM1 levels were found in Ghana in adults (mean 1800, range: 
LOD–11562 pg/mg creatinine; Jolly et al. 2006), and in Sierra Leone in children (ranges in 
two seasons of 100–124000 and 500-374000 pg/mL; Jonsyn-Ellis 2000). More recent data for 
children and adolescents in Nigeria (mean 300, range: LOD–1500 pg/mL; Ezekiel et al. 2014) 
and infant urines from Guinea (mean 97, range 8–801 pg/mL; Polychronaki et al. 2008) reveal 
that AFB1 exposure continues to be significant in several sub-Saharan African countries. 
In Europe, very low AFM1 levels (mean 0.39, range 0.02–19 pg/mg creatinine) were found in 
a large (n = 205) Czech cohort (Ostry et al. 2005). Urines from Germany (n = 101; n = 50) 
and Belgium (n = 32) had no measurable AFM1 levels (Gerding et al. 2014, 2015; Huybrechts 
et al. 2015), and only 3 of 52 urine samples (6%) in Southern Italy contained AFM1 (mean 68, 
range 20–146 pg/mL; Solfrizzo et al. 2014). In South America, two studies in Brazil reported 
AFM1 mean levels of 1.2 (range 0.25–6.9) pg/mg creatinine (Jager et al. 2014) and 5.9 (range 
1.8–39.9) pg/mL urine (Romero et al. 2010), i.e. comparative low biomarker levels.  
The AFM1 urine levels found in the Bangladeshi cohorts and the rather frequent detection 
clearly raise concerns regarding their exposure to potent carcinogenic aflatoxins. This is 
further discussed in sections 4.5 and 4.6.  
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4.2 Ochratoxin A biomarker 
Ochratoxin A has been analyzed in a) blood plasma from a student cohort (Dhaka) and b) in 
urines from adult cohorts (Rajshahi) and pregnant women cohort (Dhaka) in Bangladesh.  
a) Blood biomarker analysis 
The OTA level in plasma was higher in male than female students which may be due to often 
higher consumption of food in males. The mean plasma OTA concentrations in the Bangla-
deshi student cohort (0.85 ng/mL; Ali et al. 2014) is higher than values reported for adults in 
Pakistan (mean 0.3 ng/mL; Aslam et al. 2012) and for Japanese adults (mean 0.07 ng/mL; 
Ueno et al. 1998). The mean OTA concentration in Bangladeshi students only slightly 
exceeds what has been termed the “overall mean world OTA serum level” of 0.7 ng/mL for 
apparently healthy people (Fig. 11).  
 
 
 
 
 
 
 
 
 
 
 
Bangladesh, adults (n=64) 
Ali et al. 2014
Germany, adults (n=36) 
Märtlbauer et al. 2009
 
Fig. 11 Mean reported OTA serum levels (52 datasets) from healthy populations in different countries 
of the world (Märtlbauer et al. 2009) with new data from the Bangladeshi student cohort. 
 
 
Blood plasma/serum OTA levels can be converted by means of the Klaassen equation to 
dietary mycotoxin intake (see section 3.2.1). The dietary OTA intake estimates for the 
Bangladesh cohort (mean 1.67 ng/kg b.w. per day; Ali et al. 2014) are lower than the tolerable 
intake value of 17 ng/kg b.w. per day set by EFSA (2006). But a few subjects exceed the limit 
value of 4 ng/kg b.w./day proposed by Health Canada (Kuiper-Goodman et al. 2010).  
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b) Urine biomarker analysis 
Effects of variables (gender, region, season) on OTA levels 
In urines of the adult cohorts in Bangladesh and Germany, male participants often had slightly 
higher mean OTA concentrations than females, although the difference was no statistically 
significant. Also in other studies conducted in Europe, a gender difference was not observed 
(Duarte et al. 2009, 2010; Manique et al. 2008; Coronel et al. 2011).  
Among the Bangladeshi adults from Rajshahi district, the mean OTA urine level was higher 
in the rural than in the urban cohort in winter, whilst the level was similar in summer season 
(Ali et al. 2015b).  As region has apparently a lower impact than season, the mean urine OTA 
level for both cohorts in winter (0.19 ± 0.38 ng/mL) and summer (0.06 ± 0.10 ng/mL) season 
are presented in Table 10 (below) for a comparison with biomarker data from other countries.  
In pregnant women from Dhaka district, OTA mean urine concentrations were similar, in this 
case higher in the suburban (0.15 ± 0.19 ng/mL) than the rural (0.06 ± 0.07 ng/mL) cohort 
(Ali et al. 2016a, submitted). The variability in urine OTA levels observed among all 
Bangladeshi cohorts may be related to some differences in eating habits or seasonal changes 
in temperate and humidity suitable for growth of OTA producing fungi on stored crops (Ali et 
al. 2015b). Several Aspergillus and Penicillium species are known to produce OTA and/or the 
structurally related mycotoxin CIT under various environmental conditions (Frisvad et al. 
2006; Stoll et al. 2013; Schmidt-Heydt et al. 2015). In line with this, the biomarker results 
from my study indicate frequent co-occurrence of OTA and CIT in urines in both sampling 
seasons, and a significant correlation between OTA and total CIT in winter (Ali et al. 2015b). 
 
Comparison of OTA biomarker data with other countries 
The new OTA biomarker data for Bangladesh and German cohorts can be compared with data 
from several studies carried out in other countries on different continents. Although the 
studies applied various methods for biomarker analysis with different detection limits, the 
reported mean concentrations and ranges provide an orientation on the biomarker levels in 
these populations. The occurrences and levels of OTA in urines from different populations are 
summarized in Table 13. 
 
Table 13 Occurrence of OTA and its metabolite in urines from cohorts in different countries 
 
Country, cohort Positive  
 n (%) 
Mean ± SD (range)  
ng/mL 
 
ng/mg 
creatinine 
Method LOD/LOQ Reference 
(ng/mL) 
Asia       
Bangladesh, healthy adults       
      
    
 
 
      
Summer  
OTA 50/69 (72) 0.06 ± 0.10 (nd–0.55) 0.16 ± 0.20 LLE, HPLC-FD 0.01/0.02 Ali et al. 2015b 
OTα 36/69 (52) 
 
0.20 ± 0.77 (nd–6.10) 
 
0.50 ± 1.12 
 
 0.01/0.02  
Winter
OTA 94/95 (99) 0.17 ± 0.32 (nd–1.75) 0.22 ± 0.38     
OTα 56/95 (59) 0.16 ± 0.74 (nd–7.13) 0.16 ± 0.46    
Bangladesh, pregnant women        
OTA 50/54 (93) 0.10 ± 0.14 (nd–0.84) 0.16 ± 0.16 LLE, HPLC-FD 
 
0.01/0.02 Ali et al. 2016a, subm. 
  OTα 23/54 (43) 0.07 ± 0.14 (nd–0.76) 
 
0.14 ± 0.33 0.01/0.02
Thailand 1/60 (2)
 
  <LOQ
 
<LOQ LC-MS/MSb 0.05/0.17 
 
Warth et al. 2014 
 Europe  
Belgium 
Adults 84/239 (35) 0.03 ± na (0.003–0.37) 0.04 LC-MS/MSb 0.001/0.003 Heyndrickx et al. 2015 
Children 79/155 (51) 0.08 ± na (0.004–3.68) 0.08    
Belgium, adults 22/32 (69) 0.009 ± na (0.003–0.033) na LC-MS/MSb 0.001/0.003 Huybrechts et al. 2015  
Croatia, pregnant women       
OTA 23/40 (58) 0.13 ± 0.25 (nd–1.86) 0.17 ± 0.22 HPLC-FD 0.016/0.053 Klapec et al. 2012 
OTα 40/40 (100) 1.73 ± 1.65 (0.11–7.57) 2.14 ± 2.20  0.019/0.065  
Germany, healthy adults 
(Dortmund: 2013) 
OTA 
OTα 
  
 
50/50 (100) 
39/50 (78) 
 
 
0.21 ± 0.31 (0.02–1.82) 
1.33 ± 2.64 (nd-14.25) 
  
 
0.21 ± 0.42  
1.01 ± 1.94  
 
 
LLE, HPLC-FD 
 
 
 
0.01/0.02 
 
Ali et al.2016 unpub. 
Germany, healthy adults 
(Dortmund: 2013) 
15/50 (30) 0.04 ± 0.01 (<LOQ–0.08) 0.03 ± na LC-MS/MSb
 
0.01/0.075 Gerding et al. 2015 
Germany, healthy adults 
(Dortmund: 2008) 
OTA 
OTα 
 
 
13/13 (100) 
13/13 (100) 
 
 
0.07 ± 0.05 (0.02–0.29) 
2.88 ± 2.24 (0.49–7.12) 
  
  
na 
na 
 
 
LLE, HPLC-FD 
 
 
 
0.02/0.05 
 
 
Muñoz et al. 2010 
Hungary, healthy adults 54/88 (61) 0.013 ± na (0.006–0.065) na IAC, HPLC 0.004/0.006 Fazekas et al. 2005 
Italy, healthy adults 
(Puglia, southern Italy: 2011) 
52/52 (100) 0.144 ± 0.312 (LOQ–2.13) na IAC, UPLC-MS 0.006/NS Solfrizzo et al. 2014 
 
na: not available, nd : not detected, NS: not stated, bmulti-biomarker approach, LLE: Liquid-liquid extraction, IAC: Immunoaffinity column clean up 
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Table 13 continued. 
 
Country, cohort Positive  
 n (%) 
Mean ± SD (range)  
ng/mL 
 
ng/mg 
creatinine 
Method LOD/LOQ Reference 
(ng/mL) 
Portugal, healthy adults 
(Nationwide, 6 regions: 
2007,2008) 
Summer 
Winter 
 
 
77/95 (81) 
83/95 (87) 
 
 
0.016 ± 0.008 (nd–0.040) 
0.022 ± 0.015 (nd-0.071) 
 
 
na 
na 
 
 
IAC, HPLC-FD 
 
 
0.002 
 
 
Duarte et al. 2012 
Portugal, healthy individuals 
(Nationwide: 2007) 
143/155 (92) 0.022 ± na (nd–0.069) na IAC, LC-FD 0.008 Duarte et al. 2010 
Portugal, healthy individuals 
(Lisbon: 2007) 
31/43 (72) 0.026 ± 0.017 (nd–0.071) na  IAC, HPLC-FD 0.008 Duarte et al. 2009 
Portugal, healthy individuals 
(Coimbra: 2005, 2006) 
13/30 (43) 0.019 ± 0.041 (nd–0.208) Na  IAC, HPLC-FD na/0.007 Manique et al. 2008 
Portugal, healthy adults 
(Coimbra: 2004) 
42/60 (70) 0.038 ± na (0.021–0.105) na IAC, HPLC-FD 
 
na/0.02 Pena et al. 2006 
Spain, healthy individuals 
(Valencia: 2005) 
 25/31 (81) 0.032 ± 0.031 (nd–0.124) na IAC, HPLC-FD na/0.007 Manique et al. 2008 
Spain, healthy adults 
(Lleida: 2009) 
OTA 
OTα 
 
9/72 (12) 
43/71 (60) 
 
0.237 ± 0.181 (nd–0.562)  
0.441± 0.508 (nd–2.894) 
 
na 
 
LLE, HPLC-FD  
 
0.034/0.112 
0.023/0.076 
 
Coronel  et al. 2011 
Sweden, healthy adults 128/252 (51) 0.46 ± 0.57 (na)  0.73 ± 1.43  UPLC-MS na Wallin et al. 2015 
Turkey, healthy individuals 209/233 (90) na 14.34 ± na  HPLC-FD 
 
0.006/0.018 Akdemir et al. 2010  
 UK, healthy individuals 46/50 (92) 
 
0.013 ± na (nd–0.058) 
 
na IAC, HPLC-FD 
 
na Gilbert et al. 2001 
 Africa   
    
Ivory Coast, adults 37/99 (37) na (nd–0.42)  na LC-MS/MSb 0.01/NS Kouadio et al. 2014  
Nigeria, adults and children 34/120 (28) 0.2 ± 0.1 (nd–0.6) na LC-MS/MSb 0.05/0.15 Ezekiel et al. 2014 
Cameroon, infants 70/220 (32) 0.2 ± na (0.04–2.4) na LC-MS/MS 0.03/0.06 Ediage et al. 2013 
Sierra Leone, boys and girls 
Rainy season 
Dry season 
 
47/190 (25) 
63/244 (26) 
 
 
na (0.5–72) 
na (0.07–148)  
 
 
na 
 
HPLC-FD 
 
0.20/NS 
 
Jonsyn-Ellis 2000 
America 
Haiti, adults and children  47/142 (33) 0.11 ± 0.04 (<LOQ–0.22) 0.09 ± n.a LC-MS/MS  0.01/0.075 Gerding et al. 2015 
Chile, Infants 
Months  2 
Months 4 
Months 6 
 
18/22 (83) 
18/22 (83) 
22/22 (100) 
 
0.05 ± 0.04 (LOD–0.10) 
0.04 ± 0.02 (LOD–0.07) 
0.05 ± 0.01 (0.04–0.05) 
 
na 
na 
na  
 
LLE, HPLC-FD 
 
 
0.03/0.05 
 
Muñoz et al. 2014 
 
na: not available, nd : not detected, NS: not stated, bmulti-biomarker approach, LLE: Liquid-liquid extraction, IAC: Immunoaffinity column clean up. 
 42  
In Asia, there are no biomonitoring data for OTA to which the Bangladesh results can be 
compared to: A study in Thailand that applied multi-mycotoxin analysis (without enrichment 
of analytes) detected OTA only in 1 of 60 urine samples (Warth et al. 2014). Yet, it is of 
interest to compare OTA data for the Bangladeshi cohorts to those of some cohorts in Europe: 
The levels of urinary OTA in pregnant women (mean 0.10 ± 0.14, range nd–0.84 ng/mL) in 
Bangladesh are slightly lower than those found in pregnant women in Croatia (mean 0.13 ± 
0.25 ng/mL, range nd–1.86 ng/m; Klapec et al. 2012). The OTA urines levels found in 
German adults (mean 0.21 ± 0.31, range 0.02–1.82 ng/mL) resemble those of the Bangladeshi 
cohorts from Rajshahi district in winter season (Table 8).  
Within Europe, there are differences in OTA urine levels between countries which point to 
variable OTA exposures. For example, the OTA levels found in adults in Southern Italy 
(mean 0.144 ± 0.312, range LOQ–2.13 ng/mL; Solfrizzo et al. 2014), and in Spain (mean 
0.237 ± 0.181, range 0.057–0.562 ng/mL; Coronel et al. 2011) were both lower than urine 
OTA concentrations found in Swedish adults (mean 0.46 ± 0.57 ng/mL; Wallin et al. 2015). 
Relatively low OTA levels were found in urines of Belgian adult cohorts (mean 0.028, range 
0.002–0.368 ng/mL; Heyndrickx et al. 2015) and in the Portuguese population (mean 0.019 ± 
0.012, range nd–0.071; Duarte et al. 2012).  
In Africa, OTA was found in urines of Nigerian adults and children (mean 0.2 ± 0.1, range 
nd–0.6 ng/mL; Ezekiel et al. 2014), and in Cameroon infants (mean 0.2, range 0.04–2.4 
ng/mL; Ediage et al. 2013). The highest urinary OTA levels were previously reported in 
children in Sierra Leone in dry (range 0.07–148 ng/mL) and in rainy (range 0.6–72.2) season 
(Jonsyn-Ellis 2000). In America, OTA was detected in urines of children and adults in Haiti 
(mean 0.06, range <LOQ–0.83 ng/mL; Gerding et al. 2015) and in breastfed Chilean infants 
(mean 0.05–0.16, range LOD–0.43 ng/mL; Muñoz et al. 2014).  
Biomarker data compiled here (Table 13) and in a previous review (Duarte et al. 2011) 
indicate that OTA contamination of food is quite common on different continents, albeit 
mycotoxin intake can vary considerably. Since OTA excreted in urine reflects only a small 
fraction of an ingested dose, a conversion of urinary OTA levels to mycotoxin intake is highly 
uncertain (Degen 2015; and below section 4.5). 
 
In addition to OTA, the nontoxic metabolite OTα is also excreted in human urines, and often 
at considerably higher levels than the parent mycotoxin (Table 13). In my present study, the 
mean value of urinary OTα was clearly higher in German adults (1.33 ± 2.63 ng/mL) than in 
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the adult cohorts (summer 0.21 ± 0.81 ng/mL, winter 0.09 ± 0.15 ng/mL) or pregnant women 
(0.07 ± 0.14 ng/mL) in Bangladesh. High mean levels of urinary OTα were also reported in 
previous studies in German adults (2.88 ± 2.24 ng/mL; Muñoz et al. 2010), in Spanish adults 
(0.44 ± 0.51 ng/mL; Coronel et al. 2011) and in Croatian pregnant women (1.73 ± 1.65 
ng/mL; Klapec et al. 2012). At present, it is unclear whether the presence of higher OTα 
levels in urines from Europe is indicative of more efficient detoxication of OTA to OTα 
and/or related to dietary differences between the Bangladeshi and European population (who 
consume more milk products that can contain OTα).  Thus, further research is needed to 
elucidate the relation of ingested OTA and excreted OTA plus its main metabolite OTα in 
humans, and inter-individual differences in metabolism abilities should also be considered 
(Ali et al. 2015b). 
 
4.3 Citrinin biomarker 
Effects of variables (gender, region, season) on biomarker levels 
Male participants in Bangladesh and Germany often had higher mean levels of CIT in urines 
than females although this difference was not significant (Ali et al. 2015b; Ali et al. 2015c). 
Among the adult cohorts in Rajshahi district, urine levels of CIT and its metabolite HO-CIT 
were significantly higher in the rural than the urban cohort in summer season; for total CIT 
(sum of CIT and HO-CIT) a significant difference was observed between the rural and urban 
cohort in both seasons (Ali et al. 2015b). In pregnant women from Dhaka, CIT and HO-CIT 
levels were about 2-fold higher in the rural (0.42 ± 1.20 ng/mL; 0.55 ± 1.04 ng/mL, 
respectively) than the suburban (0.15 ± 0.13 ng/mL; 0.23 ± 0.18 ng/mL) residents (Ali et al. 
2016a, submitted). Moreover, in Rajshahi district the mean levels of CIT biomarkers in both 
cohorts were significantly higher in winter (CIT 0.59 ± 0.98 ng/mL; HO-CIT 3.18 ± 8.49 
ng/mL) than in summer (CIT 0.10 ± 0.17 ng/mL; HO-CIT 0.42 ± 0.98 ng/mL) season (Ali et 
al. 2015b).  
Regional variations observed in CIT biomarker levels may be related to differences in food 
habits and/or an additional occupational exposure in rural Bangladeshi cohorts who are active 
in grain farming (Ali et al. 2015b). The more pronounced difference in biomarker levels 
between summer and winter samples (of the same participants) may be related to seasonal 
changes in temperature/humidity suitable for growth of CIT producing fungi on crops and 
stored food (see above section 4.2).  
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Table 14 Occurrence of CIT and its metabolite in urines from cohorts in different countries 
 
Country, cohort Positive 
 n (%) 
Mean ± SD (range)  
ng/mL 
 
ng/mg creatinine 
Method LOD/LOQ Reference 
(ng/mL) 
Asia       
Bangladesh, adults       
      
    
  
      
  
Summer  
CIT 59/62 (95) 0.10 ± 0.17 (nd–1.22) 0.36 ± 0.60 LC-MS/MSa 0.02/0.05 Ali et al. 2015b 
HO-CIT 44/62 (71) 
 
0.42 ± 0.98 (nd–5.39) 
 
1.52 ± 4.4 
 
 0.05/0.10  
Winter
CIT 57/62 (92) 0.59 ± 0.98 (nd–5.03) 0.97 ± 1.76    
HO-CIT 60/62 (97) 3.18 ± 8.49 (nd–46.44) 3.94 ± 9.07    
Bangladesh, pregnant women       
CIT 47/54 (87) 0.31± 0.93 (nd–6.93) 0.51± 0.99 LC-MS/MSa 0.02/0.05 Ali et al. 2016a, subm. 
HO-CIT 46/54 (85) 
 
0.42 ±  0.82 (nd–5.53) 
 
0.65 ± 0.69 
 
 0.05/0.10 
 
 
Europe 
Belgium, adults 
CIT 140/239 (59) 0.06 ± na (0.002–1.40) 0.07 ± na  LC-MS/MSb 0.001/0.003 Heyndrickx et al. 2015 
HO-CIT 14/120 (12) 
 
0.75 ± na (0.14–2.12) 
 
0.74 ± na 
 
 0.01/0.03 
 
 
Belgium, children 
CIT 112/155 (72) 0.03 ± na (0.002–0.39) 0.04 ± na  LC-MS/MSb 0.001/0.003 Heyndrickx et al. 2015 
HO-CIT 7/124 (6) 0.55 ± na (0.26–0.89) 0.81 ± na  0.01/0.03  
Belgium, adults       
CIT 19/32 (59) 0.02 ± na (0.002–0.12) na  LC-MS/MSb 0.001/0.003 Huybrechts et al. 2015 
  HO-CIT 21/32 (66) 0.03 ± na (0.01–0.21) na   0.01/0.03
Germany, adults       
CIT 41/50 (82) 0.03 ± 0.02 (nd–0.07) 0.03 ± 0.03 LC-MS/MSa 0.02/0.05 Ali et al. 2015c 
HO-CIT 42/50 (84) 0.10 ± 0.10 (nd–0.51) 0.10 ± 0.11  0.05/0.10  
Germany, adults       
HO-CIT 14/50 (28) 
 
0.12 ± 0.02 (<LOQ–0.33) 
 
0.09 ± na 
 
LC-MS/MSb 0.02/0.05 
 
Gerding et al. 2015 
 America  
Haiti, Children and adults       
HO-CIT 20/142 (14) 0.49 ± 0.95 (LOQ–4.34) 0.28 ± na LC-MS/MSb 0.02/0.05 Gerding et al. 2015 
 
nd: not detected, na: not available, aImmunoaffinity column clean up and targeted method,  bmulti-biomarker method. 
 
Comparison of CIT biomarker data with other countries 
Compared to OTA, biomonitoring data for CIT is limited and comparatively few studies have 
been conducted so far (Table 14). All studies applied LC-MS/MS based methods for 
biomarker analysis: In my analyses of Bangladeshi and German urines (Ali et al. 2015b,c and 
2016a, submitted) IAC clean-up was used for analyte enrichment; studies by others used 
direct “dilute and shoot” multi-biomarker analyses. The occurrence and concentrations of CIT 
biomarkers in urines of different populations are listed in Table 14.  
CIT biomarker concentrations in urines from all Bangladeshi cohorts (adults and pregnant 
women) are clearly higher than those determined for German adults (CIT mean 0.03 ± 0.02, 
range nd–0.08 ng/mL and HO-CIT mean 0.10 ± 0.10, range nd–0.51 ng/mL; Ali et al. 2015c).  
Similar levels as in German urines have been reported for Belgian adult cohorts (CIT mean 
0.026, range 0.002–0.117 ng/mL and HO-CIT mean 0.035, range 0.013–0.210 ng/mL, 
Huybrechts et al. 2015; or CIT mean 0.057, range 0.002–1.398 ng/mL and HO-CIT mean 
0.752, range 0.143–2.117 ng/mL, Heyndrickx et al. 2015). Another study detected the 
metabolite HO-CIT in urines (mean 0.49 ± 0.95, range <LOQ–4.34 ng/mL) from Haitian 
children and adults and at higher levels than those found in Germany (Gerding et al. 2015).  
In all studies that determined both analytes, the metabolite HO-CIT was found to be present at 
clearly higher average levels than the parent compound CIT, although the ratios in individual 
urines were quite variable. This is of interest since formation of the metabolite HO-CIT is 
considered as detoxication reaction (Föllmann et al. 2014). It is presently unknown which 
enzymes catalyze this reaction, and the ability to convert CIT to HO-CIT may vary among 
individuals. Thus, it is indicated to measure CIT as well as its metabolite in biomonitoring 
studies, and consider the sum of both analytes as biomarker of exposure to this nephrotoxic 
mycotoxin (Ali et al. 2015b).  
 
4.4 Deoxynivalenol biomarker 
Effects of variables (gender, region, season) on biomarker levels 
DON urine concentrations were slightly higher in male participants of the Bangladeshi and 
German cohorts than in female which is probably due to lower food consumption in the latter. 
Some regional but no seasonal differences in biomarker levels were observed among the 
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Bangladeshi adult cohorts. In pregnant women from Dhaka, the DON urine level was higher 
(mean 0.86 ± 1.57, range nd–7.16 ng/mL; Ali et al. 2015e) than in the Raishahi cohorts 
sampled in summer (mean 0.17 ± 0.25, range nd–1.78 ng/mL) and winter (mean 0.16±0.18, 
range nd–1.21 ng/mL) season (Table 10). Despite some variation among the Bangladeshi 
cohorts, their DON urine levels were far lower than those determined in the German cohort 
(Table 10), or in other European populations (see below, Table 15).  
Geographical differences in exposure are likely due to environmental conditions (weather and 
climate in Asian countries like Bangladesh is different from Europe) that favour the 
contamination of crops in the field by DON-producing Fusarium species (Nielsen et al. 2011). 
Moreover, a small pilot study in the United Kingdom reported annual variations in DON 
biomarker levels in two years of different Fusarium prevalence (Gratz et al. 2014). 
 
Comparison of DON biomarker data with other countries 
Biomonitoring studies on DON occurrence have been conducted in several countries on 
different continents; the results are summarized in Table 15.  
In Asia, levels of DON in urines from Chinese adults reported by Meky et al. 2003 (high risk 
area: mean 37, range 4–94 ng/mL; low risk area: mean 12, range 4–18 ng/mL) and later on by 
Turner et al. 2011a (mean 4.8, range nd–29.9 ng/mL) are clearly higher than those determined 
in our study in the Bangladeshi population.  
In Europe, biomonitoring studies conducted in several countries indicate a variable, but 
frequent dietary DON exposure: This is reflected by DON urine levels reported for German 
adults (mean 3.38, range 2.48–17.34 ng/mL; Gerding et al. 2014), Belgian adults (mean 3.9, 
range 0.5–129.8 ng/mL; Heyndrickx et al. 2015), Spanish children and adults (mean 23.3 
ng/mg crea; Rodríguez-Carrasco et al. 2014), Swedish adults (mean 5.38 ng/mL; Wallin et al. 
2015), UK adults reported by Gratz et al. 2014 (Year 1: mean 7.1, range 0.3–27.5 ng/mL; 
Year 2: mean 13.5, range 0.3–28.6 ng/mL) and Turner et al. 2011b (mean 2.4, range 0.5–9.3 
ng/mL) and UK pregnant women (mean 10.3 ng/mg crea, range 0.5–116.7 ng/mL; Hepworth 
et al. 2012). With regard to the latter group, it is worth noting that the urinary DON 
concentration in pregnant women in Bangladesh is significantly lower (Ali et al. 2015e).   
Table 15 Occurrence of DON and its metabolite DOM-1 in urines from cohorts in different countries 
 
Country, cohort Positive 
 n (%) 
Mean ± SD (range)  
ng/mL 
 
ng/mg creatinine 
Method LOD/LOQ Reference 
(ng/mL) 
Asia       
Bangladesh, adults       
    
 
    
 
  
 
 
Summer  17/62 (27) 0.17 ± 0.25 (nd–1.78) 0.64 ± 0.68 LC-MS/MSa 0.16/0.30 Ali et al. 2016b pre. 
Winter 19/62 (31) 0.16 ± 0.18 (nd–1.21) 0.27 ± 0.27    
Bangladesh, pregnant women 
 
28/54 (52) 0.86 ± 1.57 (nd–7.16) 
 
2.14 ± 4.74 LC-MS/MSa 0.16/0.30 Ali et al. 2015e 
 China
High-risk area 11/11 (100) 37.0 ± na (4.0–94.0) na HPLC-MSa 4.0/NS Meky et al. 2003 
Low-risk area 4/4 (100) 12.0 ± na (4.0–18.0) na    
China, women 58/60 (97) 
 
4.8 ± na (nd–29.9) 
 
5.9 ± na 
 
LC-MS/MSa NS/0.5 Turner et al. 2011a 
 Europe  
Belgium, adults 89/239 (37) 3.9 ± na (0.5–129.8) 6.1 ± na  LC-MS/MSb 0.2/0.5 Heyndrickx et al. 2015 
Belgium, children 109/155 (70) 5.2 ± na (0.5–32.5) 5.5 ± na LC-MS/MSb 0.2/0.5 Heyndrickx et al. 2015 
Belgium, adults 23/32 (72) 0.44 ± na (nd–3.0) na   LC-MS/MSb 0.2/0.5 Huybrechts et al. 2015 
Croatia, pregnant women 31/40 (76) 18.3 ± na (nd–275) na LC-MS/MS 4/13 Šarkanj et al. 2013 
France, adults       
DON 75/76 (99) na (0.5–28.8) Na  LC-MS/MSa NS/0.5 Turner et al. 2010a 
  DOM-1 26/76 (34) na (0.02–2.8)  NS/0.06
Germany, adults (Dortmund)       
DON 50/50 (100) 9.02 ± 6.84 (1.06–38.44) 10.50 ± 16.46 LC-MS/MSa 0.16/0.30 Ali et al. 2016b pre. 
DOM-1 20/50 (40) 0.21 ± 0.21 (nd–0.73) 0.20 ± 0.23  0.10/0.20  
Germany, adults (Dortmund) 8/50 (16) 2.0 ± na (<LOQ–na) 2.0 ± na  LC-MS/MSb  0.4/4 Gerding et al. 2015 
Germany, adults (Dortmund)       
DON 30/30 (100) 7.15 ± 4.10 (0.85–14.63) 6.30 ± 3.12 LC-MS/MSa 0.15/0.30 
DOM-1 15/30 (50) 0.10 ± 0.06 (LOD–0.23) 0.09 ± 0.06  0.10/0.20 
Föllmann et al. 2015, in 
press 
Germany, adults (Munster) 30/101 (29) 3.38 ± na (2.48–17.34) 5.30 LC-MS/MSb 0.4/4 Gerding et al. 2014 
Italy, adults 50/52 (96) 
 
11.89 ± 10.05 (nd–67.36) 
 
Na  UPLC-MS/MSb NS/1.5 Solfrizzo et al. 2014 
 Spain, children and adults 
 
  
DON 37/54 (68) na 23.3 ± na  GC-MS/MSb 0.12/0.25 
DOM-1 2/54 (3.7) na 2.75 ± na   0.25/0.50 
Rodríguez-Carrasco et 
al. 2014 
Sweden, adults       
DON 158/252 (63)  5.38 ± 12.3 (na) 7.02 ± 24.4  LC-MS/MSb NS/1.5 Wallin et al. 2015 
DOM-1 20/252 (8)  2.32 ± 2.68 (na) 1.56 ± 1.26   NS/9.9  
UK, adults       
DON Year 1 15/15 (100) 7.1 ± 8.0 (0.3–27.5) 7.2 ± 6.0 LC-MS/MSa NS/0.1 Gratz et al. 2014 
DON Year 2 15/15 (100) 13.5 ± 12.0 (0.3–28.6)  19.7 ± 11.8    
 
nd: not detected, na: not available, NS: not stated,  aImmunoaffinity column clean up and targeted method,  bmulti-biomarker approach, gm geometric mean. 
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 Country, cohort Positive 
 n (%) 
Mean ± SD (range)  
ng/mL 
 
ng/mg creatinine 
Method LOD/LOQ Reference 
(ng/mL) 
UK, adults       
DON 23/34 (68) 2.4 ± na (0.5–9.3) 
 
na LC-MS/MSa NS/0.5 Turner et al. 2011b 
  DOM-1   
 
   
 
1/34 (3) na na  NS/0.06
UK, pregnant women 85/85 (100) 
 
0.5–116.7 
 
10.3 ± nagm LC-MS/MSa  Hepworth et al. 2012 
 Africa   
Egypt, pregnant women       
DON 63/93 (68) na 2.8 ± na (0.5–59.9) 
 
HPLC-MSa NS/0.5 Piekkola et al. 2012 
  DOM-1 2/93 (2) na na  NS/0.06
Ivory Coast, adults 21/99 (21) na (nd–10.0)  na LC-MS/MSb 0.8/NS Kouadio et al. 2014  
South Africa, women 7/53 (13) 14.0 ± na (na) 21.3±  na LC-MS/MSb 4/13 Shephard et al. 2013 
Cameroon, children 160/220 (73) 
 
2.22 ± na (na) 
 
na LC-MS/MSb 0.04/NS 
 
Ediage et al. 2013 
 America  
Haiti, adults and children 24/142 (17) 3.2 ± 2.0 (<LOQ–16.9) 3.6 ± na LC-MS/MSb 0.4/4.0 Gerding et al. 2015 
Table 15 Continued. 
 
nd: not detected, na: not available, NS: not stated,  aImmunoaffinity column clean up and targeted method,  bmulti-biomarker approach, gm geometric mean. 
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In Africa, fewer studies were conducted: Urinary DON concentrations have been reported for 
Egyptian pregnant women (mean 2.8, range 0.5–59.9 ng/mg crea; Piekkola et al. 2012), for 
South African women (mean 14 ng/mL; Shephard et al. 2013), for Cameroon children (mean 
2.2 ng/mL; Ediage et al. 2013) and Ivory Coast adults (up to 10 ng/mL; Kouadia et al. 2014). 
In America, DON has been detected also in urines from Haitian children and adults (mean 
3.2, range <LOQ–16.9 ng/mL; Gerding et al. 2015). By and large, the reported biomarker data 
are similar to DON levels found in Europeans. 
In our survey, DOM-1, the deepoxy metabolite of DON, was not detected in any urines from 
the Bangladeshi population. So far, human data on the occurrence of this detoxication product 
are limited (Table 15). DOM-1, was present at low levels in urines from German, Spanish, 
Swedish, UK adults, Egyptian pregnant women and French farmers, and only found in some 
(not all) individuals of a given cohort.   
 
4.5 Biomarker-based exposure estimates and tolerable intake values for mycotoxins 
Mycotoxin contamination of food commodities cannot be completely avoided, yet regulations 
(maximum residual levels) have been set in many countries to protect the consumer. Scientific 
advisory committees have also derived tolerable daily intake (TDI) values for certain 
mycotoxins (e.g. DON, OTA, CIT) based on toxicological risk assessments (WHO 2001ab; 
EFSA 2006, 2012). Maximum levels for total aflatoxin contamination permitted in human 
food in Europe are 4 to 15 ppb (ng/g) depending on the commodity (EC 2006). For mutagenic 
carcinogens like AFB1, and its metabolite AFM1, maximum levels are set at a level which is 
as low as reasonably achievable. This has to be distinguished from a TDI for other 
mycotoxins (with a defined NOAEL) for which ‘safe’ doses for humans can be derived.  
With regard to the question whether exposure in certain cohorts exceeds a given TDI, urine 
biomarker data may be used for estimating the probable daily intake, if enough information on 
kinetics and urinary excretion rates in humans is available. In general, mycotoxin intake 
estimates on the basis of urine biomarker concentrations involve some degree of uncertainty, 
as usually spot urines or first morning voids are analyzed rather than 24h urines.  
In the case of OTA, calculation of dietary intake is highly uncertain since only a very small 
fraction of OTA (about 2%) is excreted in urine per day in humans (Studer-Rohr et al. 2000), 
and data on temporal variability in humans and possible dose-related effects on renal OTA 
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excretion are scarce (Degen 2015). Therefore, a probable daily intake was not estimated based 
on the urinary OTA levels (Ali et al. 2015b). But, blood plasma or serum OTA concentrations 
can be converted to mycotoxin intake (exposure), and served here to assess the exposure in a 
student cohort in Bangladesh in relation to TDI values set for OTA (see section 4.2). 
Estimating exposure to CIT on the basis of urine data is possible, due to the rather high 
fraction of total CIT biomarker excretion (36%) in urine (Ali et al. 2015f). This excretion rate 
has been applied to calculate ‘provisional daily intakes’ for CIT of all Bangladeshi cohorts 
(Table 9, p.30). Their exposure was then compared to the TDI for CIT of 0.2 µg/kg bw (‘no 
concern for nephrotoxicity in human’) derived by EFSA (2012). This TDI for CIT was 
exceeded in 10% and 24% of the Rajshahi persons, in summer and winter, respectively, and in 
6% of pregnant women from Dhaka. In German adults, the estimated CIT intake was lower 
than in Bangladeshi adults and no single German participant exceeded the TDI value. 
A high fraction (about 70%) of ingested DON is excreted in human urine within a day (Turner 
et al 2010b; Warth et al. 2013). Urine biomarker data thus served to estimate daily DON 
intake in all cohorts of this study (Table 11, p.32): DON exposure was significantly higher 
among German adults (mean 0.27, max 0.98 µg/kg bw) than in all Bangladeshi residents 
(Rajshahi cohorts sampled in two seasons and the Dhaka pregnant women cohort). No 
individual exceeded the provisional maximum tolerable daily intake for DON of 1 µg/kg bw 
(WHO 2001b). This indicates that dietary DON exposure in the population of both countries 
is presently not of concern. On the other hand, when DON biomarker data compiled in Table 
15 for cohorts in other European countries are converted to dietary intake values, the TDI for 
DON would be exceeded in parts of these populations. 
 
4.6 Possible sources of dietary mycotoxin intake  
Since data on AFB1, OTA, CIT and DON contamination of food commodities in Bangladesh 
are scarce or totally unavailable, we made an attempt to correlate the individual biomarker 
levels in Bangladeshi cohorts with the consumption frequency for certain food categories. No 
significant association was observed between urinary biomarker levels and consumption of 
various foods prior to urine sampling. On the other hand, when consumption of the major 
food item rice was further categorized (as low, medium or high), the higher mean urine level 
for AFM1, OTA and CIT were often observed in the high rice consumption group (Table 6 
p.26; Ali et al. 2015b; Ali et al. 2016a, submitted; Ali et al 2016b, manuscript in preparation). 
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In Bangladesh rice is often consumed with curries prepared with several spices. Contaminated 
rice, but also spices may be sources of AFB1 intake in the Bangladeshi population considering 
occurrence data from other Asian countries. In this context, a recent analysis for aflatoxins in 
chilli samples from Sri Lanka is of interest, where 67% of the samples exceeded the EU 
regulatory limit (Yogendrarajah et al. 2014). Also a study on the presence AFB1 in pooled 
samples of 8 commonly consumed food commodities in Bangladesh reported that mean AFB1 
levels in 5 of 8 food commodities were above EU regulatory limits (Roy et al. 2013). The 
authors discussed limitations of their study (seasonal variations in contamination not captured, 
food types not analyzed). We fully agree that future efforts to analyse aflatoxin contamination 
in Bangladeshi foodstuffs are needed, in order to identify major sources and reduce their 
impact on aflatoxin exposure (Ali et al. 2015a).  
Regarding OTA and CIT, contaminated rice and spices are considered as sources of exposure 
in the Bangladeshi population (Ali et al. 2014; 2015b). This view is supported by data from 
other Asian countries where these mycotoxins have been detected in rice samples and spices 
(e.g. Nguyen et al. 2007; Lai et al. 2015; Majeeda et al. 2013; Yogendraja et al. 2014). Yet, 
other commodities, not yet analysed for CIT and/or OTA, may also contribute to exposure.  
DON is mainly a contaminant of wheat, maize or oat grains and derived products (EFSA 
2013). These commodities are consumed much more frequently in Europe than in Bangladesh, 
where rice is the main staple food. In line with this, my new data for DON biomarker analysis 
in German and Bangladeshi cohorts (Table 10, section 3.4.2) indicate clearly higher DON 
exposure in Germany. Moreover, the rather low DON urine levels in the Bangladeshi cohorts 
indicate that there are no other relevant dietary sources for DON.  
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5 Conclusions  
Results of this first biomarker-based assessment of mycotoxin exposure in the Bangladeshi 
population document a frequent intake of the carcinogenic contaminant aflatoxin B1 (AFB1) 
and also concomitant exposure to the nephrotoxic compounds ochratoxin A and citrinin (OTA 
and CIT). These findings raise concerns, primarily with regard to AFB1 exposure, since the 
biomarker (urinary AFM1) levels found in the Bangladeshi cohorts are significant, also in 
relation to biomarker data for other countries where this mycotoxin is already recognized as a 
problem for public health. In Bangladesh, surveillance of aflatoxin contamination in foods is 
clearly needed, first to identify major sources of exposure and then to reduce their impact.  
The levels for biomarkers of exposure to CIT and OTA in Bangladeshi cohorts are often 
higher than those found in several European studies. When biomarker-based exposure 
estimates are compared to existing ‘tolerable daily intake’ (TDI) values for CIT or OTA, the 
present exposure in Bangladeshi cohorts does not exceed the TDI for OTA, whilst up to 24% 
of the adult study participants have dietary CIT exposures above the TDI. Although not of 
immediate concern, exposure to CIT and OTA should be further monitored, including 
susceptible groups in the population (especially children), and in light of possible combined 
effects.   
DON biomarker levels in all Bangladeshi cohorts are clearly lower than those determined in 
the German cohort. Since the calculated daily DON intake of all individuals in both countries 
is below the TDI for this mycotoxin, present DON exposures are not of concern.  
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Appendix 1: Informed consent in Bangla  
 
সmিত পt 
 
আমরা রাজশাহী িব˞িবদƟালেয়র pাণরসায়ন o aনpুান িবjান িবভােগর eকদল গেবষকবnৃ । আমরা মাiকটিkন (ছtাকিবষ) 
eর uপর eকǅ গেবষণা পিরচালনা করেত ĺচɳা করিছ ।  
 
আমরা pিতিনয়ত ĺয খাদƟ gহন কির তার মাধƟেম িবিভn মাiকটিkন (ছtাকিবষ) আমােদর শরীের pেবশ কের । পরবতʗ সমেয় 
ei ছtাক িবষ আমােদর শরীের  িবিভn ধরেনর জǅল aসখু সিৃɳ কের । আমােদর শরীের িক পিরমান ছtাক িবষ িবদƟমান eবং 
pসূিত মাতার ĺkেt িক পিরমান ছtাক িবষ নবজাতেকর শরীের sানাnিরত হয় তার সǇক তথƟ জানা ĺনi । আমরা ei 
গেবষণার মাধƟেম তা জানার eবং িকভােব pিতেরাধ করা যায় তার ĺচɳা করব ।  
 
আপিন ei গেবষণা কােজ সহেযািগতা বা aংশgহেণ রাজী থাকেল গেবষণা সংিɮɳ আপনােক িকছু বƟিkগত pɬ করব eবং 
আপনার কাছ ĺথেক Ļজব নমনুা (pাpবয়sেদর ĺkেt মtু,  মা o িশশরু মtু, eবং pেয়াজেন িবেশেষ pাpবয়sেদর রk) সংgহ 
করব । eiসব নমনুা সংgেহ ĺকােনা ঝঁুিক ĺনi eবং eর ফেল আপনার কন শারীিরক সমসƟার সিৃɳ হেব না । সংgহকৃত নমনুা 
সমূহ আমােদর িনজs লƟাবেরটরী eবং িবেদেশ আমােদর সহেযাগী লƟাবেরটরীেত পরীkার জনƟ পাঠােনা হেব । পরীkার 
ফলাফলসমহূ uপযkু জানŪােল pকাশ করা হেব ।  
আপনার কােছ ĺথেক সংgহকৃত তথƟ eর পূণŪ ĺগাপনীয়তা রkা করা হেব । গেবষণায় আপনার aংশgহন বাধƟতামলূক নয় । 
আপিন ĺয ĺকান মু˲ েতŪ   ei গেবষণায় aংশgহন ĺথেক িবরত থাকেত পােরন eবং eজনƟ আপনােক ĺকান pকার aসিুবধায় পড়েত 
হেব না । ei গেবষণা িবষেয় আপনার মেন ĺকান pেɬর uদয় হেল ĺযাগােযাগ করনুঃ 
 
ডঃ ĺমাঃ খােলদ ĺহােসন                                                 
aধƟাপক                                                                       
pাণরসায়ন o aনpুাণ িবjান িবভাগ                             
রাজশাহী িব˞িবদƟালয়  
ĺমাবাঃ 01726 884046                                               
 
 
আিম ei গেবষণার uেdশƟ সmেকŪ    aবিহত হেয় eেত  aংশgহণ করেত করেত icুক। 
 
..………………… 
Tsাkর T eবং তািরখ 
                                                                                            T 
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Appendix 2: Participant information and food frequency questionnaire (FFQ) 
(Confidential) 
 
Project Title: Biological monitoring and exposure assessment for mycotoxins in 
inhabitants of Bangladesh  
 
Participant ID : …………………………………….  
Place and Date of sample collection: ………………………………….. 
 
PERSONAL INFORMATIONS (Please mark √ in case of Multiple Choice Questions) 
1. Name of the participant: …………………………………………………………… 
2. Age: …………………   (years) 
3. Sex :                               i) Male                    ii) Female 
4. Body weight: ……………………………… (kg) 
5. Body height: ……………………. (cm) 
6. Marital status:                i) Yes                     ii) No 
7. Smoking habits:             i) Yes                     ii) No 
8. Occupation:  …………………  
9. Education level:  i) No   ii) Primary    iii) Secondary     iv) Higher secondary   v) Graduate            
10. Socioeconomic status:    i) Low          ii) Medium          iii) Upper medium      iv) High 
11. Monthly income (Taka): About…….   
12. Living area :           i) Rural        ii) Suburban urban      iii) Urban 
 
FOOD HABITS AND FOOD FREQUENCY QUESTIONNAIRES (FFQ) 
13. Food consumption by the study subject per day?    i) Two    ii) Three  iii) More 
14. Food consumption by the study subject:                  i) Homemade     ii) Restaurant      iii) Both 
15. How many times have you eaten the following diets last two days (please mark √ where 
appropriate in below) 
 
 
Food items 6 Times 5 Times 4 Times 3 Times 2 Times 1 Time 0 Time 
Rice        
Bread (ready made 
from market)  
       
Roti/ porota 
(hand made) 
       
Noodles/pasta        
Pulses        
Vegetables        
Milk        
Milk products        
Fish        
Egg        
Chicken        
Beef        
Dry fruits        
Soft drinks        
Fruits juice        
Tea        
Coffee        
Ground nut         
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16. How often consume the following food by the subjects (please mark √ where appropriate) 
 
Name 3 times  
a day 
2 times 
a day 
1 time 
a day 
 Once  
a week 
2-4 days  
a week 
5-6 days  
a week 
Once  
a month 
Cereals 
Rice         
Bread (Ready made 
from market) 
        
Roti/ Porota (Hand 
made) 
        
Nodules/Pasta         
Pulses         
Vegetables         
Ground nut (Badam)         
Animal products 
Fish         
Chicken         
Beef         
Milk          
Milk products 
(Cheese, curd…) 
        
Beverages/Fruits 
Tea         
Coffee         
Soft drinks         
Dry fruits  
(Date, raisin…) 
        
Fruits juice         
 
17. Any visible malnutrition observed?  i) Yes      ii) No.        If yes. Please note………………..  
18. Have you suffered from any severe diseases?  i) Yes     ii) No      If yes, please note………. 
19. Have you taken the antibiotics during the last week?   i) Yes     ii) No       
 
 
Please note that the provided information is confidential and it will be used only for research purposes. 
Thanks for your participation and cooperation. 
 
 
………………………………………. 
Name & Signature of the participant: 
 
 
…………………………………………… 
Name & Signature of the investigator (s): 
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Appendix 3: Informed consent in German 
 
 
Probandeninformation 
 
Hintergrund :   
Mit Lebensmitteln werden auch geringe Mengen von Substanzen aufgenommen, die als 
unerwünschte Begleitstoffe angesehen werden. Dazu zählen auch Mykotoxine. Man weiss, 
dass in Deutschland von erwachsenen Personen üblicherweise mit der Nahrung 
aufgenommene Mengen aber kein gesundheitliches Risiko darstellen.   
Nun soll untersucht werden, in welchen Konzentrationen die Substanzen in Urin vorkommen.  
Ziel ist es, eine neue empfindliche Methode für den Nachweis von Mykotoxinen in Urin zu 
erproben.  
 
Ablauf :   
Für die oben genannten Untersuchungen werden Urinproben benötigt und zwar etwa  50 - 100 
ml pro Teilnehmer.  Bitte sammeln Sie - gleich nach dem Aufstehen - einen Morgen -Urin in 
dem bereit gestellten Behälter.  
Jedes Probengefäss bitte mit einem ausgefüllten Klebeetikett kennzeichen (Name und Datum 
der Urinspende) und dann mit diesem Blatt in der ZE Analytik abgeben. 
Ferner bitten wir um das Ausfüllen eines kurzen Fragebogen (separat) in dem 
Nahrungsgewohnheiten erfasst werden. 
 
Datenschutz: 
Es werden im Rahmen der Studie keine personenbezogenen Daten an Dritte weitergegeben. 
Die Anonymität aller Urin-Spender wird gewahrt.  
 
Einverständniserklärung 
Ich habe die Probandeninformation verstanden und bin mit der Abgabe einer Urinspende 
einverstanden.  
Meine Probe wird dem IfADo (Leibniz Institut für Arbeitsforschung an der TU Dortmund) 
unentgeltlich für eine wissenschaftliche Studie zur Verfügung gestellt.  
Ich habe verstanden, dass  
 
a) die Abgabe der Probe keine Risiken für mich darstellt; 
b) ich meine Teilnahme an der Studie jederzeit und ohne Angabe von Gründen 
widerrufen kann, ohne dass mir daraus evt. Nachteile erwachsen; 
c) die Ergebnisse der Analysen publiziert werden können, aber ohne Nennung meines 
Namens oder anderer Hinweise auf meine Identität. 
 
Ferner versichere ich, dass meine Einwilligung zur Teilnahme freiwillig und ohne jede 
weitere Verpflichtung erfolgt. 
 
 
Dortmund, den …………..         ………………………………………….. 
          (Name und Unterschrift) 
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Scope: Ochratoxin A (OTA), amycotoxin known for its nephrotoxic, immunotoxic, and carcino-
genic effects in animals, deserves attention due to its widespread occurrence as food and feed
contaminant. Studies in many countries report the presence of OTA in human blood plasma
or serum at variable levels. However, no biomonitoring study has been carried out in so far,
and also food analysis data are insufficient to assess OTA exposure.
Methods and results: Therefore, 64 blood samples were collected from healthy university
students (32 female, 32 male) in Bangladesh for biomarker analysis. OTA and its metabolite
ochratoxin alpha were determined in the plasma samples by a validated method using HPLC-
fluorescence analysis. After liquid–liquid extraction, OTA was detected in all plasma samples
(100%) at a range of 0.20–6.63 ng/mL and ochratoxin alpha was detected in 95% of the samples
at 0.10–0.79 ng/mL. The OTAmean level in plasma of males (0.92 ± 1.09 ng/mL) and females
(0.78 ± 1.02) were not significantly different. Statistical analysis of food consumption data
for the participants, provided in a food frequency questionnaire, did not reveal a significant
association between OTA level in plasma and their intake of typical staple foods (rice, wheat,
maize, and lentil).
Conclusion: The dietary intake of OTA (mean 11.7, max 91.7 ng/kg b.w./wk) calculated on the
basis of plasma concentration in Bangladeshi students was lower than the tolerable weekly OTA
intake (120 ng/kg b.w./wk) set by EFSA. Nonetheless, further biomonitoring is recommended
in cohorts from other parts of the country that may have higher mycotoxin exposure than the
present group.
Keywords:
Bangladesh / Exposure / Ochratoxin A / Ochratoxin alpha / Plasma
1 Introduction
Ochratoxin A (OTA), a mycotoxin produced by a number
of Aspergillus and Penicillium species, is found worldwide as
contaminant in different foods and feeds [1]. Due to its car-
cinogenic, nephrotoxic, hepatotoxic, immunotoxic, and ter-
Correspondence: Nurshad Ali, Leibniz Research Centre for Work-
ing Environment and Human Factors (IfADo) at TU Dortmund,
Ardeystrasse 67, D-44139 Dortmund, Germany
E-mail: nali@ifado.de; nur_rubd@yahoo.com
Abbreviations: OTA, ochratoxin A; OT, ochratoxin alpha
atogenic effects in animals, OTA is considered as hazard for
human health. The kidney is apparently the most susceptible
target organ, and long-term human exposure to OTA may be
involved in Balkan endemic nephropathy [2]. Regulatory bod-
ies in many countries have set maximal contaminant levels
in food commodities in order to limit dietary OTA exposure
[3–5].
Human OTA exposure can be assessed by two major ap-
proaches: Themycotoxin contaminant analysis in foods com-
bined with data of food consumption and dietary habits are
used to estimate dietary OTA intake of the general popula-
tion or subgroups [3, 5]. Another approach to assess human
exposure is the analysis in blood (plasma or serum) and to
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convert internal OTA levels by means of the Klaassen equa-
tion to dietary intake values [6–8]. The biomarker approach
is particularly useful as it covers mycotoxin exposure by all
routes (oral, dermal, inhalation), and it provides orientation
in situations where concentration data on contaminant levels
in food are scarce or not available [9, 10]. As this is the case
for Bangladesh (see below), biomonitoring was chosen as the
best strategy to investigate human exposure.
In the context of biomarker analysis in human blood
and/or urine, it is important to consider the toxicokinetics,
i.e. the long half-life of OTA in human blood (t1/2 35 days)
as well as OTA metabolism [11]. Thus, OTA blood levels
will integrate exposure over longer periods, while biomarker
analysis in urine apparently better reflects day-to-day varia-
tions in exposure of adults and infants [7, 12, 13]. The main
metabolite of OTA, formed by hydrolysis in the gastroin-
testinal tract, is ochratoxin alpha (OT). This metabolite
is more polar than OTA and considered as detoxication
product [11]. In humans, OT undergoes further phase
II metabolism and is excreted with urine, often at higher
levels than OTA [14–16]. OT may thus serve as additional
biomarker of mycotoxin exposure and/or indicator for the
ability of humans to detoxify OTA [16].
Data for OTA plasma or serum levels of “healthy” persons
from 30 countries indicate a wide range of exposures, but
such data are not yet available for those countries with the
highest population numbers (e.g. China, India, the United
States) and for several developing countries [8]. When we re-
cently analyzed OTA in blood plasma of two cohorts from
Pakistan, the median levels (0.19 ng/mL) were comparable
to those reported for the general population in the European
Union [17]. In Bangladesh, the occurrence of OTA in plant-
derived foods (maize, cereals, groundnuts) and feedshas been
reported [18, 19]. But this survey data from only two investi-
gational studies are insufficient to estimate typical human
dietary exposure to the mycotoxin. Therefore, the objectives
of the study were to analyze OTA and its metabolite OT in
blood plasma and assess the exposure of adults (university
students) in Dhaka, Bangladesh.
2 Materials and methods
2.1 Collection of blood samples
Sixty-four blood samples (32 female and 32 male) were col-
lected from healthy students who studied at the first year
of honours of MBBS (Bachelor of Medicine and Bachelor of
Surgery), Gonoshasthaya Samaj Vittik Medical College and
Hospital, Savar, Dhaka-1344, Bangladesh. Collection of sam-
ples was done in June 2013. All participants gave their written
consent before inclusion in the study, which was approved by
the Ethics Committee of the Medical College. Blood samples
(5–7 mL) were collected from each individual by venipunc-
ture into EDTA containing tubes. Blood was centrifuged at
3000 rpm (about 2500 × g) for 15 min for isolation of plasma.
The plasma samples were then stored at −20C and mailed
to IfADo at Dortmund for subsequent analysis of OTA. All
participants were asked to report their daily and weekly eating
habits in a short food questionnaire and some individual data
(age, gender, height, and body weight) were also recorded in
the form.
2.2 Standards and reagents
Methanol, chloroform, isopropanol, acetic acid (96%),
sodium hydrogen carbonate (NaHCO3), and phosphoric acid
(85%) were purchased from Merck (Darmstadt, Germany).
The solvents used to compose the mobile phase were of
HPLC grade. OTA (purity>98%) was obtained from Sigma–
Aldrich (Taufkirchen, Germany), and OT standard (pu-
rity 98.9%; 11.9 g/mL acetonitrile) from Biopure (Tulln,
Austria). OTAwas dissolved inmethanol and calibrated spec-
trophotometrically at 333 nm using the molar (M) extinction
coefficient of 6400 M−1 cm−1. The working standard solu-
tions were prepared weekly as dilutions in methanol/water
(1:1, v/v) in a range from 0.10 to 10 ng/mL. The
-glucuronidase/arylsulfatase (-Gluc/ArylS) enzyme from
Helix pomatia (specific activity 5.5 U/mL -glucuronidase,
2.6 U/mL arylsulfatase at 37C) was purchased from Roche
(Mannheim, Germany).
2.3 Enzymatic hydrolysis of samples
To cleave conjugates of the analytes, 100 L hydrolysis buffer
(pH 5.0) and 10 L of -Gluc/ArylS enzyme was added to
0.5 mL plasma sample and incubated at 37C for overnight
before liquid–liquid extraction ofOTA and itsmetaboliteOT
[16].
2.4 Extraction of plasma
The liquid–liquid extraction method [16] was used for sam-
ple extraction with minor modifications. The enzyme-treated
plasma sample (0.5mL)wasmixedwith 3mLof 1%NaHCO3,
and pH was adjusted to 2.8–3.0 with 1 MH3PO4. Then, 2 mL
of a mixture chloroform/isopropanol (97:3) was added and
mixed by a rotary mixer for 20 min. The mixture was cen-
trifuged at 4500 rpm for 20 min at 20C. In some cases, a
second centrifugation was required for complete separation
of the protein layer. The aqueous upper layer was discarded
and 1 mL of the organic layer was transferred with an au-
tomatic pipette to a vial and evaporated to dryness under
a stream of nitrogen at 45C. The residue was dissolved in
250 L of methanol/water (1:1). The vial was vortexed, and
the extract was filtered through a 0.45 m pore size Teflon
syringe filter (WICOM, Germany) before HPLC analysis.
2.5 HPLC analysis with fluorescence detection
Analyses were carried out with a HPLC Shimadzu system
consisting of two LC-10AS pumps, RF-10Axl fluorescence
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detector, SIL-10AD Vp auto injector, CBM-20A communica-
tionmodule, andShimadzuLC solution software. ANucleosil
100 column (C18, 250 × 3 mm, 5 m; Macherey & Nagel,
Du¨ren, Germany) was used for separation of the analytes at a
column temperature of 40C. Flow rate was 0.8 mL/min and
the injection volume was 80 L. The mobile phases were:
as phase A acetic acid 2%/methanol (66:34, v/v), and phase
B methanol/isopropanol (90:10, v/v). The stepwise gradient
was: 0–15 min 5% B, 15–16 min 5–40% B, 16–30 min 40% B,
30–31 min 40–95% B, 31–33 min 95% B, 33–34 min 95–5%
B, and reequilibration 34–45 min 5% B. Retention times for
OT and OTA were about 11 and 27 min, respectively. The
fluorescence detector was set at 333 nm excitation and 450
nm emission wavelengths.
2.6 OTA intake assessment
The daily dietary mycotoxin intake was calculated from the
mean OTA levels in plasma according to the Klaassen equa-
tion: K0 = Clp × Cp / A in the version used earlier by others
[6, 8]: K0 = 0.99 × Cp / 0.5 = 1.97 × Cp, where K0 is the
continuous dietary intake (ng/kg b.w./day); Clp is the plasma
clearance (0.99 mL/kg b.w./day); Cp is the plasma concen-
tration of OTA (ng/mL), and A is the toxin bioavailability,
estimated at 50%.
2.7 Food consumption data
All participants were asked to fill a questionnaire about
their daily and weekly food habits. The food frequency
questionnaire asked for intake of typical food consumed by
Bangladeshi people: staple foods, mainly cereals such as rice,
wheat, maize, and lentils as the major pulse. Chicken meat,
eggs, milk, and milk based products were also included, as
well as beverages. Beer, coffee, and wine, items of relevance
for OTA intake in Europe [20], are usually not consumed in
Bangladesh.
2.8 Statistical analysis
Descriptive statistics are presented as means ± SD, medians,
and interquartile ranges. Box plots are used to describe distri-
bution of OTA by gender. Differences of the baseline charac-
teristics and OTA or OT concentration between males and
females were analyzed by independent sample t-test. Spear-
man correlation coefficient was used to assess the correlation
between food consumption and OTA plasma concentration.
A level of alpha 0.05 was assigned for statistical significance.
Statistical analyses were performed using the software SPSS
Statistics version 22.
3 Results
3.1 Validation parameters
The calibration curvewas linear in the range of 0.1–10 ng/mL,
and the coefficients of determination (R2) were 0.99 for both
OTA and OT. The recoveries of analytes from matrix were
assessed at three spike levels in plasma, with mean values
of 92 and 71% for OTA and OT, respectively (Table 1). In-
traday repeatability, tested for all spiking levels at the same
day of analysis, showed RSD of 3.1 for OTA and 5.8 for OT.
Reproducibility was determined by interday assays on three
different days at a level of 0.5 ng/mL for both analytes; the
RSD was 4.3 for OTA and 7.4 % for OT. The LOD and LOQ
were determined as S/N of 3 and >10, respectively. For OTA
and OT, the LOD and LOQ were 0.05 and 0.10 ng/mL in
plasma.
3.2 Baseline characteristics of the participants
In total 64 subjects participated in the study, half of them
were female (n = 32) and the other half were male (n = 32)
students. Individual and anthropometric characteristics of the
participants are presented in Table 2. The mean age of the
female studentswas 19.8± 0.6 years (range: 18–21 years), and
20.5± 0.8 years (range: 18–21 years) for males. All volunteers
were healthy and free from any chronic diseases. The average
BMI for all subjects was 22.0 ± 3.3 kg/m2. Males (22.7 ±
3.7 kg/m2) had slightly higher BMI than females (21.4 ±
2.7 kg/m2), but the difference was not significant.
Table 1. Recovery levels and RSD for OTA and OT in plasma
after liquid–liquid extraction
Spike level
(ng/mL)
OTA OT
Recovery
(%)
RSD
(%)
Recovery
(%)
RSD
(%)
0.10 (n = 3) 97 4.6 83 3.3
0.25 (n = 3) 94 1.6 69 7.3
1.00 (n = 3) 86 3.1 60 6.8
Table 2. Baseline characteristics of the study subjects
Gender n Age (years) BMI (kg/m2)
Mean ± SD Range Mean ± SD Range
Female 32 19.8 ± 0.6 18–21 21.4 ± 2.7 16.0–27.3
Male 32 20.5 ± 0.8 18–21 22.7 ± 3.7 18.0–35.9
All 64 20.2 ± 0.8 18–21 22.0 ± 3.3 16.0–35.9
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Table 3. Levels of OTA and OT (ng/mL) in plasma according to
gender
n Positive
samples
(%)
Mean ± SD Median Range
OTA
Female 32 32 (100) 0.78 ± 1.02 0.41 0.20–5.08
Male 32 32 (100) 0.92 ± 1.09 0.69 0.22–6.63
All 64 64 (100) 0.85 ± 1.05 0.57 0.20–6.63
OT
Female 32 29 (91) 0.23 ± 0.13 0.19 <LOD–0.55
Male 32 32 (100) 0.33 ± 0.16a) 0.27 0.13–0.79
All 64 61 (95) 0.28 ± 0.15 0.25 <LOD–0.79
a) p < 0.05 when compared to female, p-value obtained from
independent sample t-test. Positive sample refer to plasma con-
taining the analyte LOD.
3.3 Plasma levels of OTA and OT
OTA and OT were detected in 64 (100%) and 61 (95%) of
all plasma samples (Table 3). Only samples with an analyte
concentration LOD were considered as positive samples.
For calculation of mean and median values, those samples
that contained OTA and OT below the limit of detection
(0.05 ng/mL) were assigned a value of one half the detec-
tion limit. The mean value of OTA and OT were 0.85 ±
1.05 ng/mL (range: 0.20–6.63 ng/mL) and 0.28± 0.15 ng/mL
(range: LOD–0.79 ng/mL), respectively. Male students had
slightly higher OTA plasma levels (0.92 ± 1.09 ng/mL) than
female students (0.78 ± 1.02 ng/mL), but the difference was
not significant, while a significant difference (p < 0.01) was
observed for OT between male (0.33 ± 0.16 ng/mL) and
female (0.23 ± 0.13 ng/mL) students. Since the data were
not normally distributed (Fig. 1), the comparison of plasma
concentrations is also presented in a box plot, with median
values and interquartile ranges (Fig. 2).
Figure 1. Distribution of OTA levels in plasma samples. Fre-
quency test was used for the calculation of distribution.
Table 4. OT:OTA ratio in the gender groups
n Mean ± SD Median Range
Female 29 0.83 ± 0.59 0.76 0.12–2.55
Male 32 0.80 ±0.58 0.65 0.09–2.59
All 61 0.82 ±0.58 0.71 0.09–2.59
Only positive samples considered for calculation. Analytes con-
centration expressed as 1 nM OTA = 0.40 ng/mL and 1 nM OT =
0.25 ng/mL.
Of interest is also the ratio between OTA and OT, the
detoxication product of the parent mycotoxin. Ratios were
calculated from nanomolar plasma concentrations after ad-
justment for the molecular weights (OTA 403 g/mol, OT
255 g/mol). The mean ratio for all students was 0.82 ± 0.58
(range: 0.09–2.59) (Table 4), with no significant difference
between males (0.80 ± 0.58) and females (0.83 ± 0.59). Their
mean ratio OT / OTA of<1 in blood plasma is considerably
lower than that calculated from data for German adults (aver-
age nanomolar ratio OT / OTA about 5) [16]. The lower level
of OT in blood of Bangladeshi students may be indicative of
Figure 2. Comparison of plasma biomarker levels between males and females. Boxplot of concentration for (a) OTA and (b) OT in the
gender groups. The outliers were labeled by subject number.
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Table 5. Daily dietary intake of OTA (ng/kg b.w.) based on OTA
plasma levels
n Mean ± SD Median Range per day
Female 32 1.54 ± 2.0 0.81 0.39–10.0
Male 32 1.81 ± 2.1 1.36 0.43–13.1
All 64 1.67 ± 2.0 1.12 0.39–13.1
Table 6. Correlation (r) between food consumption and OTA con-
centration in plasma
Foods Correlation (r) p-value
Rice 0.24 0.843
Maize/wheat −0.14 0.283
Lentil 0.17 0.191
Chicken meat 0.26 0.836
Milk and milk products 0.14 0.263
Assessment of food consumption was done using the score 1–4
(1 = do not consume at all, 2 = 1 time daily, 3 = 2 times daily,
4 = 3 times daily. p-value obtained from Spearman’s correlation
coefficient (two-tailed).
less efficient detoxication of OTA by gut bacteria. However,
other explanations cannot be ruled out, e.g. higher intake of
OT in German adults with milk and milk products.
3.4 OTA intake estimate of Bangladeshi students
The dietary mycotoxin intake was calculated from the OTA
plasma concentration by means of the Klaassen equation
(conversion factor 1.97). When expressed as ng/kg b.w./day,
the mean daily dietary intake of OTA was 1.67 ng/kg b.w.
(Table 5) or multiplied by 7 days, 11.7 ng/kg b.w./wk. Tak-
ing into account also the high end OTA plasma concentra-
tion value (6.6 ng/mL), then dietary intake was 13.1 ng/kg
b.w./day or 91.4 ng/kg b.w./wk. The average OTA exposure
of male and female students is thus markedly lower than
the tolerable intake value of 120 ng/kg b.w./wk proposed by
EFSA [3].
3.5 Correlation between OTA plasma concentrations
and food intake
Based on information provided in the food frequency ques-
tionnaires, possible correlations were analyzed between food
consumption (graded 1–4) and OTA plasma levels in the
student cohort. The food items rice, wheat/maize, lentils,
chickenmeat,milk, andmilk based products were considered
in Spearman correlation analysis (Table 6). Consumption of
rice, the main staple food in Bangladesh, did not show a sig-
nificant correlation (p = 0.84) with the plasma OTA level of
the subjects. No significant correlations were also observed
betweenOTA in plasma and other foods such aswheat/maize
(p = 0.28), lentils (p = 0.19), chicken meat (p = 0.84), or milk
and milk based products (p = 0.26).
4 Discussion
This is the first study that examined OTA blood levels
and exposure to this mycotoxin in Bangladeshi subjects.
Comparing our new data with those from studies carried out
in other countries of South or North Asia these results are of
interest: The mean and median plasma OTA concentrations
in our cohort (0.85 and 0.57 ng/mL) are higher than OTA
values reported for adults in Pakistan (mean 0.3 and median
0.19 ng/mL) [17] and for Japanese adults (mean 0.07 ng/mL)
[21]. The maximum OTA level in our cohort (Table 3)
was also higher than in the latter two studies. The mean
Bangladeshi value of 0.85 ng/mL only slightly exceeds what
has been termed the overall mean “world OTA serum level”
of 0.7 ng/mL [8], but dietary OTA exposure in Bangladesh
appears to be much lower than in several African countries.
According to previous work that estimated mycotoxin ex-
posure [6, 8, 22], a conversion factor of 1.97 was applied to
convert blood plasma OTA concentrations to dietary intake:
The daily dietary OTA intake estimates for the Bangladesh
cohort (Table 5) are lower than the tolerable intake value of
120 ng/kg b.w./wk set by EFSA, i.e. 17 ng/kg b.w./day [3].
But a few subjects exceed the limit value of 4 ng/kg b.w./day
proposed by Health Canada [5]. The fact that everyone is ap-
parently exposed toOTA (100% incidence of positive samples)
raises the question of mycotoxin contamination in foods and
feedstuffs in Bangladesh.
Surveillance results from1993 to 1995 indicated a frequent
and high contamination of groundnuts, maize, and poultry
feed with aflatoxin B1, yet low AFB1 levels in pulses, rice, or
wheat [18]. Analysis by aHPTLCmethodwith a reported LOD
10 g/kg revealed a moderate OTA contamination in 7% of
themaize samples (4.5g/kg) and a “trace amount” (2g/kg)
in one of 95 wheat samples; OTA was not detected in 98 rice
or five pulses samples [18]. A more recent analysis of OTA
in maize (50 storage samples and 70 samples collected from
different markets) reported more frequent contamination in
market samples, with 40% incidence and OTA levels ranging
from 1 to 117 g/kg [19]. Althoughmaize is mainly produced
as ingredient of poultry feed, it is also increasingly consumed
as human food in snacks or other food items. But, data on
the occurrence of OTA in the staple foods rice, lentils, millet,
or wheat are not yet available for Bangladesh, although food
safety is an emerging issue in this country [23]. Bangladesh is
amajor producer of rice, ranking 6th in theworld, after China,
India, Indonesia, Vietnam, and Thailand in 2012 (FAO; Avail-
able from http://faostat.fao.org/site/339/default.aspx). There
are reports on OTA occurrence in Korean polished rice (2.1–
6.0 ng/g in 8/88 samples) [24] and in rice from Vietnam
(0.1–2.8 ng/g in 35/100 samples) [25]. The mycotoxin con-
tamination of rice is usually lower than in wheat or corn [26].
But, contamination of rice grains with mycotoxin producing
fungi in various parts of India, also West-Bengal, the neigh-
bouring province of Bangladesh, raise some concern on the
presence of OTA and other mycotoxins, for example citrinin,
in this key commodity [27].
C© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.mnf-journal.com
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Possibly due to the small number of subjects in the study
(n = 64), we did not observe any significant correlation be-
tween OTA levels in plasma and the food consumption data
for five categories, i.e. rice, wheat/maize, lentils, chicken
meat, milk, and milk products (Table 6). Rice and wheat are
most frequently consumed foods in Bangladesh. As wheat
and maize flour are often mixed together in food prepara-
tion, it was difficult to separate them in our analysis. Among
pulses, lentils are most frequently consumed in Bangladesh
and often used to prepare soups. Chicken meat was included
because of the possible carry-over of OTA from poultry feed
[28]. Although OTA contamination of milk and milk based
products from Europe are usually very low [20], this category
was included for comparison in the Spearman correlation
analysis. Other items, known to contribute significantly to
OTA intake in Europe, i.e. wine, coffee, and beer [20], are
hardly consumed by the Bangladeshi population.
In conclusion, it can be stated that:
(i) Published information on OTA food contamination in
Bangladesh was insufficient to estimate human exposure
to this mycotoxin; thus biomarker analysis was intro-
duced.
(ii) This first biomonitoring study did not indicate a high
dietary OTA intake by the Bangladeshi student cohort.
Since the student cohort of young healthy adults from an
urban region may not reflect the situation of adults who
reside in other areas of Bangladesh, further biomonitor-
ing studies are indicated.
(iii) Such studies should also assess exposure to additional
mycotoxins of interest in Bangladeshi people, applying
biomarker analysis in urine and/or blood samples.
(iv) The ratio of OT to OTA in plasma of Bangladeshi adults
(OT/OTA <1) differs from that observed in German
adults (OT/OTA>5). This is of interest as itmay indicate
less efficient formation of the nontoxic metabolite of OTA
in the gastrointestinal tract and/or differences in OT
exposure with food.
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data or age, gender and body mass index of the participants. 
Among them, the highest mean AFM1 level (101 ± 71 pg/
mL) was observed in the 50–60 years age group. In con-
clusion, detection frequency and urinary AFM1 levels in 
the Bangladeshi adults support concerns regarding their 
dietary exposure to AFB1. These first data warrant further 
biomarker-based studies in children and in cohorts of other 
parts of the country.
Keywords Aflatoxin B1 · Aflatoxin M1 · Biomarker · 
Exposure · Mycotoxins
Abbreviations
AFB1  Aflatoxin B1
AFM1  Aflatoxin M1
ELISA  Enzyme-linked immunosorbent assay
Introduction
Aflatoxins (B1, B2, G1, G2) are a group of highly toxic 
secondary metabolites produced by Aspergillus species 
(A. flavus and A. parasiticus) which contaminate various 
crops, primarily in hot and humid climate (Gourama and 
Bullerman 1995; CAST 2003). Acute and chronic exposure 
to aflatoxin B1 (AFB1), the most prevalent aflatoxin and a 
potent hepatocarcinogen in various species, is a major cause 
of human disease in several African and some Asian coun-
tries [see reviews by Williams et al. (2004), Wild and Gong 
(2010), Kensler et al. (2011) and Dohnal et al. (2014)]. Epi-
demiological investigations applied established biomarkers 
of exposure (urinary aflatoxin M1, aflatoxin-N7-guanine, 
serum aflatoxin-albumin/lysin adduct) and confirmed that 
AFB1 contamination of the food supply puts an exposed 
population at increased risk of developing hepatocellular 
Abstract Aflatoxins are important mycotoxins produced 
by Aspergillus flavus and A. parasiticus, moulds which 
contaminate mainly grains and nuts, especially in hot and 
humid climate. Presence of aflatoxin B1 (AFB1), the most 
toxic one and a potent hepatocarcinogen, has been reported 
in food and feed in Bangladesh and raised concerns about 
mycotoxin exposure in the population. Biomonitoring pro-
vides the best approach to assess human exposure from 
various sources and by all routes. Part of the ingested AFB1 
is converted in the body to aflatoxin M1 (AFM1), a metabo-
lite that has served as biomarker of AFB1 exposure, as it is 
excreted in urine, and thus enables non-invasive sampling, 
a relevant aspect in field studies. This investigation meas-
ured the AFM1 concentration in urines collected from adult 
residents of a rural (n = 52) and an urban (n = 43) area in 
the Rajshahi district of Bangladesh. The urinary levels of 
AFM1 were determined by enzyme-linked immunosorbent 
assay. AFM1 was detected in 46 % of all urine samples at a 
range of 31–348 pg/mL. The median and mean concentra-
tion of AFM1 in urine was 61 and 80 ± 60 pg/mL, respec-
tively. A significant difference (p < 0.05) was found at the 
mean level of AFM1 between the rural (99 ± 71 pg/mL) 
and urban (54 ± 15 pg/mL) cohort. Urinary AFM1 levels 
did not show significant correlations with food frequency 
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carcinoma (Wogan et al. 2012; Turner et al. 2012). More 
recent studies [reviewed by Turner (2013)] demonstrate 
also clear dose–response relationships between early (pre- 
and post-natal) aflatoxin exposure and growth retardation 
of infants in Gambia, Benin and Togo.
Aflatoxin contamination of dietary staples, includ-
ing maize and groundnuts, often at high levels, is a major 
problem in developing countries where the tropical cli-
mate favours mould growth and where storage conditions 
for crops are poor (Williams et al. 2004; Wild and Turner 
2002). The population in low-income countries often can-
not afford to discard even visibly spoiled food or they use it 
as animal feed. Then, the transfer of AFB1 and its similarly 
toxic metabolite AFM1 into milk of lactating animals and 
in human breast milk will add to the risk of exposure for 
the youngest and most susceptible part of the population 
(Degen et al. 2013; Turner 2013).
To protect consumers, most developed countries have 
established regulations and limit values (maximum per-
missible levels) for several major mycotoxins in food, 
including aflatoxins (EC 2006; van Egmond et al. 2007). 
However, not everywhere a strict control for mycotoxins 
is enforced, as indicated, for instance, by the Rapid Alert 
System for Food and Feed (RASFF) and numerous notifi-
cations on aflatoxins in imported nuts, spices or figs (http://
ec.europa.eu/food/safety/rasff/index_en.htm).
In Bangladesh, there is no regular control of food com-
modities for mycotoxins, although there is now awareness 
of this deficit (Islam and Hoque 2013). One survey has 
detected AFB1 (by HPTLC) in plant-derived food and feed 
collected between 1993 and 1995, with the highest levels in 
groundnuts and maize, and at lower levels in pulses, wheat 
and rice (Dawlatana et al. 2002). A more recent study in 
Bangladesh (Roy et al. 2013) investigated the presence of 
AFB1 in pooled samples of eight commonly consumed 
food commodities (rice, lentils, wheat flour, dates, betelnut, 
red chilli powder, ginger and groundnuts) and in poultry 
feed. The mean levels of AFB1 exceeded the US or EU 
regulatory limits in five of eight food commodities tested. 
The authors (Roy et al. 2013) discuss a number of limita-
tions of their study (e.g. seasonal variations in contamina-
tion not captured, food types not analysed) and then recom-
mend further studies that utilize biomarkers of exposure in 
humans to improve assessment of exposure and risk due to 
aflatoxins in Bangladesh.
Indeed, when food contaminant data are scarce, as in 
the case of AFB1, analysis of biomarkers in human body 
fluids provides a better approach as biomonitoring covers 
mycotoxin intake from all dietary sources and exposure by 
various routes (Degen 2011). A recent study with analy-
sis of the AFB1-lysine adduct in human blood serum indi-
cates a rather high risk of exposure for the population in 
Bangladesh (Groopman et al. 2014). This biomarker-based 
approach requires invasive sampling (blood taken by medi-
cal personal); yet, non-invasive sampling of body fluids 
(such as urine, breast milk or saliva) is easier to perform in 
field studies and often better accepted by the participants.
AFM1, a hydroxylated metabolite of AFB1, present 
in mycotoxin exposed individuals, has been analysed in 
human blood, breast milk and urine samples from several 
countries (see Leong et al. 2012; Degen et al. 2013; Sabran 
et al. 2012a, b). As AFM1 levels in urine are strongly cor-
related with aflatoxin intake in chronically exposed persons 
(Zhu et al. 1987), there is confidence in the use of urinary 
AFM1 measures as exposure assessment tool (Turner 2013; 
Mitchell et al. 2013). Therefore, we have now investigated 
the occurrence of urinary AFM1 in two adult cohorts in 
Bangladesh.
Materials and methods
Study population and sampling
Ethical permission for the biomonitoring study was granted 
by the Institute of Biological Sciences of Rajshahi Uni-
versity, Rajshahi-6205, Bangladesh, and it was approved 
by the Institutional Internal Review Board of IfADo, Ger-
many. This study recruited 95 participants in the Rajshahi 
district of Bangladesh. Urine samples were collected from 
adult residents of a rural (n = 52) and an urban (n = 43) 
area in February 2014 (winter season). The participants 
were informed about the study, and a written consent was 
obtained from all of them prior to inclusion in the study. 
About 50 mL of first morning urine sample was collected 
into a non-sterile disposable container from each of the 
95 recruited participants prior to consumption of food 
and water on that day. The urine samples were first stored 
at −20 °C at Rajshahi University and sent on dry ice to 
IfADo, Dortmund for subsequent biomarker analysis. Uri-
nary creatinine was measured by a modified Jaffe method 
(Blaszkewicz and Liesenhoff-Henze 2012) to account for 
variability in urine concentration between individual sam-
ples. All participants were of good health, and they were 
asked to fill in a short questionnaire for anthropometric 
information (age, gender, height and weight) and occupa-
tion (Ali et al. 2015). Food habits were recorded in another 
questionnaire (see below).
Food consumption data
All participants were asked to fill in a questionnaire with a 
focus on the last 2 days of food consumption prior to urine 
sampling and in addition to record their regular food habits. 
The food frequency questionnaire (FFQ) asked for intake 
of typical food items consumed by Bangladeshi people: 
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staple foods, mainly cereals such as rice, wheat, maize and 
lentils as the major pulses. Consumption frequency was 
graded 1–4 (see Table 4). Chicken meat, eggs, groundnuts, 
milk and milk-based products were also included. Among 
all foodstuffs, only rice is regularly consumed one to three 
times in a day by the majority of participants. Milk is only 
consumed by a small number of participants on a regular 
basis. Information about consumption of dates, betelnut 
and spices were not recorded in the questionnaire.
AFM1 analysis in urine
AFM1 levels in urine were determined using enzyme-linked 
immunosorbent assay (ELISA). The aflatoxin M1 ELISA 
kits were purchased from Helica Biosystems Inc., Santa 
Ana, CA 92704, USA. The urine samples were centri-
fuged at 3200 g for 5 min, and supernatant was then used 
for AFM1 determination according to the procedure speci-
fied in method protocol. In brief, both the AFM1 standards 
(provided in the kit) and the urine samples were diluted 
with distilled water (1:20 or 1:5); 100 µL of each was mixed 
with 200 µL assay buffer. Then, 100 µL of this mixture was 
transferred to antibody-coated microtiter well, and the plate 
incubated at RT for 1 h. An automated microplate washer 
(Tecan Hydro Flex, Salzburg, Austria) was then used for 
washing the plate with washing solution (supplied with 
the kit). AFM1 conjugate (100 µL) was added to each well 
and incubated at RT for 15 min; then, the plate was washed 
again with washing solution to remove the unbound conju-
gate. Substrate reagent (100 µL) was added to each well, and 
the colour reaction was allowed to proceed in the dark for 
15 min at RT. Then stop solution (100 µL) was added to the 
wells to terminate the enzyme reaction, and within 15 min, 
the absorbance was measured at 450 nm by a microplate 
reader (Tecan Genios®, Salzburg, Austria). The absorption 
intensity is inversely proportional to AFM1 concentration 
in the samples. The AFM1 level in the samples was calcu-
lated from concurrent standard curves using AFM1 standard 
solution for each plate. All urine samples were analysed in 
duplicate at two different dilutions (1:5 and 1:20), and aver-
age values were calculated. For method validation, blank 
urines (from Germany) were spiked with different concen-
trations (20–60 pg/mL) of AFM1 standard; the recovery rate 
was in the range of 85–115 %, and the method detection 
limit (MDL) was determined to be 30 pg/mL.
Statistical analysis
Statistical analysis of data was performed using the software 
IBM SPSS Statistics version 22. Descriptive analysis was 
used to determine mean, median and interquartile ranges of 
the analyte. Differences of the baseline characteristics and 
the analyte concentration between the male–female cohort 
and regions were analysed by independent sample t test. All 
the participants are categorized into four age groups accord-
ing to frequency test, and the AFM1 levels within the groups 
were compared using ANOVA test. Spearman correlation 
coefficient (two-tailed) was used to assess the correlation 
between food consumption and urinary AFM1 concentration 
and also used to assess the correlation of analyte level with 
age, gender and body mass index (BMI). A level of alpha 
0.05 was assigned for statistical significance.
Results
Demographic characteristics of the study cohorts
The demographic information on the cohorts is summa-
rized in Table 1. Of the 95 participants, 51 % were female 
and 49 % were male. The mean age of all participants was 
37.3 ± 10.7 years (range 18–60 years) with no signifi-
cant difference between gender and regions. The average 
body mass index (BMI) of the urban cohort was signifi-
cantly higher (23.8 ± 3.2 kg/m2) than in the rural cohort 
Table 1  Regional distribution and demographic characteristics of the 
participants
SD standard deviation
* p < 0.001 as compared with rural cohort, p value obtained from 
independent sample t test
Characteristics Rural Urban All
Subjects (n) 52 43 95
Gender (n)
 Men 25 22 47
 Women 27 21 48
Age (years)
 Mean ± SD 39.3 ± 11.9 34.9 ± 8.6 37.3 ± 10.7
 Range 18–60 24–58 18–60
Occupation n, (%)
Men
 Farmers 21 (84) 0 21 (45)
 Office worker 0 20 (91) 20 (43)
 Student 1 (4) 2 (9) 3 (6)
 Others 3 (12) 0 3 (6)
Women
 Housewives 26 (96) 15 (71) 41 (85)
 Office workers 0 2 (10) 2 (4)
 Student 1 (4) 4 (19) 5 (11)
BMI (kg/m2)
 Mean ± SD 21.7 ± 3.4 23.8 ± 3.2* 22.6 ± 3.4
 Range 14.3–32.0 18.2–32.9 14.3–32.9
Creatinine (g/L)
 Mean ± SD 0.70 ± 0.39 0.87 ± 0.62 0.78 ± 0.51
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(21.7 ± 3.4 kg/m2). There was no significant difference in 
urinary creatinine levels of the rural and urban cohort. The 
rural people are mainly farmers or farm workers involved 
in grain production; housewives in rural areas often also 
take part in farm work. The urban residents are university 
employees or work at home (housewives). All participants 
consumed the typical Bangladeshi staple food rice and to 
a lesser extent roti (whole wheat flatbread); these are gen-
erally consumed with vegetables, lentils, fish, poultry and 
beef. They use several types of spices (red chilli powder is 
the most common one) for preparation of their daily food. 
There are also some differences in eating habits between 
the two cohorts (see discussion section).
Levels of AFM1 in the rural and urban cohort
The distribution of AFM1 concentrations in urine samples 
grouped according to age and gender is depicted in Fig. 1. 
Urine samples containing AFM1 levels at or above the 
method detection limit (30 pg/mL) are considered as posi-
tive samples. The overall AFM1 detection frequency is 46 %, 
with 50 % positives in the rural and 42 % in the urban cohort. 
The mean, median and range of urinary AFM1 concentra-
tions and also the creatinine-adjusted mean AFM1 concentra-
tions of all groups are given in Table 2. The range of AFM1 
was 31–348 pg/mL (or 20–533 pg/mg creatinine), with 
median and mean values of 61 and 80 ± 60 pg/mL, respec-
tively, in all urine samples. The mean AFM1 values in urines 
of the rural cohort (99 ± 71 pg/mL, 164 ± 98 pg/mg creati-
nine) were higher than in the urban cohort (54 ± 15 pg/mL 
or 83 ± 48 pg/mg creatinine), and this difference reached 
statistical significance (p < 0.05; p < 0.01; Table 2).
Further statistical data analysis revealed no significant cor-
relations for urinary AFM1 concentration with gender, age and 
BMI of the study participants. The highest mean value of uri-
nary AFM1 (101 ± 71 pg/mL or 174 ± 88 pg/mg creatinine) 
was observed in the 50–60 years age group (Table 3). The body 
mass index of the participants showed a negative trend of corre-
lation with AFM1, but at an insignificant level (data not shown).
Correlation between urinary AFM1 concentration 
and food intake
From information provided in the food frequency question-
naires, possible correlations were analysed between urinary 
AFM1 levels and food consumption (graded 1–4) in the 
cohorts. The food items rice, wheat/maize, lentils, chicken 
meat, groundnut, milk and milk-based products were con-
sidered in Spearman correlation analysis (Table 4). Con-
sumption of rice, the main staple food in Bangladesh, 
showed a positive trend of correlation (p = 0.09) with the 
urinary AFM1 level of the subjects. No significant corre-
lations were observed between AFM1 in urine and other 
foods such as wheat/maize (p = 0.53), lentils (p = 0.52), 
chicken meat (p = 0.51) or milk and milk-based products 
(p = 0.18) and groundnut (p = 0.37).
Discussion
This is the first study that reports AFM1 levels in urines 
from rural and urban residents of Bangladesh. The frequent 
detection of AFM1 (46 %)
1 in the 95 urine samples 
1 Percentage of positive samples based on the method detection limit 
of 30 pg/mL; detection frequency can vary depending on methods 
and detection limits.
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Fig. 1  Distribution of urinary AFM1 concentrations in participants 
by age and gender. Only positive samples (≥30 pg/mL) are repre-
sented in the graph (n = 44)
Table 2  AFM1 levels in urines according to gender and region
a p < 0.05 and b p < 0.01 when compared to urban, p value obtained 
from independent sample t test. The mean and median value of AFM1 
were calculated based on positive samples (≥30 pg/mL)
Cohort  
subgroup
n Positive Median 
(range)
Mean ± SD
n (%) (pg/mL) (pg/mL) (pg/mg 
creatinine)
All subjects 95 44 (46) 61 (31–348) 80 ± 60 130 ± 90
Rural
 Female 27 14 (52) 65 (34–160) 82 ± 43 181 ± 123
 Male 25 12 (48) 84 (39–348) 118 ± 93 144 ± 58
 All 52 26 (50) 75 (34–348) 99 ± 71a 164 ± 98b
Urban
 Female 21 12 (57) 50 (31–84) 50 ± 14 80 ± 46
 Male 22 6 (27) 65 (35–79) 61 ± 16 88 ± 55
 All 43 18 (42) 52 (31–84) 54 ± 15 83 ± 48
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(Table 2) and the range of concentrations detected (31–
348 pg/mL or 20–533 pg/mg creatinine) clearly indicate a 
significant aflatoxin exposure of the adult Bangladeshi pop-
ulation. To put this finding into perspective, our new data 
can be compared with urinary AFM1 biomarker data from 
studies carried out in several countries on different conti-
nents. Although different methods for urinary AFM1 analy-
sis were used with different limits of detection, the reported 
mean concentrations and ranges provide an orientation for 
aflatoxin exposure in African, Asian, European and South 
American populations.
Studies in Brazil reported AFM1 mean levels of 1.2 
(range 0.25–6.9) pg/mL (Jager et al. 2014) and 5.9 (range 
1.8–39.9) pg/mL urine (de Romero et al. 2010). These val-
ues are clearly lower than those in the Bangladeshi cohorts. 
In Europe, very low AFM1 levels (mean 0.39, range 0.02–
19 pg/mg creatinine) were found in a large (n = 205) Czech 
cohort (Ostry et al. 2005). Urines from Germany (n = 101; 
n = 50) and Belgium (n = 32) had no measurable bio-
marker levels (Gerding et al. 2014, 2015; Huybrechts et al. 
2014), and only 3 of 52 urine samples (6 %) in Southern 
Italy contained AFM1 (mean 68, range 20–146 pg/mL; Sol-
frizzo et al. 2014). In urines from various Asian countries, 
AFM1 has been detected quite frequently: in two Malaysian 
cohorts, mean levels of 23.4 and 42.1 pg/mL, with ranges 
of 11–154.7 ng/mL, were reported (Sabran et al. 2012a, b). 
These AFM1 concentrations are lower than those observed 
in our Bangladeshi cohorts (Table 2).
Many studies have been conducted in China, often in 
regions with widespread dietary aflatoxin exposure. Some 
reports do not mention mean values for urinary AFM1 lev-
els, but provide ranges LOD to 3200 pg/mL (Zhu et al. 
1987) or 170–5200 pg/mL (Qian et al. 1994). About tenfold 
lower maximum levels were reported in two other studies, 
with a mean of 9.6 (LOD to 243) pg/mL (Sun et al. 1999) 
or 40 (range 10–330) pg/mL (Mykkänen et al. 2005). But 
two more recent studies found again a wider range of uri-
nary AFM1 levels: Lei et al. (2013) reported a mean of 51.5 
(range LOD to 4900) pg/mL in a male cohort and a mean 
of 50.3 (range LOD to 3500) pg/mL in pregnant women. 
A similar extent of exposure was observed in interven-
tion studies conducted by Tang et al. (2008) who applied 
a series of AFB1 biomarkers, including AFM1: the range 
observed over 3 months in the group with no intervention 
was 0.24–1276.2 pg/mg creatinine and mean AFM1 levels 
of 59.4, 61.7 and 78.7 pg/mg creatinine. The creatinine-
adjusted values in our Bangladesh cohort give a mean of 
130 and a range of 20–533 pg/mg creatinine (Table 2). 
Thus, their average aflatoxin exposure appears to be of a 
similar magnitude as that found in several studies in China, 
although maximal AFM1 biomarker levels in Bangladeshi 
adults were lower than in Chinese individuals.
In Africa, the highest urinary AFM1 levels were found 
in Ghana in adults (mean 1800, range LOD to 11,562 pg/
mg creatinine; Jolly et al. 2006) and in Sierra Leone in 
children (ranges in two seasons of 100–124,000 and 500–
374,000 pg/mL; Jonsyn 2000). More recent data for chil-
dren and adolescents in Nigeria (mean 300, range LOD to 
1500 pg/mL; Ezekiel et al. 2014) and infant urines from 
Guinea (mean 97, range 8–801 pg/mL; Polychronaki et al. 
2008) reveal that AFB1 exposure continues to be significant 
in several sub-Saharan African countries.
Since aflatoxin contamination of food is known to 
be highly variable, one can expect that urinary excretion 
of its metabolite AFM1 by individuals consuming such 
food will be also quite variable (vide supra). With a bio-
logical half-life of about 1 day, the urinary excretion of 
AFM1 biomarker would reflect dietary AFB1 intake aver-
aged over 1–3 days (Cheng et al. 1997). Therefore, the 
food frequency questionnaire for our Bangladeshi cohort 
focused on consumption of various items during the last 
2 days prior to urine collection, yet it recorded also regu-
lar dietary habits. This information was used to look for 
correlations with urinary biomarker levels in our cohorts: a 
trend for a positive correlation was only observed between 
urinary AFM1 levels and rice consumption during the last 
Table 3  AFM1 levels in urines according to age groups of the par-
ticipants
Mean value of AFM1 calculated for the positive samples (≥30 pg/
mL). AFM1 levels within the groups were calculated using ANOVA 
test
Age (years) n Positive Mean ± SD
n (%) (pg/mL) (pg/mg creatinine)
18–29 23 15 (61) 65 ± 29 104 ± 59
30–39 35 16 (46) 84 ± 78 136 ± 118
40–49 17 4 (24) 76 ± 29 109 ± 31
50–60 20 9 (45) 101 ± 71 174 ± 88
Table 4  Correlation (r) between last 2 days food consumption and 
urinary AFM1 concentration
Assessment of food consumption was done using the score 1–4 
(1 = do not consume at all, 2 = 1 time daily, 3 = 2 times daily and 
4 = 3 times daily). Positive samples (≥30 pg/mL) were considered 
for correlation analysis. P values obtained from Spearman’s correla-
tion coefficient (two-tailed)
Food item Correlation (r) p value
Rice 0.257 0.093
Wheat/maize 0.076 0.534
Lentil −0.064 0.523
Chicken meat 0.065 0.512
Milk and milk products −0.206 0.181
Groundnut −0.138 0.371
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2 days (Table 4). The higher levels of AFM1 in residents of 
the rural area (Table 2) may be related to regularly higher 
consumption of rice by the rural people than the urban 
people. The reported AFB1 contamination of rice samples 
from Bangladesh was comparatively low (Dawlatana et al. 
2002; Roy et al. 2013), yet it is the main staple food, and 
higher AFB1 levels were found in parboiled rice in India 
(Reddy et al. 2009) and in rice in central Vietnam, with 
clear seasonal effects (Nguyen et al. 2007). However, other 
sources cannot be excluded. Rice is usually consumed 
with curries prepared with spices, mainly red chilli pow-
der. Chilli samples from Bangladesh and Sri Lanka often 
contain AFB1 at levels exceeding EU regulatory limits 
(Roy et al. 2013; Yogendrarajah et al. 2014). Whilst con-
sumption of spices was not been recorded in our food 
questionnaire, other items such as groundnuts, known as 
a source of AFB1 (Dawlatana et al. 2002; Roy et al. 2013), 
were only rarely consumed by our cohort (during the last 
2 days only once by 6 of 95 persons). Thus, it is presently 
not possible to put a tag on those food items which con-
tribute mostly to aflatoxin exposure in the Bangladeshi 
cohort.
AFM1 constitutes only a small part of the total metabo-
lized AFB1 (Neal et al. 1998) and a urinary excretion rate 
of about 2 % of an ingested dose (Zhu et al. 1987). None-
theless, the urinary AFM1 biomarker data clearly indicate a 
frequent exposure to aflatoxins in Bangladesh, and at lev-
els similar to those found in other Asian countries (China, 
Malaysia, vide supra). This new finding and the recent 
study of another (long-term) biomarker of exposure (afla-
toxin B1-lysine albumin adduct) in blood of Bangladeshi 
pregnant women and their children raise concerns (Groop-
man et al. 2014). Therefore, analysis of AFB1 contamina-
tion in food should be continued, also for commodities 
such as maize and parboiled rice which were not included 
in the recent survey (Roy et al. 2013).
Moreover, as Bangladesh has a subtropical monsoon 
climate, characterized by clear seasonal variations in rain-
fall, temperature and humidity (http://en.wikipedia.org/
wiki/Geography_of_Bangladesh) and since aflatoxin con-
tamination of crops is quite heterogenous and varies with 
environmental conditions, further human biomonitoring 
is indicated. Follow-up biomarker studies in adults, with 
urine sampling in the summer season, and also in other 
parts of the population (pregnant women and infants) will 
provide better insights regarding exposure to a highly toxic 
mycotoxin.
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rural compared to the urban cohort were only observed in 
winter urines. CIT biomarkers showed more pronounced 
variations, with a CIT mean of 0.10 ± 0.17 ng/mL (range 
0.02–1.22 ng/mL) and HO-CIT mean of 0.42 ± 0.98 ng/
mL (range 0.02–5.39 ng/mL) in summer, and CIT mean of 
0.59 ± 0.98 ng/mL (range 0.05–5.03 ng/mL) and HO-CIT 
mean of 3.18 ± 8.49 ng/mL (range 0.02–46.44 ng/mL) in 
winter urines of both cohorts. In both seasons, total CIT 
biomarker concentrations were significantly higher in the 
rural cohort than in the urban cohort. A provisional daily 
intake for CIT was calculated and exceeded a preliminary 
value set by EFSA (0.2 µg/kg/d) in 10 and 24 % of par-
ticipants in summer and winter, respectively. No significant 
correlations were found between urinary biomarker levels 
and intake of certain types of food, except for a positive 
trend for higher rice consumption. Our results in the Bang-
ladeshi population indicate frequent co-exposure to nephro-
toxic mycotoxin food contaminants that vary by season and 
region.
Keywords Biomarkers · Citrinin · Exposure · 
Mycotoxins · Ochratoxin A · Urine
Abbreviations
CIT  Citrinin
HO-CIT  Dihydrocitrinone
OTA  Ochratoxin A
OTα  Ochratoxin alpha
Introduction
Ochratoxin A (OTA) and citrinin (CIT) are secondary fun-
gal metabolites produced by some Aspergillus and Penicil-
lium species (Frisvad et al. 2006). These mycotoxins can 
Abstract Biomonitoring studies can provide valuable 
insights into human mycotoxin exposure, especially when 
food contaminant data are scarce or unavailable as in Bang-
ladesh. First biomonitoring data in Bangladeshi adults indi-
cated exposure to the nephrotoxic mycotoxins ochratoxin A 
(OTA) and citrinin (CIT). This led us to conduct a follow-
up study with analysis of urinary biomarkers for both CIT 
and OTA to investigate regional and seasonal influences on 
mycotoxin exposure in two Bangladeshi cohorts. In total, 
164 urines were collected (n = 69 in summer, n = 95 in 
winter) from residents of a rural and an urban area, among 
which there were 62 participants enrolled in both sam-
pling periods. Most urines had detectable biomarker levels 
(OTA, CIT and its metabolite dihydrocitrinone, HO-CIT), 
with more or less pronounced differences with regard 
to season and region. In both cohorts, OTA was found at 
a mean level of 0.06 ± 0.10 ng/mL urine (range 0.01–
0.55 ng/mL) in summer and a mean of 0.19 ± 0.38 ng/mL 
(range 0.01–1.75 ng/mL) in winter season. A season dif-
ference was significant in the rural cohort, but not in the 
urban cohort, and slightly higher mean OTA levels in the 
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be found in various foodstuffs and in animal feed, and their 
co-occurrence has raised concerns for human and animal 
health (Ostry et al. 2013). Both mycotoxins are nephro-
toxic to animals, although CIT is less potent than OTA 
(EFSA 2006, 2012). OTA is carcinogenic to rodents and 
has been classified as group 2B human carcinogen, while 
CIT is in group 3 due to limited evidence for carcinogenic-
ity in experimental animals (IARC 1986, 1993). Chronic 
OTA exposure has been associated with Balkan endemic 
nephropathy, although other etiologic agents including CIT 
are also discussed (Castegnaro et al. 2006; Peraica et al. 
2008; Pfohl-Leszkowicz 2009).
Co-occurrence of these mycotoxins has been found in 
cereals from Balkan endemic nephropathy regions of Bul-
garia (Petkova-Bocharova et al. 1991; Vrabcheva et al. 
2000a, b), in grains in Germany (Meister 2003; Schmidt 
et al. 2003) and in rice in India and Vietnam (Nguyen et al. 
2007; Reddy et al. 1983). While many surveys have been 
conducted on OTA contamination of human foods (EC/
SCOOP 2002), data on CIT occurrence in foodstuffs are 
still limited and insufficient to reliably estimate CIT expo-
sure in the human population (EFSA 2012).
When food contaminant data are scarce which is often 
the case in developing countries, analysis of mycotoxin 
biomarkers in human body fluids (biomonitoring) can pro-
vide useful insights into human exposure (Duarte et al. 
2011; Turner et al. 2012). Bangladesh, a developing coun-
try in subtropical South Asia, has a climate characterized 
by distinct seasonal variations in rainfall, temperature and 
humidity. This hot and humid climate makes a suitable 
environment for the growth of molds on food and feed in 
Bangladesh, and mycotoxin contamination of food com-
modities may vary between seasons. Occurrence of OTA 
has been reported in plant-derived foods (maize, cereals 
and groundnuts) and in feeds in Bangladesh (Dawlatana 
et al. 2002, 2008), but data on CIT in food or feed are 
unavailable.
A recent biomonitoring study indicated the presence 
of OTA in blood plasma of adult Bangladeshi students at 
levels similar to those found in Germany (Ali et al. 2014). 
First analysis of CIT biomarkers in urines from adult peo-
ple in Bangladesh indicated a frequent exposure, higher 
than in Germany (Ali et al. 2015b). However, information 
on seasonal and regional variations and a possible co-expo-
sure to both nephrotoxic mycotoxins in the population of 
Bangladesh is still lacking.
Therefore, in total 164 urine samples were collected on 
two occasions (n = 69 in summer and n = 95 in winter) 
from residents of a rural and an urban area of Bangladesh, 
among which there were 62 participants who enrolled in 
both sampling periods. Their urine samples were analyzed 
by two sensitive methods for targeted analysis of OTA 
(Muñoz et al. 2010) and CIT (Blaszkewicz et al. 2013) 
biomarkers in human urine. These methods have proved to 
be useful for analysis of urines from Chile, Germany and 
Bangladesh (Muñoz et al. 2014; Ali et al. 2015a, b). In 
addition to the parent compounds OTA and CIT, their main 
metabolites ochratoxin alpha (OTα) and dihydrocitrinone 
(HO-CIT) were analyzed also, since the often higher 
metabolite levels in urine may increase sensitivity and 
thereby facilitate exposure monitoring (Muñoz et al. 2010; 
Coronel et al. 2011; Klapec et al. 2012; Ali et al. 2015c).
Materials and methods
Chemicals and materials
Methanol (HPLC grade), chloroform, isopropanol, ace-
tic acid (96 %), sodium hydrogen carbonate (NaHCO3) 
and phosphoric acid (85 %) were purchased from Merck 
(Darmstadt, Germany). Acetonitrile and methanol (LC–
MS grade) were from Promochem (Wesel, Germany). 
OTA (purity >98 %) was obtained from Sigma-Aldrich 
(Taufkirchen, Germany) and OTα standard (purity 
98.9 %; 11.9 µg/mL acetonitrile) from Biopure (Tulln, 
Austria). OTA was dissolved in methanol and calibrated 
spectrophotometrically at 333 nm using the molar (M) 
extinction coefficient of 6400 M−1 cm−1. CIT stand-
ard material (5 mg, purity >98 %) was purchased from 
Sigma-Aldrich (Taufkirchen, Germany); CIT solutions 
in methanol were calibrated at 321 nm using the absorp-
tivity ε = 5490 M−1 cm−1 (Molinie et al. 2005). The 
CIT metabolite dihydrocitrinone (HO-CIT) [C13H14O6; 
(3R,4S)-6,8-dihydroxy-3,4,5-trimethyl-1-oxo-3,4-dihydro-
1H-iso-chromene-7-carboxilic acid; purity 98.9 %] was 
from AnalytiCon Discovery GmbH (Potsdam, Germany). 
For OTA and OTα, the working standard solutions were 
prepared weekly as dilutions in methanol/water (1:1, v/v) 
in a range from 0.10 to 10 ng/mL. For CIT and HO-CIT, 
working standard solutions were prepared weekly from a 
stock solution of CIT (200 µg/mL acetonitrile) and HO-CIT 
(500 µg/mL acetonitrile), by dilution in methanol in a range 
of 1–20 ng/mL. The β-glucuronidase/arylsulfatase (β-Gluc/
ArylS) enzyme from Helix pomatia (specific activity 5.5 
U/mL β-glucuronidase, 2.6 U/mL arylsulfatase at 37 °C) 
was purchased from Roche (Mannheim, Germany).
Cohorts and collection of urines
In May 2013 (summer season), urine samples were col-
lected from 69 volunteers of which 32 were residents of a 
rural area (Mongol Para, Puthia) and 37 of an urban area 
(Rajshahi University region) in the Rajshahi District of 
Bangladesh. In February 2014 (winter season), 95 urine 
samples (52 rural and 43 urban participants) were collected 
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from the same areas. There were 62 volunteers who pro-
vided urines in both sampling rounds. Urine donors were 
informed about the study, and a written consent was 
obtained from all participants prior to inclusion in the 
study. The participants were of good health, and they were 
asked to fill a short questionnaire for anthropometric infor-
mation (age, gender, height and weight), occupation and 
food habits. First morning urine samples were collected 
into a non-sterile disposable container (approximately 
50 mL) in both collection periods. Urine samples were first 
stored at −20 °C at Rajshahi University and sent on dry ice 
to IfADo, Dortmund, for subsequent biomarkers analysis. 
To control for differences of urine dilution between individ-
ual spot urines, creatinine was also measured by a modified 
Jaffe method (Blaszkewicz and Liesenhoff-Henze 2012). 
This study was approved by the Institute of Biological Sci-
ences of Rajshahi University, Rajshahi-6205, Bangladesh, 
and by the Institutional Internal Review Board of IfADo.
Collection of food consumption data
All participants were asked to fill a questionnaire about 
their daily, weekly and normal food habits. Foods con-
sumed by the study subjects 2 days prior of sample col-
lection were also recorded in the questionnaire. The food 
frequency questionnaire (FFQ) asked for intake of typi-
cal food consumed by Bangladeshi people: staple foods, 
mainly cereals such as rice, wheat, maize and lentils as 
the major pulse. Chicken meat, eggs, milk and milk-based 
products were also included, as well as coffee and bever-
ages. Among all foodstuffs, only rice is regularly consumed 
by the participants one to three times in a day. Beer and 
wine, items of relevance for OTA intake in Europe (EC/
SCOOP 2002), are usually not consumed in Bangladesh, 
and coffee is generally consumed only by a few urban peo-
ple. Assessment of food consumption was done using the 
score 1–4 (1 = do not consume at all, 2 = 1 time daily, 
3 = 2 times daily and 4 = 3 times daily).
Sample preparation and chromatographic analysis
Urinary concentrations of OTA and CIT biomarkers were 
analyzed by validated methods (Muñoz et al. 2010; Blasz-
kewicz et al. 2013) which apply liquid–liquid extraction for 
OTA, and immunoaffinity column cleanup for CIT extrac-
tion. Briefly, for OTA prior to extraction, 3 mL urine sam-
ple was enzymatically treated by adding 250 µL hydrolysis 
buffer (pH 5.0) and 40 µL of β-Gluc/ArylS and incubation 
at 37 °C overnight. Then, the hydrolyzed urine sample was 
mixed with 3 mL of 1 % NaHCO3, and pH was adjusted 
to 2.8–3.0 with 1 M H3PO4. Then 3 mL chloroform/iso-
propanol (97:3) mixture was added and kept on a rotary 
mixer for 20 min, followed by centrifugation at 4500 rpm 
for 20 min at 20 °C. The aqueous upper layer was dis-
carded, and 2 mL of the organic layer was transferred with 
a pipette to a vial and evaporated to dryness under a stream 
of nitrogen at 45 °C. The residue was dissolved in 500 µL 
of methanol/water (1:1). The vial was vortexed and cen-
trifuged, and the extract was filtered through a 0.45-µm 
pore size Teflon syringe filter (WICOM, Germany) before 
HPLC analysis. For CIT and HO-CIT extraction, urine ali-
quots were diluted with the same volume of 1 mM acetic 
acid and then loaded on a CitriTest® column (Vicam® pur-
chased from Ruttmann, Hamburg, Germany) for cleanup 
and enrichment of the analytes; further details of the proce-
dure are described elsewhere (Ali et al. 2015b).
Analysis of OTA and its metabolite OTα was carried out 
by high-performance liquid chromatography with fluores-
cence detection (Ali et al. 2014), and CIT and its metabo-
lite HO-CIT were measured by liquid chromatography with 
tandem mass spectrometry (Ali et al. 2015b). Spiked sam-
ples were used to define the minimum detectable level: The 
limit of detection (LOD) and limit of quantification (LOQ) 
were determined based on the lowest quantity of analyte 
that can be clearly distinguished (LOD) from the back-
ground (S/N = 3) or quantified (LOQ; S/N ≥ 6). The LOD 
and LOQ for OTA and OTα in urine were 0.01 and 0.02 ng/
mL, respectively. For CIT and HO-CIT, the LOD was 0.02 
and 0.05 ng/mL, and the LOQ was 0.05 and 0.10 ng/mL, 
respectively. Recovery assays were performed in urine with 
no measurable background of the analytes. For OTA and 
OTα, recovery of analytes was assessed at three concentra-
tion levels in triplicate spiked samples with mean values 
of 97 and 68 %, respectively. For CIT and HO-CIT, recov-
ery of analytes was assessed at three concentration levels 
in triplicate spiked samples with mean values of 79 and 
82 %, respectively. The intraday repeatability and inter-day 
repeatability at a spike concentration of 0.25 ng/mL (n = 6) 
were determined using also mycotoxin-free urine, and 
showed acceptable precisions for both OTA and CIT and 
their metabolites at these low concentrations.
CIT intake assessment
The estimation of CIT intake among the participants 
was performed based on results of urinary total CIT 
(CIT + HO-CIT) analysis. The following equation was 
used to assess the provisional daily intake (PDI) of CIT 
among the participants.
where C = biomarker concentration (µg/L), V = daily urine 
excretion (L), W = body weight (kg) and E = excretion 
rate (%). In the calculation, urinary output was considered 
as 1.5 L per day and the urinary total CIT daily excretion 
PDI
(
µg
kg
body weight
)
= C ×
V
W
×
100
E
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rate as 36 % of an ingested dose (Ali et al. 2015c). Indi-
vidual body weight was used during the calculation of PDI.
Statistical analysis
Statistical analysis of data was performed using the soft-
ware IBM SPSS Statistics version 22. Descriptive analy-
sis was used to determine mean, median and interquartile 
ranges of the analytes. Those samples containing analyte 
levels below the limit of detection (LOD) were assigned 
a value of one-half the detection limit for calculation of 
mean and median values, since this is considered a better 
approach to estimate average concentrations for left cen-
sored data rather than assigning a value of zero to measure-
ments below a detection limit (Hornung and Reed 1990). 
Differences of the analytes’ concentrations between the 
male–female cohorts, regions and seasons were analyzed 
by independent sample t test. Spearman correlation coeffi-
cient (two-tailed) was used to assess the correlation of ana-
lytes with food consumption, age, gender and body mass 
index (BMI). One-way ANOVA was used to compare ana-
lyte concentrations in the rice consumption groups. A level 
of alpha 0.05 was assigned for statistical significance. Box 
plots were used to describe analyte concentration by region 
and season. The box represents the central data of distribu-
tion where upper and lower limits of the box indicate 25th 
and 75th percentiles (first quartile or Q1 and third quartile 
or Q3, respectively), and the median value is presented as a 
line inside the box.
Results
Demographic characteristics of the study cohorts
Demographic characteristics of the two cohorts are sum-
marized in Table 1. One-half of the participants enrolled 
in both samples collection were male and the other half 
female. Among all participants, 30 (15 males, 15 females) 
were inhabitants of a rural and 32 (16 males and 16 
females) of an urban area. The mean age of our volun-
teers was 39 ± 11 years (range 22–60 years) with no sig-
nificant difference in gender or regions. The average body 
mass index (BMI) of the urban cohort was significantly 
higher (23.8 ± 3.2 kg/m2) than that of the rural cohort 
(21.4 ± 2.6 kg/m2). There were no significant differ-
ences in urinary creatinine levels between rural and urban 
cohorts, yet a significant difference was observed between 
summer (0.43 ± 0.51 g/L) and winter (0.78 ± 0.51 g/L) 
season. The higher level of urinary creatinine found in win-
ter may be related to seasonal differences in food/drinking 
habits and/or collection of first morning void urine which 
is more concentrated. The rural people are mainly farmers 
or farm workers involved in grain production; housewives 
in rural areas often also take part in farm work. The urban 
residents are university employees or work at home (house-
wives). All participants consumed the typical Bangladeshi 
staple food rice and, to a lesser extent, roti (whole wheat 
flatbread); these are generally consumed with vegetables, 
lentils, fish, poultry and beef.
Urinary levels of OTA and OTα by cohorts and seasons
Urines with analyte concentrations at or above the limit 
of detection (LOD) were considered as positive samples. 
The distribution of urinary levels of ochratoxin A and its 
metabolite OTα in the rural and urban cohort are shown 
in Fig. 1. Overall, in summer the OTA and OTα detection 
frequency was 71 and 53 % and in winter 98 and 62 %, 
respectively (Table 2). Urinary levels of OTA and OTα in 
the two cohorts and male–female subgroups in summer and 
winter are given in Table 2. For OTA, no significant dif-
ference was found between the rural and urban cohorts in 
summer. However, in rural cohort a significant difference 
Table 1  Regional distribution and demographic characteristics of the 
participants
a p < 0.001 when compared to rural cohort and b p < 0.05 when com-
pared to summer
c Value presented as mean ± SD
Characteristics Rural cohort Urban cohort All
Subjects (n) 30 32 62
Gender (n)
 Men 15 16 31
 Women 15 16 31
Age (years)
 Mean ± SD 41 ± 12 36 ± 9 39 ± 11
 Range 22–60 24–57 22–60
Occupation, n (%)
 Men
  Farmers 11 (73) 0 11 (35)
  Office worker 0 16 (100) 16 (52)
  Student 1 (7) 0 1 (3)
  Others 3 (20) 0 3 (10)
 Women
  Housewives 15 (100) 11 (69) 26 (84)
  Office workers 0 2 (12) 2 (6)
  Student 0 3 (19) 3 (10)
BMI (kg/m2)
 Mean ± SD 21.4 ± 2.6 23.8 ± 3.2a 22.6 ± 3.2
 Range 16.2–27.3 18.9–32.9 16.2–32.9
Creatinine (mg/L)c
 Summer 388 ± 407 412 ± 468 400 ± 436
 Winter 719 ± 405 871 ± 664b 798 ± 554
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(p < 0.05) was found for the mean OTA level between the 
summer (0.05 ± 0.08 ng/mL) and winter (0.28 ± 0.52 ng/
mL) season. The mean level of OTA for all subjects (both 
cohorts) was significantly higher (p < 0.01) in winter 
(0.19 ± 0.38 ng/mL) than in summer (0.06 ± 0.10 ng/mL) 
season (Table 2).
The metabolite OTα was present in summer urine at 
about fourfold higher levels than OTA (mainly due to one 
OTα value of 6.10 ng/mL) and twofold lower than the par-
ent compound in winter. The ratio of OTA to OTα in the 
male and female subgroups of both cohorts varied consid-
erably (Fig. 1). The rural cohort with higher urinary levels 
of parent compound OTA apparently excreted also more of 
the non-toxic metabolite (Table 2). As depicted in Fig. 3a, 
excretion of OTA is significantly higher (p < 0.05) in win-
ter than in summer season in the rural area. Statistical 
analysis revealed no significant correlation of urinary bio-
markers with age, gender and BMI of the study subjects. 
The biomarker levels for all subjects enrolled in summer 
(n = 69) and in winter (n = 95) are presented in Supple-
mentary Table 1.
Urinary levels of CIT and HO‑CIT by cohorts 
and seasons
The distribution of urinary levels of CIT and its metabo-
lite HO-CIT in the rural and urban cohort are shown in 
Fig. 2. Urines with analyte concentrations at or above the 
limit of detection (LOD) were considered as positive sam-
ples. Overall, in summer the CIT and HO-CIT detection 
frequency was 95 and 71 % and in winter 92 and 97 %, 
respectively (Table 3). Urinary CIT and HO-CIT levels of 
the two cohorts and of subgroups in two seasons are given 
in Table 3. In summer, a significant difference (p < 0.05 
and p < 0.01) was found for the mean level of CIT and HO-
CIT between the rural (0.14 ± 0.22, 0.78 ± 1.33 ng/mL) 
and the urban (0.06 ± 0.08, 0.08 ± 0.08 ng/mL) cohort. 
In winter season, only the mean level of HO-CIT showed 
a significant difference (p < 0.001) between the rural 
(5.95 ± 1.63 ng/mL) and the urban (0.60 ± 1.02 ng/mL) 
cohort. On the other hand, in both cohorts a significant dif-
ference (p < 0.05) was found for CIT and HO-CIT levels 
between summer and winter season (Table 3).
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Fig. 1  Distribution of ochratoxin A and ochratoxin alpha in the rural 
(a, b) and urban (c, d) cohort in summer and winter season. Accord-
ing to serial number on the x-axis, the first half are men and second 
half are women participants in both cohorts. Log-transformed values 
are presented in the graph
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In urines from both seasons, the metabolite HO-CIT 
was present at about fivefold higher levels than the par-
ent compound, indicative of HO-CIT as useful additional 
biomarker of citrinin exposure. Although the ratio of CIT 
to HO-CIT in the male and female subgroups of both 
cohorts varied considerably (Fig. 2), the rural cohort with 
higher urinary levels of CIT (parent compound) apparently 
excretes also more of the metabolite (Fig. 2; Table 3). Uri-
nary total citrinin (CIT + HO-CIT) is significantly higher 
in the rural cohort than in the urban cohort of Bangladeshi 
adults, and a significant difference between summer and 
winter season also indicates a different exposure by season 
(Fig. 3b). The biomarker levels for all subjects enrolled in 
summer (n = 69) and in winter (n = 95) are presented in 
Supplementary Table 2. Statistical analysis revealed no sig-
nificant correlation of urinary biomarkers with age, gender 
and BMI of the study subjects.
Co‑occurrence and correlation of OTA with total CIT
Considering all positive samples (≥LOD), the presence 
(co-occurrence) of both OTA and total CIT biomarkers 
in urine was 68 % in summer and 97 % in winter season, 
respectively (Table 4). A significant positive co-relationship 
was found between OTA and total CIT in the rural cohort 
(p < 0.05) and also for all subjects (p < 0.01) in winter sea-
son. The higher percentage of co-occurrence and significant 
positive correlation between two biomarkers may be related 
to the higher levels of OTA and total CIT in winter urines 
and/or the presence of fungi on stored crops which may 
produce both mycotoxins under certain climatic conditions.
Biomarker‑based CIT intake estimates for the 
Bangladeshi cohorts
The daily intake of CIT was calculated based on a urinary 
excretion rate of total CIT (36 %) over 24 h as observed in 
a human volunteer (Ali et al. 2015c). When expressed as µg/
kg b.w./day, the mean daily intake of CIT was 0.043 ± 0.099 
and 0.304 ± 0.776 µg/kg b.w./day in the summer and win-
ter season, respectively (Table 5). The estimated daily intake 
was significantly higher in the rural cohort than in the urban 
cohort, both in summer (p < 0.01) and in winter (p < 0.05) 
season (Table 5). This can be compared with the preliminary 
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Fig. 2  Distribution of citrinin and dihydrocitrinone in the rural (a, b) 
and urban (c, d) cohort in summer and winter season. According to 
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women participants in both cohorts. Log-transformed values are pre-
sented in the graph
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tolerable daily intake for CIT of 0.2 µg/kg body weight per 
day discussed by EFSA (2012) (‘no concern for nephrotoxic-
ity in humans’). There were 10 % participants in summer and 
24 % participants in winter who had a CIT exposure above 
the tolerable daily intake proposed by EFSA (2012), and 
the highest calculated intake in one person was 4.66 µg/kg 
b.w./day (Table 5).
Correlation between biomarker levels in urine and food 
consumption pattern
Based on information provided in the food frequency 
questionnaires (FFQ), possible correlations were analyzed 
between food consumption (graded 1–4) in the cohorts 
and urinary biomarkers level of OTA, CIT and their 
Fig. 3  Urinary biomarker levels of OTA (a) and total CIT (b) in the 
rural and urban cohorts in summer and winter season. In a, significant 
difference found between a and b (p < 0.05). In b, significant differ-
ence found between a and b (p < 0.05), c and d (p < 0.01), a and c 
(p < 0.01) and b and d (p < 0.05)
Table 4  Co-occurrence and 
correlation of ochratoxin A with 
total citrinin
p value obtained from Spearman’s correlation coefficient (two-tailed)
Positive samples (≥LOD) are considered for the calculation. * p < 0.05, ** p < 0.01
Cohort n Summer Winter
Co-occurrence n (%) Correlation (r) Co-occurrence n (%) Correlation (r)
Rural 30 23 (77) 0.249 29 (97) 0.443*
Urban 32 19 (59) 0.024 31 (97) 0.223
All 62 42 (68) 0.114 60 (97) 0.333**
Table 5  Provisional daily intake (PDI) of citrinin (µg/kg b.w.) calculated from urine biomarker concentrations
See ‘Methods’ section and text for further explanations
a p < 0.01, b p < 0.05 when compared to urban cohort. p value obtained from independent sample t test
c Preliminary TDI ‘no concern for nephrotoxicity in humans’ at 0.2 µg/kg b.w. per day (EFSA 2012)
Cohort Summer Winter
n Mean ± SD Median Range Exceeding 
TDIc, n (%)
n Mean ± SD Median Range Exceeding 
TDIc, n (%)
Rural 30 0.079 ± 0.134a 0.022 0.003–0.506 3 (10) 30 0.550 ± 1.064b 0.073 0.005–4.663 11 (37)
Urban 32 0.009 ± 0.009 0.005 0.002–0.049 0 (0) 32 0.073 ± 0.109 0.026 0.002–0.461 4 (12)
All 62 0.043 ± 0.099 0.014 0.002–0.506 3 (10) 62 0.304 ±  0.776 0.043 0.002–4.663 15 (24)
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metabolites. Using Spearman correlation analysis, intake of 
the food items rice, wheat/maize, lentil soup, chicken meat, 
milk and milk-based products and coffee did not show 
significant associations with the urinary biomarker lev-
els (Table 6). However, by one-way ANOVA analysis, the 
highest OTA and total CIT biomarker levels were observed 
in the high rice consumption group compared to medium 
and low rice consumption group (Table 7). The biomarker 
levels with respect to consumption of other food commodi-
ties are presented in Supplementary Table 3.
Discussion
When food contaminant data are scarce or missing as in 
Bangladesh (Islam and Hoque 2013), analysis of mycotoxin 
biomarkers in human urines (biomonitoring) is a valuable 
approach to gain more insights into human exposure to cer-
tain mycotoxins. Based on findings from a pilot study (Ali 
et al. 2015b) and a screening that used multitoxin analysis 
in urines (Gerding et al. 2015), the present investigation 
focused on the two nephrotoxic mycotoxins CIT and OTA. 
This is the first study in rural and urban residents of Bangla-
desh that investigated their exposure to OTA and CIT along 
with regional and seasonal influences on urinary biomarker 
levels and/or possible gender differences. Sensitive targeted 
methods of analysis enabled detection of OTA, CIT and 
their main metabolites (OTα and HO-CIT) in most urines 
collected in summer and winter season (Tables 2, 3). The 
data are discussed first with regard to variables (gender, 
region, season) and possible sources of dietary mycotoxin 
intake in our cohorts. Then biomarker levels in Bangladeshi 
urines are compared with those reported for other countries. 
Finally, possibilities and limitations to relate biomarker-
based exposure estimates to existing tolerable daily intake 
values for CIT and OTA are addressed.
Effects of variables (gender, region, season, dietary 
habits) on biomarker levels
Gender Females often had lower mean levels of OTA 
and CIT biomarkers in urines collected in both seasons, 
except for a higher CIT level in the rural cohort in summer 
(Tables 2, 3). But, statistical data analysis did not reveal 
significant differences in biomarker levels between the 
male and female subgroups. This is not surprising in light 
of considerable interindividual variability in biomarker 
levels (Figs. 1, 2). For urinary OTA, a lack of significant 
difference between male and female participants was also 
observed in several studies carried out in Europe (Duarte 
et al. 2009, 2010; Manique et al. 2008; Coronel et al. 2011). 
Such data are not yet available for CIT biomarkers.
Table 6  Correlation between 
urinary biomarker levels and 
last 2 days of food consumption
Assessment of food consumption is done using the score 1–4 (1 = do not consume at all, 2 = 1 time daily, 
3 = 2 times daily and 4 = 3 times daily. Positive samples (≥LOD) are considered for correlation analysis
p values obtained from Spearman’s correlation coefficient (two-tailed)
Food items Summer Winter
Correlation r (p value) Correlation r (p value)
OTA Total CIT OTA Total CIT
Rice 0.07 (0.56) 0.25 (0.07) 0.03 (0.85) 0.16 (0.20)
Wheat/maize −0.05 (0.56) −0.20 (0.12) −0.07 (0.59) −0.21 (0.10)
Lentil 0.01 (0.92) −0.21 (0.09) 0.19 (0.13) −0.07 (0.56)
Milk and milk products −0.05 (0.71) −0.21 (0.09) 0.19 (0.12) 0.02 (0.88)
Chicken −0.04 (0.08) −0.15 (0.14) −0.03 (0.80) 0.06 (0.64)
Coffee −0.17 (0.18) −0.14 (0.26) −0.12 (0.35) −0.09 (0.45)
Table 7  Urinary biomarkers 
level and last 2 days of rice 
consumption
Low = 1 time/day, medium = 2 times/day and high = 3 times/day rice consumption
* p < 0.05 when compared to low consumption group. One-way ANOVA used for analysis
Group n Summer Winter
Mean ± SD Mean ± SD
OTA (ng/mL) Total CIT (ng/mL) OTA (ng/mL) Total CIT (ng/mL)
Low 8 0.04 ± 0.05 0.08 ± 0.06 0.11 ± 0.07 0.41 ± 0.18
Medium 27 0.05 ± 0.07 0.54 ± 1.38 0.11 ± 0.14 2.34 ± 5.66
High 27 0.07 ± 0.13 0.62 ± 0.93* 0.30 ± 0.54 5.59 ± 12.10
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Region Overall, the mean biomarker levels were higher 
in the rural than in the urban cohort in both seasons (Fig. 3). 
For OTA, the difference between the two cohorts was sta-
tistically not significant. Yet, CIT and HO-CIT levels were 
significantly higher in the rural than in the urban cohort in 
summer season (Table 3), and when considering total CIT 
(the sum of CIT and its metabolite HO-CIT), a signifi-
cant difference was observed between the cohorts in both 
seasons (Fig. 3). At present, it is unclear whether this bio-
marker result reflects a difference in food habits and/or an 
additional occupational exposure in the rural cohort: They 
are mainly farmers involved in grain production, while 
urban people mainly work in offices or at home (Table 1). 
There are also some differences in eating habits between 
these cohorts. Rural people mainly depend on home-cooked 
food, while urban people also take restaurant food occasion-
ally beside the homemade food. The urban people eat less 
rice than the rural people (more details in Ali et al. 2015b).
Season The biomarker levels for both nephrotoxic 
mycotoxins were significantly higher in winter (OTA 
0.19 ± 0.38 ng/mL; CIT 0.59 ± 0.98 ng/mL) than in sum-
mer (OTA 0.06 ± 0.10 ng/mL; CIT 0.10 ± 0.17 ng/mL) 
season (Tables 2, 3). The clear effect of season on urinary 
biomarkers is not only observed for study participants who 
provided urines in both sampling periods (n = 62; Fig. 3; 
Tables 2, 3), but also seen in the larger cohorts (n = 69 in 
summer, n = 95 in winter; Supplementary Table 1 and 2). 
This seasonal variation may be related to the following fac-
tors: Bangladesh has a subtropical monsoon climate with 
wide seasonal variations in rainfall, temperature and humid-
ity, while regional climatic differences in this flat country are 
minor (http://en.wikipedia.org/wiki/Geography_of_Bangla-
desh). Crops are mainly produced in summer and in winter-
time, and harvested crops from one season are largely con-
sumed in the next season until new ones become available. 
The climate with mostly high humidity can favor the growth 
of various mycotoxin-producing fungi on crops in the field 
or in stored food commodities in Bangladesh. Several Asper-
gillus and Penicillium species are known to produce OTA 
and/or CIT under various environmental conditions (Frisvad 
et al. 2006; Stoll et al. 2013; Schmidt-Heydt et al. 2015). 
The biomarker results from our study indicated frequent co-
occurrence of OTA and CIT in both sampling periods, and a 
significant positive correlation was observed between OTA 
and total CIT in urine in winter season (Table 4).
Possible sources of dietary mycotoxin intake
Data on CIT and OTA contamination of food commodi-
ties in Bangladesh are not available, yet we made an 
attempt to correlate the individual biomarker levels with 
the consumption frequency for certain food categories in 
our cohort. There was no significant correlation between 
urinary biomarker levels and consumption of several food 
items during the last 2 days (Table 6). However, the mean 
levels of OTA and total CIT were considerably higher in 
the high rice consumption group when we categorized the 
entire cohort by rice consumption frequency during the last 
2 days (Table 7) or by regular food habit records (data not 
shown). Consumption of other foodstuffs such as wheat/
maize, lentil soup, milk products, chicken meat and coffee 
did not show significant correlations with mycotoxin bio-
marker levels in urine (Supplementary Table 3).
Rice is staple food in Bangladesh and often consumed 
with curries prepared with several spices. Both rice and 
spices may be sources of CIT and OTA intake in our 
cohorts, considering mycotoxin occurrence data from other 
countries: CIT and/or OTA have been detected in rice from 
India and Vietnam (Reddy et al. 1983; Nguyen et al. 2007) 
and also in rice from China, Pakistan and Canada (Lai et al. 
2015; Majeeda et al. 2013; Bansal et al. 2011). OTA and 
CIT were also found in different spices commonly mar-
keted in India (Saxena and Mehrotra 1989; Jeswal and 
Kumar 2015) and in chilies in Sri Lanka (Yogendrarajah 
et al. 2014). Such information on mycotoxin contamination 
of rice and spices marketed in Bangladesh is not available, 
and also other food items may contribute to exposure.
Comparison of biomarker levels in Bangladesh 
and other countries
Our new results for Bangladesh can be compared with OTA 
and CIT biomarker data from studies carried out in other 
countries on different continents. Although these studies 
often applied various methods for biomarker analysis with 
different detection limits, the reported mean concentra-
tions and ranges can provide an orientation for OTA and 
CIT urinary levels found in these populations. As urine data 
for OTA have been reviewed earlier (Coronel et al. 2011; 
Duarte et al. 2011), the following comparison will only 
focus on some more recent studies.
OTA biomarkers In the present study, the mean level 
of OTA was 0.06 ± 0.10 (range <LOD–0.55) in sum-
mer, but 0.19 ± 0.38 (range <LOD–1.75) ng/mL in win-
ter urines of both Bangladeshi cohorts (Table 2). Lower 
or similar levels of OTA were found in urines of Belgian 
cohorts (in adults: mean 0.028, range 0.002–0.368 ng/
mL, in children: mean 0.079, range 0.003–3.683 ng/mL; 
Heyndrickx et al. 2015) and in two German cohorts (mean 
0.04 ± 0.01, range <LOQ–0.0.08 ng/mL; Gerding et al. 
2015; and mean 0.07 ± 0.05, range 0.02–0.29 ng/mL; 
Muñoz et al. 2010). Relatively, low OTA levels were also 
found in the Portuguese population (mean 0.019 ± 0.012, 
range nd–0.071 reported by Duarte et al. 2012, and mean 
0.022, range nd–0.069 in Duarte et al. 2010). Higher lev-
els of urinary OTA were found in adults in Southern Italy 
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(mean 0.144 ± 0.312, range LOQ–2.13 ng/mL; Solfrizzo 
et al. 2014) and in Spain (mean 0.237 ± 0.181, range 
0.057–0.562 ng/mL; Coronel et al. 2011). A recent study in 
Swedish adults reported even higher average levels of uri-
nary OTA (mean 0.46 ± 0.57 ng/mL; Wallin et al. 2015). 
Some data are also available for non-European countries: 
Urinary OTA was detected in children and adults in Haiti 
(mean 0.06, range <LOQ–0.83 ng/mL; Gerding et al. 2015) 
and in breastfed Chilean infants (mean 0.05–0.16, range 
LOD–0.43 ng/mL; Muñoz et al. 2014). OTA was found 
in urines of Nigerian adults and children (mean 0.2 ± 0.1, 
range nd–0.6 ng/mL; Ezekiel et al. 2014) and in Cam-
eroon infants (mean 0.2, range 0.04–2.4 ng/mL; Ediage 
et al. 2013). The highest urinary OTA levels were previ-
ously reported in children in Sierra Leone in dry (range 
0.07–148 ng/mL) and in rainy (range 0.6–72.2) season 
(Jonsyn 2000). This study found also rather high levels of 
4-hydroxy-OTA (4R-OH-OTA) in urines from boys and 
girls. The same metabolite was detected, yet not quanti-
fied, in urines of Bulgarian adults (Castegnaro et al. 2006). 
However, as 4R-OH-OTA was not detectable in an earlier 
study of BEN patients by the same group, or in other stud-
ies, its role as additional biomarker of OTA exposure is 
unclear (Castegnaro et al. 1991).
Cleavage of the peptide bond in OTA by the intestinal 
microflora produces the nontoxic metabolite OTα that is 
then excreted mainly as glucuronide and often present in 
urine at clearly higher amounts than OTA parent compound 
(Muñoz et al. 2010; Coronel et al. 2011; Klapec et al. 
2012). In Bangladeshi adults, OTα (Table 2) was found in 
summer (mean 0.21 ± 0.81, range nd–6.10 ng/mL) and in 
winter urine (mean 0.09 ± 0.15, range nd–0.79 ng/mL). 
Their mean OTα levels are lower compared to those found 
in Spanish (0.44 ± 0.51, range 0.06–2.89 ng/mL; Coronel 
et al. 2011) and in German adults (mean 2.88 ± 2.24, range 
0.49–7.12 ng/mL; Muñoz et al. 2010) or in Croatian preg-
nant women (mean 1.73 ± 1.65, range 0.11–7.57 ng/mL; 
Klapec et al. 2012). As yet it is unclear whether the pres-
ence of higher OTα levels in European samples is indica-
tive of more efficient detoxication of OTA to OTα and/
or related to dietary differences between Bangladeshi and 
European cohorts. Thus, we agree with conclusions of Cor-
onel et al. (2011) that further research is needed to eluci-
date the relation between ingested OTA and excreted OTA 
and metabolites in humans and that inter-individual differ-
ences in metabolism abilities should also be considered.
CIT biomarkers Compared to OTA, the biomonitor-
ing for CIT is far less developed, and therefore, fewer 
biomarker data from other countries are as yet available. 
Concentrations of CIT biomarkers in urines from Bang-
ladeshi adults (see Table 3 for CIT and HO-CIT mean 
values and ranges and Fig. 3 for total CIT) are clearly 
higher than those reported for German adults (CIT mean 
0.03 ± 0.02, range nd–0.08 ng/mL and HO-CIT mean 
0.10 ± 0.10, range nd–0.51 ng/mL; Ali et al. 2015a) and 
those for Belgian adult cohorts (CIT mean 0.026, range 
0.002–0.117 ng/mL and HO-CIT mean 0.035, range 0.013–
0.210 ng/mL, Huybrechts et al. 2015; or CIT mean 0.057, 
range 0.002–1.398 ng/mL and HO-CIT mean 0.752, range 
0.143–2.117 ng/mL (Heyndrickx et al. 2015). Another 
recent study by Gerding et al. (2015) with analysis of the 
metabolite HO-CIT (but not parent compound) confirmed 
clearly higher levels in Bangladeshi (winter) urines (mean 
2.75 ± 8.43, range <LOQ–58 ng/mL) than in Haitian 
(mean 0.49 ± 0.95, range <LOQ–4.34 ng/mL) and German 
samples (mean 0.12 ± 0.02, range <LOQ–0.33 ng/mL). 
Overall, these biomarker data indicate notable differences 
in citrinin exposure between the Bangladeshi and other 
populations.
All studies, including the present one, report often 
clearly lower concentrations of CIT than its metabolite 
HO-CIT in urine, while average and inter-individual ratios 
of CIT/HO-CIT urine levels are apparently quite variable 
(Ali et al. 2015a, b; Heyndrickx et al. 2015; Huybrechts 
et al. 2015). This observation is of interest since the for-
mation of the metabolite HO-CIT is considered as detoxi-
cation reaction (Föllmann et al. 2014). It is presently 
unknown which enzymes catalyze this reaction, and the 
ability to convert CIT to HO-CIT may vary among indi-
viduals. Thus, it is indicated to measure CIT as well as its 
metabolite in biomonitoring studies, and consider the sum 
of both analytes as biomarker of exposure to this nephro-
toxic mycotoxin.
In short, biomonitoring studies indicate more or less 
pronounced differences in OTA and CIT exposure between 
populations of several countries. Their urinary biomarker 
levels reflect probably a different degree of mycotoxin con-
tamination of local food commodities and also differences 
in food consumption patterns.
Biomarker‑based exposure estimates and tolerable 
intake values for OTA and CIT
Mycotoxin contamination of food commodities cannot be 
completely avoided, yet regulations (maximum residual 
levels) have been set in many countries to protect the con-
sumer, and Scientific Advisory Committees have derived 
tolerable daily intake (TDI) values for certain mycotoxins 
based on toxicological risk assessments (e.g., EFSA 2006, 
2012). With regard to the question whether exposure in 
certain cohorts exceeds a given TDI, urine biomarker data 
may be used for estimating the probable daily intake, if 
enough information on kinetics and urinary excretion rates 
in humans is available. Below, we discuss uncertainties that 
exist when converting urine biomarker concentrations for 
OTA and CIT to amounts of mycotoxin intake.
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Overall, a good correlation was reported between urine 
OTA levels in UK adults and dietary OTA consumption 
(Gilbert et al. 2001) and, more recently, also between 
infant OTA intake with breast milk and OTA concentra-
tions in babies’ urines (Muñoz et al. 2014). But, the relation 
between ingested OTA dose and excreted OTA amounts 
can vary between individuals (Castegnaro et al. 2006), 
possibly due to inter-individual differences in metabolism 
as discussed already above. Moreover, one has to keep in 
mind that only a very small fraction of OTA is excreted: 
In a human volunteer who ingested 3H-OTA, about 5 % 
of the 3H-dose was excreted over 24 h in urine, and only 
part of the radioactivity (between 42 and 54 %) in urine 
extracts was unmetabolized OTA (Studer-Rohr et al. 2000). 
This indicates a human urinary OTA excretion rate of 2 % 
or less per day at the given exposure, a value similar to 
about 2.5 % OTA excretion found in 24 h urines of pig-
lets fed with OTA (Gambacorta et al. 2013). Mycotoxin 
intake estimates on the basis of urine OTA concentrations 
thus involve a high degree of uncertainty, also as usually 
spot urines or first morning voids (not 24 h urines) are ana-
lyzed, and data on temporal variability in humans and pos-
sible dose-related effects on renal OTA excretion are scarce 
(Degen 2015). For this reason, we and others refrain so far 
from ‘translating’ OTA urine levels to probable daily intake 
values. On the other hand, blood is a suitable matrix for 
OTA biomonitoring, and in several studies the mean OTA 
levels in plasma or serum have served to estimate daily die-
tary OTA intake, based on the Klaassen equation (Duarte 
et al. 2011; Märtlbauer et al. 2009).
For CIT, there is now information on kinetics in a human 
volunteer who ingested a small dose (45 ng/kg b.w.): Urine 
analysis during the next 24 h revealed a cumulative excre-
tion of about 36 % of the CIT dose (12 % as parent com-
pound, 24 % as HO-CIT; Ali et al. 2015c). This value for 
excretion can be used now for converting the total bio-
marker concentrations to mycotoxin intake (probably 
daily intake, calculated as described in the Methods sec-
tion), and was applied here to assess CIT exposure in the 
Bangladeshi cohort (Table 5). Their probable daily intake 
(PDI) for CIT was then compared to the tolerable daily 
intake value (TDI) for CIT of 0.2 µg/kg bw (‘no concern 
for nephrotoxicity in human’) derived by EFSA (2012). 
The TDI value of 0.2 µg/kg b.w./day proposed by EFSA 
(2012) was exceeded in 10 % of all study participants in 
summer and 24 % in winter, and more than 20-fold in one 
person with a calculated CIT intake of >4 µg/kg b.w. The 
uncertainty in estimates of probably daily intake for CIT is 
much lower than in the case of OTA, due to the rather high 
fraction of CIT biomarker excretion in urine. Finally, OTA 
being a more potent nephrotoxin than CIT (EFSA 2006, 
2012), the observed frequent co-exposure to both mycotox-
ins (Table 4) in Bangladeshi cohorts raises some concern.
Conclusions
The results of this biomonitoring study indicate a variable 
but frequent exposure to the two nephrotoxic mycotoxins 
CIT and OTA in the Bangladeshi population. Biomarker 
data analysis revealed season, region and food consump-
tion patterns as determinants of mycotoxin exposure in 
our cohorts. Their urinary levels for CIT and OTA bio-
markers are often higher than those found in several Euro-
pean studies. The new data point to the need to identify 
major sources of CIT and OTA intake in Bangladesh, and 
conduct also biomonitoring studies in population groups 
which may be at increased risk such as children and preg-
nant women.
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Introduction
Citrinin [C13H14O5; IUPAC Name: (3R,4S)-8-hy-
droxy-3,4,5-trimethyl-6-oxo-4,6-dihydro-3H-isochromene-
7-carboxylic acid] is a polyketide mycotoxin produced by 
several fungi of the genera Penicillium, Aspergillus and 
Monascus (Frisvad et al. 2006). In animal studies, CIT has 
similar toxic properties as ochratoxin A (OTA), another 
nephrotoxic mycotoxin contaminant in food commodi-
ties (Frank 1992; Flajs and Peraica 2009). This and co-
occurrence of CIT and OTA in food and feed have raised 
concerns on possible risks for human and animal health 
(EFSA 2006, 2012; Ostry et al. 2013). Both mycotoxins 
have been detected in cereals from Bulgarian villages with 
a history of Balkan endemic nephropathy (BEN) and in 
pooled food of Serbian BEN families (Petkova-Bocharova 
et al. 1991; Vrabcheva et al. 2000a, b; Pfohl-Leszkowicz 
et al. 2007), in grains in Germany (Schmidt et al. 2003), 
as well as in breakfast cereals and in wheat samples from 
France (Molinié et al. 2005; Pfohl-Leszkowicz et al. 2007), 
and in rice in Vietnam (Nguyen et al. 2007). In contrast to 
many surveys on OTA contamination of human foods (EC/
SCOOP 2002), data on CIT occurrence in commodities are 
scarce: Up to now, there are no legal requirements for food 
surveillance (Flajs and Peraica 2009), except for a recent 
Commission Regulation (EU No. 212/2014) with regard to 
maximum levels of CIT in food supplements based on rice 
fermented with red yeast Monascus purpureus. Moreover, 
CIT analysis in food or feed is not trivial (Schmidt et al. 
2003; Xu et al. 2006). Thus, the available data, recently 
reviewed by EFSA (EFSA 2012), are insufficient to reli-
ably estimate CIT exposure in the human population.
Two complementary approaches can be used to assess 
human exposure, as exemplified for OTA (Castegnaro et al. 
2006; Duarte et al. 2011; EC/SCOOP 2002): Analysis of 
Abstract As data on food contamination with the 
mycotoxin citrinin (CIT) are scarce, a recently devel-
oped method for biomarker analysis (Blaszkewicz et al. 
in Arch Toxicol 87:1087–1094, 2013) was applied to 
investigate CIT exposure of German adults. CIT and 
its human metabolite dihydrocitrinone (HO-CIT) were 
determined in urine samples from a group of 50 healthy 
adults (n = 27 females and n = 23 males). After cleanup 
by immunoaffinity (CitriTest®) columns, extracts were 
analyzed by LC–MS/MS. The mycotoxin and its major 
metabolite HO-CIT were detected in 82 and 84 % of all 
urine samples, at concentrations ranging from 0.02 (limit 
of detection, LOD) to 0.08 ng/mL for CIT, and 0.05 
(LOD) to 0.51 ng/mL for HO-CIT. Median urine ana-
lyte levels in the cohort were 0.03 (CIT) and 0.06 ng/mL 
(OH-CIT) or adjusted to creatinine 20.2 ng/g crea (CIT) 
and 60.9 ng/g crea (HO-CIT), respectively. Except for 
higher urinary CIT levels in males, differences between 
subgroups were not significant. This first biomarker 
analysis indicates widespread and variable exposure to 
CIT in German adults, and conversion of ingested myco-
toxin to its less toxic metabolite HO-CIT, which may 
serve as biomarker of exposure in addition to the parent 
compound.
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mycotoxin concentrations in food commodities combined 
with food intake estimates for the general population or 
population subgroups (external exposure) and/or analysis of 
suitable biomarkers in human body fluids (biomonitoring) 
to assess internal exposure. Biomonitoring covers human 
exposure from various sources and by all routes and is the 
best tool to investigate occurrence and ranges of myco-
toxins in different populations (Degen 2011; Duarte et al. 
2011; Leong et al. 2012; Malir et al. 2012; Turner 2010). 
This “bottom-up” approach can provide first insights when 
food analysis data are scarce or insufficient, as in the case 
of CIT. A recently developed method for targeted analysis 
of CIT and its metabolite dihydrocitrinone (HO-CIT) in 
human blood plasma and urine have been applied in a small 
pilot study that indicated the frequent presence of measur-
able biomarker levels in these matrices (Blaszkewicz et al. 
2013). This method now served to analyze CIT and HO-
CIT in urine samples from 50 healthy German adults, with 
the aim to establish concentration ranges that result from 
dietary mycotoxin intake in this cohort, and for future com-
parison with results for cohorts from other countries.
Materials and methods
Standards and reagents
CIT standard material (5 mg, purity >98 %) was purchased 
from Sigma-Aldrich (Taufkirchen, Germany); CIT solu-
tions in methanol were calibrated at 321 nm using the 
molar absorptivity ε = 5,490 M−1 cm−1 (Molinié et al. 
2005). The CIT metabolite dihydrocitrinone [C13H14O6; 
(3R,4S)-6,8-dihydroxy-3,4,5-trimethyl-1-oxo-3,4-dihydro-
1H-isochromene-7-carboxilic acid; purity 98.9 %] was 
from AnalytiCon Discovery GmbH (Potsdam, Germany). 
Working standard solutions of CIT and HO-CIT were pre-
pared weekly from a stock solution of CIT (200 µg/mL ace-
tonitrile) and HO-CIT (500 µg/mL acetonitrile), by dilution 
in methanol in a range of 1–20 ng/mL. Acetonitrile, metha-
nol (LC–MS grade) and acetic acid (96 %) were purchased 
from Merck (Darmstadt, Germany).
Urine sample collection
Fifty healthy IfADo employees (27 females and 23 males) 
volunteered to participate and gave their written consent 
before inclusion in the study. First, morning urine sam-
ples were collected into a non-sterile disposable container 
(approximately 80 mL) between July and August 2013. All 
samples were immediately stored at −20 °C until analy-
sis. Volunteers were asked to fill a short questionnaire for 
anthropometric information (age, gender, height, weight 
and occupation).
Creatinine analysis
Creatinine was determined in urine samples to correct for 
differences in urine dilution between individual spot urines 
by a modified Jaffe method (Blaszkewicz and Liesenhoff 
2012). Analysis of creatinine was carried out with a plate 
reader, Tecan Genios® (Salzburg, Austria). In the results 
section, measured CIT and HO-CIT concentrations in urine 
are also given as ng/g creatinine.
Sample extraction
Urine sample cleanup and enrichment used immunoaf-
finity column (IAC) extraction with CitriTest® columns 
(Vicam®, purchased from Ruttmann, Hamburg, Germany) 
as described by Blaszkewicz et al. (2013): 5 mL of urine 
was diluted with 5 mL of 1 mM acetic acid in water and 
mixed for 15 min on a rotary shaker. The sample was then 
loaded on a CitriTest® column at a flow rate of 1 drop/s. 
The column was washed twice with 5 mL distilled water; 
then, CIT was eluted (flow rate 1 drop/s) from the column 
using 4 mL of methanol. The eluate was evaporated to dry-
ness under a stream of nitrogen at 40 °C, and the residue 
was dissolved in 500 µL methanol, vortexed and filtered 
through a 0.45-µm pore size Teflon syringe filter prior to 
LC–MS/MS analysis.
LC–MS/MS analysis
Liquid chromatography with tandem mass spectrometry 
was used to measure CIT and its metabolite HO-CIT in 
urine samples by the method of Blaszkewicz et al. (2013). 
Detection was performed with a 1200-L Quadrupole MS/
MS equipped with an electrospray ionization (ESI) source 
and a Prostar® Varian HPLC system and Varian MS Work-
station version 6.9.1 data system (Agilent Technologies, 
Germany). The following settings were used: nitrogen 
as drying gas (19 psi), gas temperature 200 °C and argon 
used as collision gas (2.0 mTorr). Chromatographic sepa-
ration was carried out at 21 °C on a Nucleosil® 100-5 
C18 HD 125 × 3 mm column with ammonium formate 
1 mM in water (mobile phase A) and ammonium formate 
1 mM in methanol (mobile phase B) as eluents in the fol-
lowing gradient: 0–1 min 20 % B, 1–3 min 20–75 % B, 
3–11 min 75 % B, 11–12 min 75–100 % B, 12–14 min 
100 % B (column wash), 14–14.5 min 100–20 % B, and 
from 14.5 to 20 min 20 % B (re-equilibration). The flow 
rate was 0.2 mL/min. ESI–MS/MS was executed by mul-
tiple reaction monitoring (MRM) in negative ion mode. 
The specific transitions of precursor ion and product ion 
were as follows: 249.0 → 204.7 m/z (loss of the carboxyl 
group) and 249.0 → 176.7 for CIT. The optimized colli-
sion energy (CE) was 15 and 19 eV, respectively. For 
575Arch Toxicol (2015) 89:573–578 
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HO-CIT, the transitions of precursor and product ions were 
265.0 → 221.0 and 265.0 → 176.7 m/z with an optimized 
CE of 16 and 20 eV, in that order. The retention time for 
CIT and its metabolite HO-CIT was 9.3 and 8.7 min.
Statistical analysis
Descriptive statistics are presented as mean ± SD or medi-
ans and inter-quartile ranges. For calculation of mean and 
median values, those samples that contained CIT and HO-
CIT below the LOD were assigned a value of one-half the 
detection limit. Differences in urinary CIT and HO-CIT 
concentrations between males and females were analyzed 
by independent-sample t test. Correlation between CIT and 
HO-CIT with age and body mass index was assessed by 
Spearman’s correlation coefficient (two-tailed). Box plots 
were used to describe analytes by gender groups. The box 
represents the central data of distribution where upper and 
lower limits of the box indicate 25th and 75th percentiles 
(first quartile or Q1 and third quartile or Q3, respectively), 
and the median value is presented as a line inside the box. 
In the box plot, outlier values are more than 1.5 times the 
inter-quartile range (IQR) and the Q1 and Q3, respectively. 
Outlier values mark as circle are more than 1.5 times the 
IQR away from Q1 and Q3 and mark as asterisk are three 
times the IQR away from Q1 and Q3. All analyses were 
performed using software of IBM SPSS Statistics 22.
Results
Validation parameters for CIT and HO-CIT analysis
The calibration curve with pure standards in mobile phase 
was linear in the range of 0.5–20 ng/mL, and the coeffi-
cients of determination (R2) were 0.995 and 0.998 for CIT 
and HO-CIT, respectively. Analysis of spiked urine extracts 
yielded similarly good correlations at low concentrations. 
Spiked samples were used to define the minimum detecta-
ble level: The limit of detection (LOD) and limit of quanti-
fication (LOQ) were determined based on the lowest quan-
tity of analyte that can be clearly distinguished (LOD) from 
the background (S/N = 3) or quantified (LOQ; S/N ≥ 6). 
For CIT, the LOD was 0.02 and LOQ was 0.05 ng/mL. 
For HO-CIT, the LOD and LOQ were 0.05 and 0.10 ng/
mL, respectively. Recovery assays were performed in a 
urine with no measurable background of CIT and HO-CIT: 
Recovery of analytes were assessed at four concentration 
levels in triplicate spiked samples with mean values of 75 
and 86 % for CIT and HO-CIT, respectively (Table 1). The 
same CIT- and HO-CIT-free urine was applied to determine 
the intra-day and inter-day repeatability (Table 2) at a spike 
concentration of 0.5 ng/mL (n = 6).
Characteristics of the urine donor cohort
Of the 50 subjects in this study, 54 % were females and 
46 % were males. The basic anthropometric characteris-
tics of the cohort are given in Table 3. The mean age of all 
participants was 38.5 years, with no significant difference 
between females and males. The average body mass index 
Table 1  Recovery of CIT and HO-CIT in human urine after cleanup 
with IAC
Spike level (ng/
mL)
CIT HO-CIT
Recovery (%) RSD (%) Recovery (%) RSD (%)
0.05 (n = 3) 80 13.3 80 1.5
0.5 (n = 3) 76 13.2 82 11.4
1.0 (n = 3) 73 14.8 95 1.2
2.0 (n = 3) 69 7.0 87 6.0
Table 2  Intra-day and inter-day assay repeatability for CIT and HO-CIT in urine
Spike level (ng/mL) CIT HO-CIT
Mean ± SD Recovery (%) RSD (%) Mean ± SD Recovery (%) RSD (%)
Intra-day (n = 6) 0.5 ng/mL 0.39 ± 0.05 78 13.3 0.41 ± 0.03 82 7.7
Inter-day (n = 6) 0.5 ng/mL 0.38 ± 0.05 75 13.1 0.40 ± 0.05 80 12.6
Table 3  Basic anthropometric 
characteristics of the 
participants
Gender n Age (years) BMI (kg/m2) Creatinine (g/L)
Mean ± SD Range Mean ± SD Range Mean ± SD
Female 27 38.7 ± 12.7 20–65 24.8 ± 3.8 20–35 1.1 ± 0.5
Male 23 38.3 ± 14.0 18–62 25.6 ± 3.9 19–35 1.6 ± 1.1
All 50 38.5 ± 13.2 18–65 25.2 ± 3.8 19–35 1.3 ± 0.9
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(BMI) for all subjects was 25.2 ± 3.8 kg/m2. Males had 
slightly higher BMI than females, but the difference was 
not significant. All urine donors were healthy and free from 
any chronic diseases. Their average urinary creatinine con-
centration was 1.3 ± 0.9 g/L. The participants consumed 
typical mixed German food (grain-based products, potatoes 
and vegetables, milk and milk-based products, eggs, meat 
and meat-products); three were vegetarians. They are all 
employees at IfADo (scientists, technicians, office workers, 
etc.) residing in Dortmund or nearby urban settlements.
Occurrence and levels of CIT and HO-CIT
Urine samples containing analyte concentration at or above 
the limit of detection (LOD) were considered as positive 
samples: CIT was detected in 41 (82 %), and HO-CIT was 
detected in 42 urine samples (84 %) (Table 4). The distri-
bution of CIT and HO-CIT concentrations in all urines is 
shown in Fig. 1. Samples with CIT and HO-CIT below 
the LOD were assigned a value of one-half the detection 
limit for the distribution graph and for the calculation of 
mean and median values. Descriptive statistics for CIT and 
HO-CIT urinary levels of all study subjects and of gen-
der groups are given in Table 4, as concentration (ng/mL) 
and also adjusted for urinary creatinine content (ng/g). A 
significant difference was found for the CIT concentra-
tion between the male and female subgroup (p = 0.020), 
whereas no significant difference was observed for the 
metabolite HO-CIT or the sum of both, i.e., “total CIT” 
excreted (Fig. 2). Citrinin and its metabolite had no signifi-
cant correlation with age and BMI of the study subjects.
Interestingly, the metabolite was present in urines of 
the German adults at about threefold higher levels than the 
parent compound, suggesting that HO-CIT may be a use-
ful additional biomarker of citrinin exposure. On the other 
hand, the ratio of CIT to OH-CIT in individuals which 
excrete both analytes at readily measurable concentrations 
varies considerably between 0.75 and 11 (data not shown).
Discussion
This is the first study that examined the occurrence of 
CIT and its metabolite in urines from a cohort of German 
adults. The method of Blaszkewicz et al. (2013) with IAC 
cleanup and analysis by LC–MS/MS allowed frequent 
detection of CIT and HO-CIT in the 50 urine samples (82 
and 84 %, respectively). A study with a different sample 
cleanup method for subsequent multi-mycotoxin analysis 
reported one CIT-positive sample in 40 urines from Bel-
gium (Njumbe Ediage et al. 2012). This is not in contrast 
to our result in German urines, since the CIT detection lev-
els of both methods differ considerably (LOD 2.88 ng/mL; 
Table 4  Descriptive statistics of CIT and HO-CIT in urines according to gender
Positive sample refer to urines containing the analyte ≥ LOD; nd, level below LOD
For calculation of mean and median values, those samples that contained CIT and HO-CIT below LOD were assigned a value of one-half the 
detection limit
a
 p < 0.05 when compared to female, p value obtained from independent-sample t test
n Positive  
samples (%)
Mean ± SD  
(ng/mL)
Median (range)  
(ng/mL)
Mean ± SD  
(ng/g creatinine)
Median (range) 
(ng/g creatinine)
CIT
 Female 27 20 (74) 0.03 ± 0.02 0.02 (nd–0.07) 29.4 ± 26.7 20.6 (nd–120.0)
 Male 23 21 (91) 0.04 ± 0.02a 0.04 (nd–0.08) 39.9 ± 44.6 19.8 (nd–190.5)
 All 50 41 (82) 0.03 ± 0.02 0.03 (nd–0.08) 34.2 ± 36.0 20.2 (nd–190.5)
HO-CIT
 Female 27 21 (78) 0.10 ± 0.10 0.05 (nd–0.43) 103.5 ± 107.7 63.3 (nd–480.0)
 Male 23 21 (91) 0.11 ± 0.11 0.07 (nd–0.51) 100.0 ± 115.8 55.3 (nd–548.4)
 All 50 42 (84) 0.10 ± 0.10 0.06 (nd–0.51) 102.0 ± 110.4 60.9 (nd–548.4)
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Fig. 1  Distribution of CIT and HO-CIT levels in urine samples. Fre-
quency test was used for the calculation of distribution
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Njumbe Ediage et al. 2012 versus LOD 0.02 ng/mL; Blasz-
kewicz et al. 2013 and this study). The detection frequencies 
in our study with German urines are still higher than those 
reported recently for urine samples from n = 29 Belgian 
adults (59 % for CIT and 66 % for HO-CIT) analyzed by 
a direct multi-mycotoxin method: The average urinary lev-
els for CIT (26 pg/mL, range 2–117 pg/mL) and for HO-
CIT (35 pg/mL, range 13–210 pg/mL) found in the Belgium 
study (Huybrechts et al. 2014) are slightly lower than those 
measured in the present study for German adults (Table 4).
Together these novel findings on the occurrence of CIT 
and its metabolite in urine indicate a frequent exposure 
to this mycotoxin in the population of two western Euro-
pean countries. No other biomonitoring data for CIT are 
available so far, except for preliminary results from two 
cohorts in Bangladesh (Ali et al. 2014), where one cohort 
has higher urine levels than the German volunteers. At pre-
sent, it is not possible to convert urine biomarker levels to 
dietary CIT intake since kinetic studies in humans have not 
been conducted, which allow to estimate bioavailability 
and renal clearance. This supports the view of EFSA that 
additional research on CIT is needed (EFSA 2012).
It is worth noting that HO-CIT was present in urines of 
all adult German subjects on at about threefold higher lev-
els on average than the parent compound, suggesting that 
the metabolite may be a useful additional biomarker of 
mycotoxin exposure. But, the ratio for CIT/OH-CIT levels 
in urine can be quite variable among individuals (0.75–11). 
Recent data show that HO-CIT is much less toxic than CIT, 
suggesting that formation of this metabolite can be consid-
ered as detoxication reaction (Föllmann et al. 2014). HO-
CIT has been first identified in urine of rats, albeit only as 
minor metabolite of CIT (Dunn et al. 1983). Thus, kinet-
ics of CIT could differ between rodents and humans, an 
aspect of interest for a toxicological risk assessment. Pres-
ently, studies are underway to gain further insights into the 
disposition of CIT in humans: First data show consistently 
higher levels of CIT and HO-CIT in blood than in urine 
(Degen et al. 2014). Finally, it should be kept in mind that 
OTA, another nephrotoxic mycotoxin, is also often detected 
in humans (Duarte et al. 2011; EFSA 2006; Malir et al. 
2012; Pfohl-Leszkowicz et al. 2007).
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Abstract Citrinin (CIT) is a mycotoxin contaminant in food
commodities and can co-occur with ochratoxin A (OTA),
another nephrotoxic contaminant in food and feed. Presence
of OTA in maize from Bangladesh has been reported, but no
data exist on CIT occurrence in food or feed in Bangladesh.
Since biomonitoring provides the best approach to assess
human exposure to contaminants from various sources and
by all routes, a validated method for biomarker analysis has
been used to investigate the presence of CITand its metabolite
dihydrocitrinone (HO-CIT) in urines from two Bangladeshi
cohorts: Both analytes were determined in urine samples
collected from inhabitants of a rural (n=32) and an urban
(n=37) area in the Rajshahi district of Bangladesh. After
cleanup by immunoaffinity columns, extracts were analyzed
by LC-MS/MS; the limits of detection for CIT and HO-CIT in
urine were 0.02 and 0.05 ng/mL, respectively. CIT and HO-
CIT were detectable in 94 and 71 % of all urine samples.
Urinary biomarker levels did not show significant correlations
with age, gender, and body mass index of the donors. How-
ever, excretion of CIT together with its metabolite HO-CIT
was significantly higher (p<0.01) in the rural cohort (mean
1.1±1.9 ng/mL) than in the urban cohort (mean 0.14±0.14 ng/
mL). This clearly indicates differences in mycotoxin expo-
sure. As food habits differ between rural and urban people and
also their main areas of occupation, further research is needed
with regard to the major contributors of CIT exposure in the
two cohorts. In conclusion, this first biomarker analysis indi-
cates widespread and variable exposure to CIT in Bangladeshi
adults.
Keywords Citrinin . Dihydrocitrinone . Exposure .
Mycotoxins . Urine
Introduction
Citrinin (CIT) is a toxic fungal metabolite produced by several
fungi of the genera Penicillium and Aspergillus (Frisvad et al.
2006). CIT contamination occurs mainly in grains and grain-
based products (European Food Safety Authority EFSA
2012). CIT is also known to occur as undesirable contaminant
inMonascus fermentation products, so-called “red mold rice”
(Li et al. 2012; Liao et al. 2014) that is used in Asia for meat
preservation and for food coloring but now is also marketed as
a food supplement (DFG Permanent Senate Commission on
Food Safety 2013).
In repeated dose studies in animals, the kidney was identi-
fied as the principal target organ for CIT toxicity. Thus, CIT
shows similar toxic properties as ochratoxin A (OTA), al-
though CIT is a less potent nephrotoxin compared to OTA
(European Food Safety Authority EFSA 2006, 2012; Frank
1992). Co-occurrence of CIT and OTA in various foodstuffs
and in animal feeds has raised concerns on possible risks for
human and animal health (European Food Safety Authority
EFSA 2006, 2012; Flajs and Peraica 2009; Ostry et al. 2013).
Both mycotoxins have been found in cereals from Bulgarian
villages with a history of Balkan endemic nephropathy
(Petkova-Bocharova et al. 1991; Vrabcheva et al. 2000a, b).
CIT and OTA were detected in grains in Germany (Meister
2003; Schmidt et al. 2003), in breakfast cereals in France
(Molinie et al. 2005), and in rice in Vietnam and India
N. Ali :M. Blaszkewicz :G. H. Degen (*)
Leibniz-Research Centre for Working Environment and Human
Factors (IfADo), Ardeystr. 67, D-44139 Dortmund, Germany
e-mail: degen@ifado.de
N. C. Mohanto :M. Rahman :K. Hossain
Department of Biochemistry and Molecular Biology, Rajshahi
University, Rajshahi 6205, Bangladesh
A. Alim
Department of Zoology, Rajshahi College, National University,
Rajshahi 6100, Bangladesh
Mycotoxin Res (2015) 31:9–16
DOI 10.1007/s12550-014-0217-z
(Nguyen et al. 2007; Reddy et al. 1983). Further reports on
CIT occurrence in wheat in Tunisia (Zaied et al. 2012) and in
various feed ingredients in Russia (Kononenko and Burkin
2008) support the view that CIT, like other mycotoxins, is a
contaminant of various food commodities in several parts of
the world.
While many surveys have been conducted on OTA con-
tamination of human foods (EC/SCOOP 2002), data on CIT
occurrence are still scarce. This may be in part related to the
fact that no legal requirements for food surveillance exist as
yet, except for a recent Commission regulation (Commission
Regulation EU No 212/2014 of 6 March 2014) with regard
to maximum levels of CIT in food supplements based on
rice fermented with Monascus purpureus. Moreover, CIT
analysis in food or feed is not trivial (Meister 2003; Xu
et al. 2006). The available data, recently reviewed by EFSA,
are therefore insufficient to reliably estimate CIT exposure in
the human population (European Food Safety Authority
EFSA 2012).
In situations where food analysis data is scarce or insuffi-
cient, as in the case of CIT, analysis of mycotoxin biomarkers
in human body fluids (biomonitoring) can provide useful
insights into human exposure. As exemplified for OTA, bio-
marker analysis in blood, urine, or breast milk serves to assess
the occurrence and levels in certain population groups (e.g.,
Castegnaro et al. 2006; Duarte et al. 2011; Muñoz et al. 2014).
Biomonitoring is thus a complementary approach to classical
exposure assessments that are based on analysis of mycotoxin
concentrations in food commodities combined with food in-
take estimates for the general population or population sub-
groups (EC/SCOOP 2002). Biomonitoring covers human ex-
posure from various sources of dietary intake, but also by all
other potential routes; it is thus a useful tool to assess addi-
tional workplace-related exposure by inhalation of myco-
toxins (Degen 2011; Turner et al. 2010) or by dermal contact
(Boonen et al. 2012).
We have recently developed a sensitive method for targeted
analysis of CIT and its metabolite dihydrocitrinone (HO-CIT)
in human blood plasma and urine: When applied in a small
pilot study, the presence of measurable biomarker levels in
these matrices was detected (Blaszkewicz et al. 2013). This
method now proved to be useful for analysis of CIT and HO-
CIT (Fig. 1) in urine samples from 50 healthy German adults
(Ali et al. 2014a) and for the present study. In Bangladesh, the
occurrence of OTA in plant-derived foods (maize, cereals, and
ground-nuts) and in feeds has been reported (Dawlatana et al.
2002, 2008), and a recent human biomonitoring study docu-
mented the presence of OTA in blood plasma of adult students
in Bangladesh (Ali et al. 2014b). However, no study has been
carried out on CIT contamination in foods or feed in Bangla-
desh. Therefore, biomarkers of CITexposure were analyzed in
urine samples from two cohorts in the Rajshahi district of
Bangladesh. The first results of this larger project on myco-
toxin biomonitoring in this developing country are reported
here.
Materials and methods
Chemicals and materials
Citrinin standardmaterial (5 mg, purity >98%)was purchased
from Sigma-Aldrich (Taufkirchen, Germany); CIT solutions
in methanol were calibrated at 321 nm using the molar ab-
sorptivity ε=5490 M−1 cm−1 (Molinie et al. 2005). The CIT
metabolite dihydrocitrinone [C13H14O6; (3R,4S)-6,8-Dihy-
droxy-3,4,5-trimethyl-1-oxo-3,4-dihydro-1H-isochromene-7-
carboxilic acid; purity 98.9 %] was from AnalytiCon Discov-
ery GmbH (Potsdam, Germany). Working standard solutions
of CIT and HO-CIT were prepared weekly from a stock
solution of CIT (200 μg/mL acetonitrile) and HO-CIT
(500 μg/mL acetonitrile), by dilution in methanol in a range
of 1–20 ng/mL. Acetonitrile, methanol (LC-MS grade), and
acetic acid (96 %) were purchased from Merck (Darmstadt,
Germany).
Cohorts and collection of urines
Ethical permission for conducting this study was granted by
the Institute of Biological Sciences, Rajshahi University, Ban-
gladesh. Sixty-nine volunteers in total participated in this
study of which 32 (15 females, 17 males) were residents of a
rural area (Mongol Para, Puthia) and 37 (19 females, 18
males) of an urban area (Rajshahi University region) in the
Rajshahi district of Bangladesh. All participants were of good
health and gave written consent before inclusion in the study.
Volunteers were asked to fill a short questionnaire for anthro-
pometric information (age, gender, height, and weight), occu-
pation, and food habits. First morning urine samples were
collected into a non-sterile disposable container (approximate-
ly 50 mL) in May 2013. Urine samples were first stored at
−20 °C at Rajshahi University and then mailed to Dortmund
for subsequent biomarker analysis. Also, creatinine was mea-
sured by a modified Jaffe method (Blaszkewicz and
Liesenhoff-Henze 2012) to control for differences in urine
dilution between individual spot urines.
Fig. 1 Structures of analytes: citrinin (left) and its metabolite
dihydrocitrinone (right)
10 Mycotoxin Res (2015) 31:9–16
Extraction of urine samples
The immunoaffinity CitriTest® columns (Vicam®, purchased
from Ruttmann, Hamburg, Germany) were used for cleanup
and enrichment of analytes as described by Blaszkewicz et al.
(2013): 5 mL of urine was diluted with 5 mL of 1 mM acetic
acid in water and mixed for 15 min on a rotary shaker. The
sample was then loaded on a CitriTest® column at a flow rate
of 1 drop/s. The columnwas washed twice with 5 mL distilled
water; then, CIT and its metabolite HO-CITwere eluted (flow
rate 1 drop/s) using 4 mL of methanol. The eluate was evap-
orated to dryness under a stream of nitrogen at 40 °C, and the
residue was dissolved in 500 μL methanol, vortexed, and
filtered through a 0.45-μm pore size Teflon syringe filter
(WICOM GmbH, Germany) prior to LC-MS/MS analysis.
LC-MS/MS analysis
CIT and its metabolite HO-CIT were measured in urine sam-
ple extracts by liquid chromatography with tandem mass
spectrometry according to a validated method (Blaszkewicz
et al. 2013). Detection was performed with a Varian 1200-L
Quadrupole MS/MS equipped with an electrospray ionization
(ESI) source and a Prostar® Varian HPLC system and Varian
MS Workstation version 6.9.1 data system (Agilent Technol-
ogies, Germany). The following settings were used: nitrogen
as drying gas (19 psi), gas temperature 200 °C, and argon used
as collision gas (2.0 mTorr). Chromatographic separation was
carried out at 21 °C on a Nucleosil® 100-5 C18 HD 125×
3 mm column with ammonium formate 1 mM in water (mo-
bile phase A) and ammonium formate 1 mM in methanol
(mobile phase B) as eluents in the following gradient: 0–
1 min 20 % B, 1–3 min 20–75 % B, 3–11 min 75 % B, 11–
12 min 75–100 % B, 12–14 min 100 % B (column wash), 14–
14.5 min 100–20 % B, and from 14.5 to 20 min 20 % B (re-
equilibration). The flow rate was 0.2 mL/min. The retention
times for CIT and its metabolite HO-CIT were 9.3 and
8.7 min, respectively. ESI–MS/MS was executed by multiple
reaction monitoring (MRM) in negative ion mode. The spe-
cific transitions of precursor ion and product ion were as
follows: 249.0→204.7 m/z (loss of the carboxyl group) and
249.0→176.7 for CIT. The optimized collision energies (CE)
were 15 and 19 eV, respectively. For HO-CIT, the transitions
of precursor and product ions were 265.0→221.0 and
265.0→176.7 m/z with optimized CE of 16 and 20 eV, in that
order.
Statistical analysis
The results are presented as means±standard deviation or
medians and interquartile ranges. Those samples containing
CIT and HO-CIT below the limit of detection (LOD) were
assigned a value of one-half the detection limit for calculation
of mean and median values, since this is considered a better
approach to estimate average concentrations for left censored
data rather than assigning a value of zero to measurements
below a detection limit (Hornung and Reed 1990). Differences
in urinary CIT and HO-CIT levels between the rural and the
urban cohort were analyzed by independent sample t test.
Correlation between CITand HO-CITwith age and bodymass
index (BMI) was assessed by Spearman correlation coefficient
(two-tailed). Box plots were used to describe analytes by
regions. The box represents the central data of distribution
where upper and lower limits of the box indicate 25th and 75th
percentiles (first quartile or Q1 and third quartile or Q3,
respectively) and the median value is presented as a line inside
the box. A level of alpha 0.05 was assigned for statistical
significance. Analysis of data was performed using the soft-
ware IBM SPSS Statistics version 22.
Results
Validation parameters
The calibration curve with pure standards in mobile phase
showed linearity in the range of 0.1–20 ng/mL for both
analytes. Analysis of CIT and HO-CIT spiked urine extracts
yielded similar data in the relevant concentration range. The
limit of detection (LOD) and limit of quantification (LOQ)
were determined based on the lowest quantity of analyte that
can be clearly distinguished (LOD) from the background
(S/N=3) or quantified (LOQ; S/N≥6). For CIT, the LOD
was 0.02 and LOQ was 0.05 ng/mL. For HO-CIT, the LOD
and LOQ were 0.05 and 0.10 ng/mL, respectively. Recovery
assays were performed in a urine with no measurable back-
ground of CIT and HO-CIT: Recovery of analytes were
assessed at three concentration levels in triplicate spiked sam-
ples with mean values of 78 and 86 % for CIT and HO-CIT,
respectively (Table 1). The intra-day and inter-day repeatabil-
ity (Table 2) at a spike concentration of 0.25 ng/mL (n=5)
were determined using also the mycotoxin-free urine and
showed acceptable precisions for these low concentrations.
Characteristics of the study cohorts
The basic characteristics of the cohorts are summarized in
Table 3. Of the 69 subjects, 49 % are females and 51 % are
males. The mean age of the participants was 38.3±10.6 years
(range=21–60 years), with no significant difference between
females and males. The average BMI for all subjects was 22.7
±3.2 kg/m2. People of the urban cohort had significantly
higher BMI (24.1±3.1 kg/m2) than those in the rural cohort
(21.2±2.6 kg/m2). There were no significant differences in
urinary creatinine levels (data not shown) between the rural
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and urban cohort. The rural people are mainly farmers or farm
workers involved in grain production; housewives in rural
areas often also take part in farm work. The urban residents
are university employees or work at home (housewives). All
participants consumed the typical Bangladeshi staple food rice
and, to a lesser extent, roti (whole wheat flatbread); these are
generally consumed with vegetables, lentils, fish, poultry, and
beef. For some differences in eating habits between the two
cohorts, see the “Discussion” section.
Levels of CIT and HO-CIT in the rural and the urban cohort
Urines containing analyte concentration at or above the limit
of detection (LOD) were considered as positive samples:
Overall, CIT was detected in 65 (94 %) and HO-CIT in 49
(71 %) of the urines from both cohorts (Table 4). The distri-
bution of urinary levels of citrinin biomarkers (parent com-
pound and metabolite) in the rural and urban cohort is shown
in Fig. 2. Samples with CIT or HO-CIT below the LOD were
assigned a value of one half the detection limit for the distri-
bution graph and for the calculation of mean and median
values. CIT and HO-CIT urinary levels of the two cohorts
and of subgroups are given in Table 4. Statistical analysis
revealed no significant correlation of urinary biomarkers with
age, gender, and BMI of the study subjects. However, a
significant difference was found for the CIT and HO-CIT
concentration between the rural and the urban cohort
(p<0.05 and p<0.01).
In urines of most Bangladeshi subjects the metabolite was
present at about fivefold higher levels than the parent com-
pound, indicating that the metabolite HO-CIT is a useful
second biomarker of citrinin exposure. On the one hand, the
ratio of CIT to OH-CIT in the male and female subgroups of
both cohorts can vary considerably (data not shown). On the
other hand, the rural subgroups with higher urinary levels of
the parent compound apparently excrete also more of the non-
toxic metabolite (Table 4). As depicted in Fig. 3, excretion of
total CIT (sum of CIT and HO-CIT) is significantly higher in
rural than in urban Bangladeshi adults, indicative of different
exposure. Whether this may be related to differences in their
food habits and/or additional occupational mycotoxin expo-
sure in the rural cohort is unclear at present, as no data on CIT
contamination of grains or food commodities are available.
Discussion
This is the first study that examined the occurrence of CITand
its metabolite in urines from two cohorts of Bangladeshi
adults. The method with IAC cleanup and analysis by LC-
MS/MS (Blaszkewicz et al. 2013) allowed frequent detection
of CIT and HO-CIT (94 and 71 %, respectively) in the 69
urine samples (Table 4). Detection frequencies in the present
study with Bangladeshi urines are similar to those (82 and
84 % for CIT and HO-CIT, respectively) of a recent analysis
for urines from 50 German adults (Ali et al. 2014a). In
German urine samples, the mean analyte levels were 30±
20 pg/mL for CIT and 100±100 pg/mL for HO-CIT with
maximum values of 80 pg/mL CIT and 510 pg/mL HO-CIT
(Ali et al. 2014a). The “German” data resemble results from a
study with urine samples from n=29 Belgian adults, which
reported average urinary levels for CITof 26 pg/mL (range 2–
117 pg/mL) and for HO-CIT of 35 pg/mL (range 13–210 pg/
mL) upon analysis by a direct multi-mycotoxin method
(Huybrechts et al. 2014).
The biomarker concentration data available now for adults
in two Western European countries are somewhat lower than
those measured in the present study for Bangladeshi adults.
Our first findings on the occurrence of CIT and its metabolite
in urine indicate a frequent exposure in the Bangladeshi
population. Of further interest are the significantly higher
Table 1 Recovery and RSD of
analytes CIT and HO-CIT in
human urine
Spike level (ng/mL) CIT HO-CIT
Recovery (%) RSD (%) Recovery (%) RSD (%)
0.10 (n=3) 82 11.2 80 2.5
0.25 (n=3) 76 12.4 84 8.4
1.00 (n=3) 77 13.4 94 2.2
Table 2 Precision of intra-day and inter-day assay repeatability for CIT and HO-CIT in urine
Spike level (ng/mL) CIT HO-CIT
Mean±SD (ng/mL) Recovery (%) RSD (%) Mean±SD (ng/mL) Recovery (%) RSD (%)
Intra-day (n=5) 0.25 0.20±0.02 80 10.4 0.21±0.01 84 6.6
Inter-day (n=5) 0.25 0.19±0.02 76 11.9 0.20±0.02 80 9.8
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levels of CITand its metabolite in the rural cohort compared to
the urban cohort (Table 4 and Fig. 3). At present it is unclear,
whether this biomarker result reflects a difference in food
habits and/or an additional occupational exposure: Most of
the people in the rural cohort of Bangladesh are grain farmers
or housewives taking part in field work while urban residents
mainly work in offices or at home. There are also some
differences in eating habits between the rural and the urban
population in Bangladesh. Rural people mainly depend on
home-cooked food while urban people also take restaurant
food occasionally beside the homemade food. Rural people
consume rice for breakfast, lunch, and dinner with one or two
curries everyday. For breakfast, they eat much rice and some-
times roti (whole wheat flatbread) with some vegetables be-
fore they work in the fields. The urban people eat less rice than
the rural people: For breakfast, normally they take bread,
parata (handmade fried bread), vegetables, eggs, and some
take banana. For daily food, the rural population cannot bear
the expenses of so many different food items as the urban
population. In contrast to other Asian countries, red mold rice
is not popular in Bangladesh.
To further assess the variability in both cohorts, a follow-up
biomarker analysis for urines collected in another season will
be conducted. Bangladesh has a subtropical monsoon climate,
characterized by seasonal variations in rainfall, temperature,
and humidity (http://en.wikipedia.org/wiki/Geography_of_
Table 3 Basic characteristics of the study participants in the rural and
the urban area
Characteristics All subjects Rural Urban
Subjects (n) 69 32 37
Gender (n)
Female 34 15 19
Male 35 17 18
Age (years)
Mean±SD 38.3±10.6 40±12.5 36.8±8.5
Range 21–60 21–60 24–57
Occupation [n, (%)]
Female
Housewives 27 (79.4) 15 (100) 12 (63.2)
Office workers 4 (11.8) 0 4 (21.1)
Student 3 (8.8) 0 3 (15.8)
Male
Farmers 11 (31.4) 11 (64.7) 0
Office worker 17 (48.6) 0 17 (94.4)
Student 3 (8.6) 2 (11.8) 1 (5.6)
Others 4 (11.4) 4 (23.5) 0
BMI (kg/m2)a
Mean±SD 22.7±3.2 21.2±2.6 24.1±3.1
Range 16.2–32.9 16.2–27.3 18.9–32.9
a BMI: significantly different (p<0.001) between rural and urban people
Table 4 Levels of CIT and HO-CIT in urines according to region
Analyte cohort subgroup n Positive samples (%) Mean±SD (ng/mL) Median (ng/mL) 75th percentile Range (ng/mL)
CIT
Rural
Female 15 14 (93) 0.17±0.31 0.07 0.12 nd–1.22
Male 17 17 (100) 0.11±0.11 0.08 0.15 0.02–0.41
All 32 31 (97) 0.14±0.22* 0.08 0.13 nd–1.22
Urban
Female 19 17 (89) 0.04±0.03 0.03 0.06 nd–0.13
Male 18 17 (94) 0.07±0.10 0.03 0.07 nd–0.45
All 37 34 (92) 0.06±0.07 0.03 0.07 nd–0.45
HO-CIT
Rural
Female 15 13 (87) 0.80±1.30 0.19 1.12 nd–4.39
Male 17 16 (94) 1.11±2.10 0.22 0.87 nd–7.47
All 32 29 (91) 0.97±1.75** 0.20 0.99 nd–7.47
Urban
Female 19 9 (47) 0.06±0.05 0.03 0.07 nd–0.22
Male 18 11 (61) 0.11±0.11 0.05 0.17 nd–0.36
All 37 20 (54) 0.08±0.09 0.05 0.11 nd–0.36
Positive sample refer to urines containing the analyte ≥LOD. For calculation of mean and median values, those samples that contained CIT and HO-CIT
below LOD were assigned a value of one half the detection limit
nd level below LOD
*p<0.05 and **p<0.01 when compared to urban, p value obtained from independent sample t test
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Bangladesh). Three seasons are usually recognized: a hot,
humid summer (32–40 °C) from March to June; a humid
rainy monsoon season (28–35 °C) from July to October; and
a warm, dry winter (15–25 °C) from November to February.
In Bangladesh, crops are mainly produced in summer and in
winter time. Food stored in one season (e.g., summer) is
largely consumed in the next season until new seasonal (e.g.,
winter) crops become available. In the absence of fungal
analysis or data on CIT level in food commodities from
Bangladesh, one can only speculate on possible sources of
CIT intake in the two cohorts. We assume that Aspergillus and
Penicillium species rather than Monascus are responsible for
producing of citrinin in food consumed by our cohorts,
because “red mold rice” is not common in their food. Rice is
staple food in Bangladesh and may be one important source of
CIT, as occurrence of this mycotoxin has been reported in rice
from other Asian countries (Reddy et al. 1983; Nguyen et al.
2007). Spices might be another source of CIT: One study
(Saxena and Mehrotra 1989) reported on the occurrence of
CIT in different spices commonly marketed in India. Spices
such as turmeric, coriander, fennel, black pepper, cardamom,
and cumin are also used to make curries in Bangladesh.
At present, urine biomarker levels cannot be converted to
amounts of CIT intake since kinetic studies in humans have
not been conducted which allow to estimate bioavailability
and renal clearance, as in the case of OTA (Studer-Rohr et al.
2000). This strengthens the view that additional research on
CIT is needed (European Food Safety Authority EFSA 2012).
In rats dosed with radiolabeled mycotoxin (14C-CIT), either
by i.v. or s.c. injection, about 75 % of the dose was recovered
in urine within 24 h and a biphasic elimination from blood was
observed (Phillips et al. 1979; Reddy et al. 1982). In the only
study with per os administration of 14C-CIT, HO-CIT has
been first identified in urine of rats, albeit only as minor
metabolite of CIT and only unchanged CIT was found in
blood collected 24 h after administration (Dunn et al. 1983).
As HO-CIT is much less toxic than CIT, formation of this
metabolite can be considered as detoxication reaction
(Föllmann et al. 2014). This is of interest for a toxicological
risk assessment since the kinetics of CIT can differ between
rodents and humans, at least in quantitative terms.
In this context, it is worth noting that the novel data point to
HO-CIT as major metabolite in humans, in contrast to the rat
where it is a minor metabolite in urine. In urines of most
Bangladeshi subjects, HO-CIT is present at clearly (up to
fivefold) higher levels than the parent compound CIT, al-
though the ratios for urinary CIT/HO-CIT levels are variable
among individuals (1.3–6.6). Also, biomarker analysis in
German urines revealed on average about threefold higher
levels of the metabolite than the parent compound and a
variable ratio of urinary CIT/HO-CIT concentrations among
individuals (Ali et al. 2014a).
In recent studies, where blood plasma and first morning
urines were repeatedly collected from two male volunteers
over a period of several weeks, the analyte concentrations
showed small fluctuations over time but distinct differences
in biomarker levels (and the CIT/HO-CIT ratio) for the two
persons (Degen et al. 2014). Interestingly, the data showed
also consistently higher levels of CIT and HO-CIT in blood
plasma than in urine, although at lower plasma concentrations
than those measured for OTA. Nonetheless, further studies are
needed to validate CIT and HO-CIT as biomarkers of expo-
sure in humans. Presently, such studies are underway to gain
further insights in the kinetics of CIT in humans and to
determine the fraction of ingested CIT that is eliminated with
urine within a day.
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Fig. 2 Distribution of individual
levels of biomarkers a citrinin and
b dihydrocitrinone in the rural and
urban cohorts, plotted by
increasing concentration
Bangladesh Germany
Fig. 3 Boxplot of urinary biomarker levels in the rural and urban cohorts
of Bangladesh. The concentration for total CIT (sum of CITandHO-CIT)
in the rural cohort is significantly different (p<0.01) compared to that for
the urban cohort that presents similar values as those determined in urines
of a German cohort (Ali et al. 2014a); see text for details
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Abstract: The trichothecene mycotoxin deoxynivalenol (DON) is a contaminant of crops 
worldwide and known to cause adverse health effects in exposed animals and humans.  
A small survey reported the presence of DON in maize samples in Bangladesh, but these 
data are insufficient to assess human exposure, and also, biomonitoring data are still scarce. 
The present study applied biomarker analysis to investigate the DON exposure of pregnant 
women in Bangladesh. Urine samples were collected from pregnant women living in a rural 
(n = 32) and in a suburban (n = 22) area of the country. Urines were subjected to enzymatic 
hydrolysis of glucuronic acid conjugates and to immunoaffinity column clean-up prior to 
LC-MS/MS analysis of DON and its de-epoxy metabolite DOM-1. The limits of detection 
(LOD) for DON and DOM-1 in urine were 0.16 ng/mL and 0.10 ng/mL, respectively.  
DOM-1 was not detected in any of the urines, whilst DON was detectable in 52% of the 
samples at levels ranging from 0.18–7.16 ng/mL and a mean DON concentration of  
0.86 ± 1.57 ng/mL or 2.14 ± 4.74 ng/mg creatinine. A significant difference in mean urinary 
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DON levels was found between the rural (0.47 ± 0.73 ng/mL) and suburban (1.44 ± 2.20 ng/mL) 
cohort, which may be related to different food habits in the two cohorts. Analysis of food 
consumption data for the participants did not show significant correlations between their 
intake of typical staple foods and DON levels in urine. The biomarker concentrations found 
and published urinary excretion rates for DON were used to estimate daily mycotoxin intake 
in the cohort: the mean DON intake was 0.05 µg/kg b.w., and the maximum intake was  
0.46 µg/kg b.w., values lower than the tolerable daily intake of 1 µg/kg b.w. These first 
results indicate a low dietary exposure of pregnant women in Bangladesh to DON. 
Nonetheless, further biomonitoring studies in children and in adult cohorts from other parts 
of the country are of interest to gain more insight into DON exposure in the population  
of Bangladesh. 
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1. Introduction 
Deoxynivalenol (DON) is a trichothecene mycotoxin produced by Fusarium species, mainly  
F. graminearum and F. culmorum, and the most frequently-detected mycotoxin contaminant of maize, 
wheat and barley in temperate regions of the world [1,2]. Consumption of DON-contaminated feed has 
been associated with a number of adverse effects in animals, including feed refusal, vomiting, diarrhea, 
dizziness and fever, and chronic exposure to DON can lead to growth faltering, immunological and 
neurological dysfunction [3,4]. The acute effects of DON (or “vomitoxin”) in humans are similar to 
those seen in animals, and chronic dietary exposure of animals to DON causes altered nutritional 
efficiency [2,5], whilst long-term effects in humans have not been established so far. The primary toxic 
effect of DON is inhibition of protein synthesis, and it activates a signaling pathway known as ribotoxic 
stress response in cells and induces apoptosis [4,6]. Moreover, the effects include altered neuroendocrine 
signaling, impaired gut integrity and immune function [7,8]. 
DON is thus a concern for human health, and exposure early in life is of special interest in light of 
the following: DON transfer via the placenta to the fetus occurs in sows [9], and maternal exposure has 
been linked to growth retardation [10] and immunosuppression in the offspring [11]. Since DON has 
been shown to cross also the human placenta, dietary exposure during pregnancy will lead to DON 
exposure of the fetus, whose detoxification mechanisms are not yet well developed [12]. 
Along with conventional mycotoxin analysis in food, biomonitoring has greatly advanced  
an assessment of human DON exposure. As reviewed by Turner et al. (2012) [13], sensitive analytical 
methods for the analysis of DON and its metabolites in urine have been developed and validated as 
biomarkers of exposure: unmetabolized or “free” DON together with DON-glucuronides in urine reflect 
rather strong dietary mycotoxin exposure, and the mean estimated amount of biomarkers excreted within 
a day are rather high, with about 68% [14] and 72% of the DON intake [15]. As DON is largely present 
as a glucuronide conjugate in human urine [14,15], enzymatic hydrolysis of samples (deconjugation) is 
used in most single- or multi-analyte methods for biomarker determination to increase the detectability 
of total DON [16]. Analysis should also include DOM-1, the detoxification product of DON formed by 
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gut microbiota in animals and humans: a recent study found relatively high levels of DOM-1, indicating 
that a substantial proportion of DON can be detoxified in humans [17], whilst the DOM-1 metabolite 
has been rarely detected or at only very low levels in urines from other cohorts [15,18–20]. 
DON biomarker occurrence has been analyzed in the urines of pregnant women from the U.K., Egypt 
and Croatia [21–23]. More studies have been conducted in the general population of some Asian [19,24], 
European [15,18,20,25–30] and African countries [31,32]. Overall, the results from these biomonitoring 
studies (in terms of frequency of detection and urinary analyte levels) indicate quite variable human 
exposure to DON, a finding in accord with reported differences in DON contamination of food 
commodities in various regions of the world [1,6]. 
When food contaminant data are scarce, as often is the case in developing countries, analysis of 
biomarkers in human body fluids provides useful insights, since biomonitoring covers mycotoxin intake 
from all dietary sources and exposure by various routes [14,33]. In Bangladesh, a small survey detected 
the presence of DON in 10 maize samples (17% positive) with the highest level of 337 µg/kg in maize 
from the northern part of the country [34]. The reported DON levels did not exceed the U.S. or EU 
regulatory limits, but this survey focused on maize alone and did not include analysis of other possibly 
contaminated food commodities. In short, these data are insufficient to assess human DON exposure  
in Bangladesh. 
Therefore, to gain more insight into maternal DON exposure during pregnancy, urine samples were 
collected from inhabitants of a rural and a suburban area of the Savar region in the Dhaka district of 
Bangladesh. The present study is the first biomarker-based DON exposure assessment for pregnant 
women in Bangladesh. 
2. Results 
2.1. Validation Parameters for Biomarker Analysis 
The calibration curve with pure standards in the mobile phase showed linearity in the range of  
0.5–20 ng/mL for both analytes with a coefficient of determination (R2) of 0.998 for DON and 0.997 for 
DOM-1, respectively. Analysis of DON and DOM-1 spiked urine yielded similar data for linearity in 
the range of LOD, 10 ng/mL. The limit of detection (LOD) and limit of quantification (LOQ) were 
determined based on the lowest quantity of analyte that can be clearly distinguished from the background 
(LOD; signal to noise ratio, S/N = 3) or quantified (LOQ; S/N ≥ 6). For DON, the LOD was 0.16, and 
the LOQ was 0.30 ng/mL. For DOM-1, the LOD and LOQ were 0.10 and 0.20 ng/mL, respectively. 
Recovery assays were performed in a urine with no measurable background of DON and DOM-1. 
Isotope-labeled internal standard ([13C15] DON) was used to correct for recovery. Recovery of analytes 
was assessed at three concentration levels in triplicates of spiked samples with mean values of 93% and 
86% for DON and DOM-1, respectively (Table 1). The intra-day and inter-day repeatability (Table 2) at 
a spike concentration of 1.0 ng/mL (n = 6) were determined using also the mycotoxin-free urine and 
showed acceptable precision for the measurements. 
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Table 1. Recovery of DON and DOM-1 in human urine. 
Spike Level (ng/mL) 
DON DOM-1 
Recovery (%) RSD (%) Recovery (%) RSD (%) 
0.5 (n = 3) 102 12.2 88 8.5 
1.0 (n = 3) 90 8.4 92 4.8 
2.0 (n = 3) 94 10.4 78 4.2 
Table 2. Intra-day and inter-day assay repeatability for DON and DOM-1 in urine. 
Spike Level  
(ng/mL) 
DON DOM-1 
Mean ± SD  
(ng/mL) 
Recovery 
(%) 
RSD 
(%) 
Mean ± SD 
(ng/mL) 
Recovery  
(%) 
RSD  
(%) 
Intra-day (1.0) n = 6 0.92 ± 0.12 92 13.0 0.82 ± 0.06 82 7.3 
Inter-day (1.0) n = 6  0.88 ± 0.08 88 9.1 0.80 ± 0.08 80 10.0 
2.2. Demographic Characteristics of the Participants 
The baseline anthropometric data of the participants are summarized in Table 3. The mean age of the 
participants was 25 ± 5 years, ranging from 18–36 years with no significant difference between the rural 
and suburban cohort. The average body mass index (BMI) for all subjects was 20.1 ± 3.0 kg/m2. 
Volunteers of the rural cohort had significantly higher BMI (21.2 ± 2.3 kg/m2) than those in the  
suburban cohort (18.6 ± 3.2 kg/m2). There were no significant differences (p < 0.01) in urinary creatinine 
levels between the rural (652 ± 509 mg/L) and suburban (710 ± 472 mg/L) cohort. Regarding occupation, 
83% of the participants were housewives, and 17% were office workers. All participants consumed the 
typical Bangladeshi staple food rice and, to a lesser extent, roti (whole wheat flatbread); these are 
generally consumed with vegetables, lentils, fish, poultry and beef. 
Table 3. Demographic characteristics of the participant. 
Characteristics Rural Suburban Total 
n 31 22 54 
Age (years) 
Mean ± SD 25 ± 5 26 ± 5 25 ± 5 
Range 18–36 18–36 18–36 
Occupation (n, %) 
Housewives 29 (91) 16 (73) 45 (83) 
Office workers 3 (9) 6 (27) 9 (17) 
BMI (kg/m2) 
Mean ± SD 21.2 ± 2.3 * 18.6 ± 3.2 20.1 ± 3.0 
Range 14.3–28.2 12.0–24.4 12.0–28.2 
Creatinine (mg/L) 
Mean ± SD 652 ± 509 710 ± 472 676 ± 490 
* p < 0.01 when compared to suburban; p-value obtained from independent sample t-test. 
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2.3. Urinary Level of DON in the Cohorts 
Urines with analyte concentrations at or above the limit of detection (LOD) were considered as 
positive samples. DOM-1 was not detected in any of the urines, whilst DON was detectable in 52% of 
the urines, at concentrations ranging from 0.18–7.16 ng/mL (Table 4). The distribution of urinary DON 
levels according to age of both cohorts is presented in Figure 1. The mean concentration of urinary DON 
was 0.86 ± 1.57 ng/mL or 2.14 ± 4.74 ng/mg creatinine for all study participants. A significant difference 
(p < 0.05) in mean urinary DON levels was found between the rural (0.47 ± 0.73 ng/mL) and the 
suburban (1.44 ± 2.20 ng/mL) cohort (Table 4), which may be related to different food habits in the two 
cohorts. Statistical analysis revealed no significant correlation of urinary biomarkers with age,  
gender and BMI of the study subjects. 
Table 4. Occurrence and contamination levels of DON in urine. 
Cohort n 
Positive Samples  
n (%) 
Mean ± SD 
(ng/mL) 
Median (Range) 
(ng/mL) 
75th Percentile  
(ng/mL) 
Mean ± SD  
(ng/mg Creatinine) 
Rural 32 13 (41) 0.47 ± 0.73 nd (nd–3.09) 0.65 1.14 ± 2.47 
Suburban 22 15 (68) 1.44 ± 2.20 * 0.51 (nd–7.16) 1.94 3.60 ± 6.63 
Total 54 28 (52) 0.86 ± 1.57 0.19 (nd–7.16) 0.85 2.14 ± 4.74 
A positive sample refers to urines containing the analyte ≥LOD; nd refers to levels below the LOD. For the calculation of 
mean and median values, biomarker concentration was set to half of the LOD if the DON urine concentration was below 
the LOD. * p < 0.05 when compared to rural; p-value obtained from independent sample t-test. 
 
Figure 1. Distribution of urinary DON in the rural and suburban cohort. Biomarker 
concentration was set to half of the LOD for samples with DON below the LOD. 
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2.4. Estimation of DON Intake 
Using the urinary biomarker analysis data, the provisional daily DON intake among all participants 
was on average 52.5 ± 94.4 ng/kg body weight (b.w.), and the highest DON intake was 461 ng/kg b.w. 
(Table 5). A significant difference (p < 0.05) was found between the rural (27 ng/kg b.w.) and suburban 
(90 ng/kg b.w.) cohort. No individual had an estimated daily DON intake above the tolerable daily intake 
(TDI) of 1000 ng/kg b.w./day [1]. 
Table 5. Provisional daily intake (PDI) of DON a. TDI, tolerable daily intake. 
Cohort n 
Mean ± SD  
ng/kg b.w. 
Median  
ng/kg b.w. 
Range  
ng/kg b.w. 
Exceeding TDI 
n (%) 
Rural 32 26.8 ± 39.0 5.0 3.1–154.0 - 
Suburban 22 89.9 ± 133.2 * 31.1 4.7–460.8 - 
Total 54 52.5 ± 94.4 11.2 3.1–460.8 - 
a Dietary DON intake was calculated based on urinary DON concentrations, adjusted for 24-h urine volume, 
assuming a 68% clearance rate and individual body weight (see the Experimental Section for details).  
* p < 0.05 when compared to rural; p-value obtained from independent sample t-test. 
2.5. Correlation between Urinary DON and Food Intake 
Based on information provided in the food frequency questionnaires (FFQ), possible correlations 
were analyzed between food consumption (graded 1–4) and urinary DON levels in the pregnant women 
cohort. The food items rice, wheat/maize, lentils and chicken meat were considered in Spearman 
correlation analysis (Table 6). Consumption of rice, the main staple food in Bangladesh, did not show a 
significant correlation (p = 0.39) with the urinary DON level of the subjects. No significant correlations 
were observed between DON in urine and other food items, such as wheat/maize (p = 0.75), lentil soup 
(p = 0.37) or chicken meat (p = 0.46). 
Table 6. Correlation (r) between food consumption and DON concentration in urine. 
Foodstuff Correlation (r) p-Value
Rice −0.174 0.395 
Wheat/maize 0.067 0.746 
Lentil soup 0.182 0.374 
Chicken meat 0.151 0.462 
Only positive samples (≥LOD) are considered for the calculation. Assessment of food consumption was done 
using the score 1–4 (1 = do not consume at all, 2 = 1 time daily, 3 = 2 times daily, 4 = 3 times daily. p-values 
are obtained from Spearman’s correlation coefficient (two-tailed). 
3. Discussion 
As briefly outlined in the Introduction, DON is known to cause a range of adverse effects in animals 
and can also cross the placenta. Thus, exposure of pregnant women to DON is of particular concern,  
yet only few biomonitoring studies have been conducted so far in this group of the population. 
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The present study is the first biomarker survey for DON exposure of pregnant women in Bangladesh: 
frequent detection of DON (52%) at a mean concentration of 0.86 ± 1.57 ng/mL or 2.14 ± 4.74 ng/mg 
creatinine (Table 4) indicates DON exposure in pregnant women living in a rural and a suburban area of 
Bangladesh, albeit at comparatively moderate levels. The urinary DON concentrations determined in 
this study are similar to levels found in the urines of pregnant women from Egypt (geometric mean  
1.11 ng/mg creatinine, range 0.5–59.9 ng/mg creatinine [22]). On the other hand, values in our cohort 
(mean 2.1 ng/mg creatinine, range 0.6–24.3 ng/mg creatinine) are clearly lower than those reported for 
pregnant women (n = 85) from Bradford, the U.K. (geometric mean 10.3 ng/mg creatinine, range  
0.5–116.7 ng/mg creatinine [21]) and for pregnant women (n = 40) from Croatia (DON equivalents: 
mean 111.8 ng/mL, range 4.8–1238 ng/mg [23]). The authors noted that maximum concentration in the 
rural sub-cohort of Croatian pregnant women indicated a nine-times higher exposure to DON than in 
U.K. pregnant women. Moreover, biomarker-based calculation of DON intake revealed mycotoxin 
exposures that clearly exceeded the tolerable daily intake (TDI) for DON of 1 µg/kg b.w., both in the 
U.K. and the Croatian cohort [21,23]. In the Bangladeshi cohort of pregnant women, even the highest 
calculated provisional daily DON intake of 461 ng/kg b.w. (Table 5) did not exceed the TDI. 
In our survey, DOM-1 metabolite was not detected in any of the 54 Bangladeshi urines. This is of 
interest, since human data on the occurrence of this detoxication product are limited. DOM-1 was  
found at modest levels in urines from Egyptian pregnant women (2/69; [22]) and from French farmers 
(26/76; [18]), but it was not detected in studies of U.K. adults [20] or U.K. pregnant women [21]. 
However, in a recent small pilot study with 15 volunteers who provided spot urines in two years,  
DOM-1 was detected in 37% and 40% of the samples: The prevalence and the proportion of DOM-1  
(up to 17.8% of urinary DON in some individuals) indicated that a substantial fraction of DON can be 
detoxified in humans harboring gut microbiota capable of DON detoxication [17]. Other recent studies 
from Europe detected DOM-1 less frequently and also at very low levels compared to DON and DON 
glucuronide [28,35,36]. DON toxicity in humans may be also related to their ability to produce  
DON-glucuronide [37]. Yet, in light of the limited availability of urines, we did not determine the ratio 
of free DON (aglycone) to DON-glucuronides in our cohort. 
Regarding possible sources of DON intake in Bangladesh: analysis of correlations between urinary 
biomarker levels and food consumption pattern based on FFQ data did not show significant associations 
with typical food items (Table 6), and this may be due to the overall rather low DON exposure among 
the participants. Interestingly, pregnant women from the suburban area had a significantly higher mean 
level of urinary DON and also provisional daily DON intake than our rural cohort (Tables 4 and 5). The 
higher DON exposure in the suburban participants may be related to higher consumption of wheat bread 
by the suburban residents than the rural residents. However, maize cannot be excluded, since our FFQ 
did not assess wheat and maize consumption separately, and wheat and maize flours are sometimes 
mixed together for making homemade bread and also in the bakery industry in Bangladesh. A small 
survey reported DON contamination at a low level in maize samples collected from the northern part  
of Bangladesh [34], but food analysis data for DON are not available for other staple food, such as rice 
or wheat. 
Finally, the present biomonitoring study revealed only moderate exposure of pregnant women in 
Bangladesh. Nonetheless, further studies are indicated: urine samples were collected in wintertime 
(2014), but the country has a subtropical monsoon climate, characterized by clear seasonal variations in 
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rainfall, temperature and humidity (http://en.wikipedia.org/wiki/Geography_of_Bangladesh). Since the 
growth and distribution of Fusarium fungi depends on climatic factors, such as moisture and temperature, 
quite variable DON contamination of crops cannot be excluded [17,38]. 
4. Experimental Section 
4.1. Standards and Reagents 
Standards for deoxynivalenol (DON), de-epoxy DON (DOM-1) and isotope-labeled internal standard 
([13C15] DON) were obtained from Romer Labs Diagnostics GmbH (Tulln, Austria). The enzyme  
β-glucuronidase/arylsulfatase (β-Gluc/ArylS) from Helix pomatia (with specific activity 5.5 U/mL  
β-glucuronidase, 2.6 U/mL arylsulfatase at 37 °C) was from Roche Diagnostics (Mannheim, Germany) 
and used with 10-fold hydrolysis buffer (13.6 g sodium acetate hydrate, 1.0 g ascorbic acid, 0.1 g EDTA 
in 100 mL deionized water, adjusted to pH 5.0 with acetic acid 98%) for enzymatic treatment of urine 
samples. Immunoaffinity DONTest™ columns (Vicam®, purchased from Ruttmann, Hamburg, Germany) 
were used for clean-up and enrichment of analytes. Methanol (LC-MS grade) was purchased from Merck 
(Darmstadt, Germany). 
4.2. Participants and Sample Collection 
During February–March 2014, fifty-four pregnant women (n = 47 in the third, n = 6 in the second 
and n = 1 in the first trimester) were recruited from a rural (Dhamrai, Dhamsona, Nolam, Paichail) and  
a suburban area (Baipail, Dhamrai, Kashimpur, Modhupur, Namabazar) of the Savar region in the Dhaka 
district of Bangladesh. All participants were apparently healthy according to external clinical 
examination by professional nurses. Written consent was obtained from the women before inclusion in 
this study. Volunteers were asked to fill out a short questionnaire for anthropometric information  
(age, height and weight), occupation and food habits, using the same food frequency questionnaire (FFQ) 
as in our previous studies in Bangladesh [39]. The spot urine samples were collected in the morning 
(between 8:00 and 11:00 am) into non-sterile disposable containers and then stored at −20 °C. All urine 
samples were shipped on dry ice to IfADo (Dortmund, Germany) in March 2014, and biomarker analysis 
was conducted in January 2015. This study was approved by the Institute of Biological Sciences of 
Rajshahi University, Rajshahi-6205, Bangladesh (Memo no. 40/320/IAMEBBC/IDSC), and by the 
Institutional Internal Review Board of IfADo. 
4.3. Enzymatic Hydrolysis 
To cleave DON (and DOM-1) conjugates, 250 µL hydrolysis buffer (pH 5.0) and 40 µL of β-Gluc/ArylS 
enzyme were added to 3 mL urine aliquots and incubated at 37 °C overnight before sample extraction. 
4.4. Sample Preparation 
Urine sample clean-up and enrichment of analytes was performed by immunoaffinity column (IAC) 
extraction with DONTest™ following the protocol provided by the manufacturer (VICAM). Briefly, 
after rinsing the column with 1 mL of water, the entire hydrolyzed urine sample was loaded on  
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a DONTest™ column at a flow rate of 1 drop/s. The column was washed with 5 mL distilled water, then 
DON was eluted (flow rate 1 drop/s) from the column using 2 mL of methanol. The elute was evaporated 
to dryness under a stream of nitrogen at 45 °C; the residue was dissolved in 500 µL water/methanol 
(90:10), vortexed and filtered through a 0.45-µm pore size Teflon syringe filter prior to LC-MS/MS 
analysis. Thus, the enrichment factor was 6. 
4.5. LC-MS/MS Analysis 
DON and its metabolite DOM-1 were measured in urine extracts by liquid chromatography with 
tandem mass spectrometry. Analysis was performed with a Varian 1200-L Quadrupole MS/MS equipped 
with an electrospray ionization (ESI) source, a Prostar® Varian HPLC system and a Varian MS 
Workstation version 6.9.1 data system (Agilent Technologies, Germany). The following settings were 
used: nitrogen as the drying gas (21 psi), gas temperature 250 °C, and argon used as the collision gas  
(2.0 mTorr). Chromatographic separation was carried out at 25 °C on a Nucleosil® 100-5 C18 125 × 3 mm 
column (Macherey-Nagel, Dŭren, Germany) with water (Mobile Phase A) and methanol (Mobile Phase B) 
as eluents in the following gradient: 0–1.1 min 45% B, 1.1–5.3 min 60% B, 5.3–7.3 min 95% B (column 
wash), 8–18 min 45% B (re-equilibration). The flow rate was 0.2 mL/min, and the injection volume was 
20 µL. The retention time for DON and its metabolite DOM-1 was 4.5 and 5.6 min and for the internal 
standard (IS) 4.5 min. ESI-MS/MS was executed by multiple reaction monitoring (MRM) in negative 
ion mode. The specific transitions of precursor ion and product ion were as follows: 295.1 → 265.1 m/z 
and 295.1 → 138.1 for DON. The optimized collision energy (CE) was −10 and −15.5 eV, respectively. 
For DOM-1, the transitions of precursor and product ions were 279.1 → 248.9 and 279.1 → 231.1 m/z 
with an optimized CE of −9 and −13 eV, and for the internal standard (IS), the transition of precursor 
and product ions was 310.0 → 279.2 m/z with an optimized CE of −9 in that order. 
4.6. Creatinine Analysis 
Urinary creatinine was measured by a modified Jaffe method on a 96-well plate reader  
(Tecan Genios) [40] to account for variability in urine dilution between individual samples.  
Urinary DON levels determined in ng/mL were adjusted for creatinine in the urine sample and their 
concentrations expressed as ng/mg creatinine to allow also comparison with other biomarker data. 
4.7. Exposure Assessment 
The estimation of DON intake among the participants was performed based on the results of urinary 
DON analysis. The following equation was used to assess the provisional daily intake (PDI) of DON 
among the participants: 
μg 100bodyweight
Kg
  
 
C VPDI
W E
   
 
  (1)
with C = biomarker concentration (µg/L), V = daily urine excretion (L), W = body weight (kg) and  
E = excretion rate (%). In the calculation, urinary output during pregnancy was considered as 2 L per 
day [41]. Individual body weight was used during the calculation of PDI and a daily urinary DON 
excretion rate of 68% [14], a value close to estimates in other studies [15,42]. 
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4.8. Food Consumption Data 
All participants were asked to fill in a questionnaire with a focus on the last two days of food 
consumption prior to urine sampling and in addition to record their regular food habits. The food 
frequency questionnaire (FFQ) asked for the intake of typical food items consumed by Bangladeshi 
people: staple foods, mainly cereals, such as rice, wheat, maize and lentils, as the major pulses. Consumption 
frequency was graded 1–4 (see Table 4). Chicken meat, eggs, groundnuts, milk and milk-based products 
were also included. Among these items, only rice is regularly consumed one to three times in a day and, 
to a lesser extent, also roti (whole wheat flatbread) for breakfast by the majority of participants. 
4.9. Statistical Analysis 
Descriptive statistics are presented as means (±SD), medians and interquartile ranges. Those samples 
containing DON below the limit of detection (LOD) were assigned a value of one-half the detection limit 
for the calculation of mean and median values, since this is considered a better approach to estimate 
average concentrations for left censored data, rather than assigning a value of zero to measurements 
below the detection limit [43]. Differences in urinary DON levels between the rural and the suburban 
cohort were analyzed by an independent sample t-test. The Spearman correlation coefficient (two-tailed) 
was used to assess the correlation between urinary DON concentration with food consumption, age and 
body mass index (BMI) of the participants. All analyses were carried out using IBM SPSS Statistics 
Version 22. A level of alpha 0.05 was assigned for statistical significance. 
5. Conclusions 
DON exposure in pregnant women in Bangladesh appears to be modest and lower than observed in 
biomonitoring studies performed in Europe and Africa. However, the present investigation comprises 
analysis of urine samples collected in one district and season only. Therefore, further studies in children 
and adult cohorts from other parts of the country and another season are indicated to gain more insights 
into the DON exposure of the Bangladeshi population. 
Acknowledgments 
The authors are grateful to all volunteers for participating in this study and wish to thank Iris Glaeser 
for excellent technical assistance in LC-MS/MS analysis. This work was supported by the German 
Academic Exchange Service (DAAD) with a scholarship to Nurshad Ali.  
Author Contributions 
Nurshad Ali and Gisela H. Degen co-conceived of the study idea, its design and funding.  
Nurshad Ali conducted biomarker analysis, statistical data analysis and drafted the manuscript.  
Gisela H. Degen supervised data collection and interpretation; and co-wrote the manuscript with the first 
author. Meinolf Blaszkewicz supervised LC-MS/MS analysis and its optimization; and contributed to the 
final editing of the manuscript. Abdullah Al Nahid and Mustafizur Rahman were instrumental in the 
collection of urine samples and questionnaires; and aided in FFQ data interpretation. 
Toxins 2015, 7 3855 
 
 
Conflicts of Interest 
The authors declare that they have no conflicts of interest. 
References 
1. WHO. WHO food additives series 47. In Proceedings of the 56th Meeting of the Joint FAO/WHO 
Expert Committee on Food Additives (JECFA), Geneva, Switzerland, 6–15 February 2001. 
2. European Food Safety Authority (EFSA). Deoxynivalenol in food and feed. EFSA J. 2013, 11, 
3379, doi:10.2903/j.efsa.2013.3379. 
3. Rotter, B.A.; Prelusky, D.B.; Pestka, J.J. Toxicology of deoxynivalenol (vomitoxin). J. Toxicol. 
Environ. Health 1996, 48, 1–34. 
4. Pestka, J.J.; Smolinski, A.T. Deoxynivalenol: Toxicology and potential effects on humans.  
J. Toxicol. Environ. Health B Crit. Rev. 2005, 8, 39–69. 
5. Alizadeh. A.; Braber, S.; Akbari, P.; Garssen, J.; Fink-Gremmels, J. Deoxynivalenol impairs weight 
gain and affects markers of gut health after low-dose, short-term exposure of growing pigs. Toxins 
2015, 7, 2071–2095. 
6. Wang, Z.; Wu, Q.; Kuča, K.; Dohnal, V.; Tian, Z. Deoxynivalenol: Signaling pathways and human 
exposure risk assessment—An update. Arch. Toxicol. 2014, 88, 1915–1928. 
7. Pestka, J.J. Deoxynivalenol: Mechanisms of action, human exposure, and toxicological relevance. 
Arch. Toxicol. 2010, 84, 663–679. 
8. Maresca, M. From the gut to the brain: Journey and pathophysiological effects of the food-associated 
trichothecene mycotoxin deoxynivalenol. Toxins 2013, 5, 784–820. 
9. Goyarts, T.; Dänicke, S.; Brussow, K.P.; Valenta, H.; Ueberschär, K.H.; Tiemann, U. On the transfer 
of the Fusarium toxins deoxynivalenol (DON) and zearalenone (ZON) from sows to their fetuses 
during days 35–70 of gestation. Toxicol. Lett. 2007, 171, 38–49. 
10. Tiemann, U.; Brussow, K.P.; Dänicke, S.; Vanselow, J. Feeding of pregnant sows with  
mycotoxin-contaminated diets and their non-effect on foetal and maternal hepatic transcription of 
genes of the insulin-like growth factor system. Food Addit. Contam. Part A 2008, 25, 1365–1373. 
11. Jakovac-Strajn, B.; Vengust, A.; Pestevsek, U. Effects of a deoxynivalenol contaminated diet on 
the reproductive performance and immunoglobulin concentrations in pigs. Vet. Rec. 2009, 165, 
713–718. 
12. Nielsen, J.K.S.; Vikström, A.C.; Turner, P.C.; Knudsen, L.E. Deoxynivalenol transport across the 
human placental barrier. Food Chem. Toxicol. 2011, 49, 2046–2052. 
13. Turner, P.C.; Flannery, B.; Isitt, C.; Ali, M.; Pestka, J. The role of biomarkers in evaluating human 
health concerns from fungal contaminants in food. Nutr. Res. Rev. 2012, 25, 162–179. 
14. Warth, B.; Sulyok, M.; Berthiller, F.; Schuhmacher, R.; Krska, R. New insights into the human 
metabolism of the Fusarium mycotoxins deoxynivalenol and zearalenone. Toxicol. Lett. 2013, 220, 
88–94. 
15. Turner, P.C.; White, K.L.; Burley, V.J.; Hopton, R.P.; Rajendram, A.; Fisher, J.; Cade, J.E.;  
Wild, C.P. A comparison of deoxynivalenol intake and urinary deoxynivalenol in UK adults. 
Biomarkers 2010, 15, 553–562. 
Toxins 2015, 7 3856 
 
 
16. Solfrizzo, M.; Gambacorta, L.; Warth, B.; White, K.; Srey, C.; Sulyok, M.; Krska, R.; Gong, Y.Y. 
Comparison of single and multi-analyte methods based on LC-MS/MS for mycotoxin biomarker 
determination in human urine. World Mycotoxin J. 2013, 6, 355–366. 
17. Gratz, S.W.; Richardson, A.J.; Duncan, G.; Holtrop, G. Annual variation of dietary deoxynivalenol 
exposure during years of different Fusarium prevalence: A pilot biomonitoring study. Food Addit. 
Contam. Part A, 2014, 31, 1579–1585. 
18. Turner, P.C.; Hopton, R.P.; Lecluse, Y.; White, K.L.; Fisher, J.; Lebailly, P. Determinants of urinary 
deoxynivalenol and de-epoxy deoxynivalenol in male farmers from Normandy, France. J. Agric. 
Food Chem. 2010, 58, 5206–5212. 
19. Turner, P.C.; Ji, B.T.; Shu, X.O.; Zheng, W.; Chow, W.H.; Gao, Y.T.; Hardie, L.J. A biomarker 
survey of urinary deoxynivalenol in China: The Shanghai Women’s Health Study. Food Addit. 
Contam. Part A 2011, 28, 1220–1223. 
20. Turner, P.C.; Hopton, R.P.; White, K.L.; Fisher, J.; Cade, J.E.; Wild, C.P. Assessment of 
deoxynivalenol metabolite profiles in UK adults. Food Chem. Toxicol. 2011, 49, 132–135. 
21. Hepworth, S.J.; Hardie, L.J.; Fraser, L.K.; Burley, V.J.; Mijal, R.S.; Wild, C.P.; Azad, R.; 
Mckinney, P.A.; Turner, P.C. Deoxynivalenol exposure assessment in a cohort of pregnant women 
from Bradford, UK. Food Addit. Contam. Part A 2012, 29, 269–276. 
22. Piekkola, S.; Turner, P.C.; Abdel-Hamid, M.; Ezzat, S.; El-Daly, M.; El-Kafrawy, S.; Savchenko, E.; 
Poussa, T.; Woo, J.C.S.; Mykkänen, H.; El-Nezami, H. Characterisation of aflatoxin and 
deoxynivalenol exposure among pregnant Egyptian women. Food Addit. Contam. Part A 2012,  
29, 962–971. 
23. Šarkanj, B.; Warth, B.; Uhlig, S.; Abia, W.A.; Sulyok, M.; Klapec, T.; Krska, R.; Banjari, I.  
Urinary analysis reveals high deoxynivalenol exposure in pregnant women from Croatia.  
Food Chem. Toxicol. 2013, 62, 231–237. 
24. Warth, B.; Petchkongkaew, A.; Sulyok, M.; Krska, R. Utilising an LCMS/ MS-based multi-biomarker 
approach to assess mycotoxin exposure in the Bangkok metropolitan area and surrounding provinces. 
Food Addit. Contam. Part A 2014, 12, 2040–2046. 
25. Warth, B.; Sulyok, M.; Fruhmann, P.; Berthiller, F.; Schuhmacher, R.; Hametner, C.; Adam, G.; 
Fröhlich, J.; Krska, R. Assessment of human deoxynivalenol exposure using an LC-MS/MS based 
biomarker method. Toxicol. Lett. 2012, 211, 85–90. 
26. Wallin, S.; Hardie, L.J.; Kotova, N.; Warensjö Lemming, E.; Nälsén, C.; Ridefelt, P.; Turner, P.C.; 
White, K.L.M.; Olsen, M. Biomonitoring study of deoxynivalenol exposure and association with 
typical cereal consumption in Swedish adults. World Mycotoxin J. 2013, 6, 439–448. 
27. Solfrizzo, M.; Gambacorta, L.; Visconti, A. Assessment of multi-mycotoxin exposure in southern 
Italy by urinary multi-biomarker determination. Toxins 2014, 6, 523–538. 
28. Huybrechts, B.; Debongnie, P.; Uhlig, S.; Callebaut, A. Fast and sensitive LC-MS/MS method 
measuring human mycotoxin exposure using biomarkers in urine. Arch. Toxicol. 2014, 
doi:10.1007/s00204-014-1358-8. 
29. Gerding, J.; Cramer, B.; Humpf, H.U. Determination of mycotoxin exposure in Germany using  
an LC-MS/MS multibiomarker approach. Mol. Nutr. Food Res. 2014, 58, 2358–2368. 
Toxins 2015, 7 3857 
 
 
30. Gerding, J.; Ali, N.; Schwartzbord, J.; Cramer, B.; Brown, D.L.; Degen, G.H.; Humpf, H.U.  
A comparative study of the human urinary mycotoxin excretion patterns in Bangladesh, Germany 
and Haiti using a rapid and sensitive LC-MS/MS approach. Mycotoxin Res. 2015, 31, 127–136. 
31. Ezekiel, C.; Warth, B.; Ogara, I.M.; Abia, W.; Ezekiel, V.C.; Sulyok, M.; Turner, P.C.; Krska, R.; 
Tayo, G. Exposure to mycotoxins in rural residents in northern Nigeria: A pilot, multi-urinary 
biomarker study. Environ. Int. 2014, 66, 138–145. 
32. Shephard, G.S.; Burger, H.M.; Gambacorta. L.; Gong, Y.Y.; Krska. R.; Rheeder, J.P.; Solfrizzo, M.; 
Srey, C.; Sulyok, M.; Visconti, A.; et al. Multiple mycotoxin exposure determined by urinary 
biomarkers in rural subsistence farmers in the former Transkei, South Africa. Food Chem. Toxicol. 
2013, 62, 217–225. 
33. Degen, G.H. Tools for investigating workplace related risks from mycotoxin exposure.  
World Mycotoxin J. 2011, 4, 315–327. 
34. Dawlatana, M.; Coker, R.D.; Nagler, M.J.; Wild, C.P.; Hassan, M.S.; Blunden, G. The occurrence 
of mycotoxins in key commodities in Bangladesh: Surveillance results from 1993 to 1995.  
J. Nat. Toxins 2002, 11, 379–386. 
35. Wallin, S.; Gambacorta, L.; Kotova, N.; Warensjo Lemming, E.; Nalsen, C.; Solfrizzo, M.;  
Olsen, M. Biomonitoring of of concurrent mycotoxin exposure among adults in Sweden through 
urinary multi-biomarker analysis. Food Chem. Toxicol. 2015, 83, 133–139. 
36. Heyndrickx, E.; Sioen, I.; Huybrechts, B.; Callebaut, A.; De Henauw, S.; de Saeger, S. Human 
biomonitoring of multiple mycotoxins in the Belgian population: Results of the BIOMYCO study. 
Environ. Int. 2015, 84, 82–89. 
37. Wu, X.; Murphy, P.; Cunnick, J.; Hendrich, S. Synthesis and characterization of deoxynivalenol 
glucuronide: Its comparative immunotoxicity with deoxynivalenol. Food Chem. Toxicol. 2007,  
45, 1846–1855. 
38. Doohan, F.M.; Brennan. J.; Cooke, B.M. Influence of climatic factors on Fusarium species 
pathogenic to cereals. Eur. J. Plant Pathol. 2003, 109, 755–768. 
39. Ali, N.; Blaszkewicz, M.; Mohanto, N.C.; Rahman, M.; Alim, A.; Hossain, K.; Degen, G.H. First 
results on analysis of citrinin biomarkers in urines from two cohorts in Bangladesh. Mycotoxin Res. 
2015, 31, 9–16. 
40. Blaszkewicz, M.; Liesenhoff-Henze, K. Creatinine in Urine. In The MAK Collection for 
Occupational Health and Safety; Part IV, Biomonitoring Methods, Vol 12; Wiley-VCH Verlag: 
Weinheim, Germany, 2010; pp. 169–184, doi:10.1002/3527600418.bi6027urie0012. 
41. Mikhail, M.S.; Anyaegbunam, A. Lower urinary tract dysfunction in pregnancy: A review.  
Obstet. Gynecol. Surv. 1995, 50, 675–683. 
42. Rodríguez-Carrasco, Y.; Mañes, J.; Berrada, H.; Font, G. Preliminary estimation of deoxynivalenol 
excretion through a 24 h pilot study. Toxins 2015, 7, 705–718. 
43. Hornung, R.W.; Reed, L.D. Estimation of average concentration in the presence of nondetectable 
values. Appl. Occup. Environ. Hyg. 1990, 5, 46–51. 
© 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/4.0/). 
  
Reprint of peer-reviewed original publications 
Publication 7  
A comparative study of the human urinary mycotoxin excretion patterns in 
Bangladesh, Germany and Haiti using a rapid and sensitive LC-MS/MS 
approach 
Gerding J, Ali  N, Schwartzbord J, Cramer B, Brown DL, Degen GH, Humpf HU (2015). 
Mycotoxin Res 31:127–36  
 
 
Contribution statement 
JG performed biomarker analysis, statistical data analysis and drafted the manuscript. NA 
provided urine samples from Bangladesh and Germany, supported data analysis and 
interpretation. JS collected urine samples from Haiti cohorts and provided input in the 
manuscript draft. BC supervised the LC-MS/MS analysis. All senior co-authors, DLB, GHD 
and HUH contributed to the concept and final editing of the manuscript. HUH co-conceived 
study idea and acted as corresponding author for the manuscript. 
 
 
 
 
 
 
 
 
 
 
ORIGINAL PAPER
A comparative study of the human urinary mycotoxin excretion
patterns in Bangladesh, Germany, and Haiti using a rapid
and sensitive LC-MS/MS approach
Johannes Gerding1,2 & Nurshad Ali3 & Jeremy Schwartzbord4 & Benedikt Cramer1 &
Dan L. Brown4 & Gisela H. Degen3 & Hans-Ulrich Humpf1,2
Received: 27 February 2015 /Revised: 24 April 2015 /Accepted: 27 April 2015 /Published online: 10 May 2015
# Society for Mycotoxin Research and Springer-Verlag Berlin Heidelberg 2015
Abstract An improved “dilute and shoot” LC-MS/MS
multibiomarker approach was used to monitor urinary
excretion of 23 mycotoxins and their metabolites in hu-
man populations from Asia (Bangladesh), Europe (Ger-
many), and the Caribbean region (Haiti). Deoxynivalenol
(DON), deoxynivalenol-3-glucuronide (DON-3-GlcA),
T-2-toxin (T-2), HT-2-toxin (HT-2), HT-2-toxin-4-
glucuronide (HT-2-4-GlcA), fumonisin B1 (FB1), afla-
toxins (AFB1, AFB2, AFG1, AFG2, AFM1), zearalenone
(ZEA), zearalanone (ZAN), their urinary metabolites α-
zearalanol (α-ZEL) and β-zearalanol (β-ZEL), and cor-
responding 14-O-glucuronic acid conjugates (ZEA-14-
GlcA, ZAN-14-GlcA, β-ZEL, α/β–ZEL-14-GlcA), och-
ratoxin A (OTA), and ochratoxin alpha (OTα) as well as
enniatin B (EnB) and dihydrocitrinone (DH-CIT) were
among these compounds. Eight urinary mycotoxin
biomarkers were detected (AFM1, DH-CIT, DON,
DON-GLcA, EnB, FB1, OTA, and α-ZEL). DON and
DON-GlcA were exclusively detected in urines from
Germany and Haiti whereas urinary OTA and DH-CIT
concentrations were significantly higher in Bangladeshi
samples. AFM1 was present in samples from Bangladesh
and Haiti only. Exposure was estimated by the calcula-
tion of probable daily intakes (PDI), and estimates sug-
gested occasional instances of toxin intakes that exceed
established tolerable daily intakes (TDI). The detection
of individual mycotoxin exposure by biomarker-based
approaches is a meaningful addition to the classical mon-
itoring of the mycotoxin content of the food supply.
Keywords Urinary biomarker . Exposure assessment .Mass
spectrometry .Mycotoxins . Urine
Introduction
Mycotoxins are toxic secondary metabolites of numerous
fungal strains infesting a large variety of food and feed
commodities. Mycotoxin production can take place at all
stages of plant growth, processing, or storage (Bennett and
Klich 2003). In order to protect humans against adverse
health effects of mycotoxins, maximum levels in food-
stuffs were set by regulatory authorities (Egmond et al.
2007). A reliable database concerning the human exposure
to mycotoxins is critical to these regulatory attempts (Mar-
in et al. 2013). Biomarker-based approaches to assess hu-
man exposure to mycotoxins have gained increased accep-
tance in recent years (Warth et al. 2013b). State-of-the-art
LC-MS/MS methods allow detection and quantitation of
mycotoxins and their metabolites in blood or urine at trace
levels. Several pilot-scale studies applying multibiomarker
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approaches to investigate exposure of populations in Afri-
ca, Asia, or Europe have revealed regional differences in
urinary biomarker excretion patterns (Warth et al. 2014;
Njumbe Ediage et al. 2013; Gerding et al. 2014; Abia
et al. 2013). Differences in nutritional habits and quality
of consumed foodstuffs are likely the reason for interre-
gional variations in mycotoxin excretion. Nevertheless, dif-
ferences in analytical methodology and diversity in avail-
able biomarkers limit comparison of the results.
The present study provides comparable data on the uri-
nary mycotoxin excretion patterns of populations from
Bangladesh, Germany, and Haiti using an improved “dilute
and shoot” LC-MS/MS multibiomarker approach for the
simultaneous detection of 23 analytes, parent mycotoxins,
and mycotoxin metabolites. Compounds monitored in this
study were deoxynivalenol (DON), deoxynivalenol-3-
glucuronide (DON-3-GlcA), T-2-toxin (T-2), HT-2-toxin
(HT-2), HT-2-toxin-4-glucuronide (HT-2-4-GlcA),
fumonisin B1 (FB1), aflatoxins (AFB1, AFB2, AFG1,
AFG2, AFM1), zearalenone (ZEA), zearalanone (ZAN),
their urinary metabolites α-zearalanol (α-ZEL), and β-
zearalanol (β-ZEL) and corresponding 14-O-glucuronic ac-
id conjugates (ZEA-14-GlcA, ZAN-14-GlcA, α/β–ZEL-
14-GlcA), ochratoxin A (OTA), and ochratoxin alpha
(OTα), as well as enniatin B (EnB) and dihydrocitrinone
(DH-CIT), a urinary metabolite of citrinin (Dunn et al.
1983; Ali et al. 2015b). Since in previous human or ani-
mal studies a good correlation has been observed between
dietary mycotoxin intake and urinary excretion, AFM1,
OTA, DON, FB1, and ZEA can be considered as suitable
biomarkers of exposure (Zhu et al. 1987; Gilbert et al.
2001; Šarkanj et al. 2013; Turner et al. 2010; Riley
et al. 2012; Gambacorta et al. 2013; Muñoz et al. 2014).
When reliable urinary excretion rates were available, these
data were used in our study to calculate the PDI to esti-
mate the human exposure to mycotoxins.
Material and methods
Chemicals and reagents
Methanol and acetonitrile were of LC gradient grade purity
(VWR, Darmstadt, Germany). Formic acid was purchased
from Merck (Darmstadt, Germany). ZAN, α-ZEL, β-ZEL,
AFM1, and AFB1/2, AFG1/2 were purchased from Sigma
Aldrich (Schnelldorf, Germany). DH-CIT was purchased
from AnalytiCon Discovery (Potsdam, Germany). EnB
was from Enzo Life Sciences (Lörrach, Germany). ZEA,
DON, FB1, OTA, OTα, T-2, and HT-2 were isolated and
purified from fungal cultures (Beyer et al. 2009; Cramer
et al. 2007, 2010; Bittner et al. 2013; Bretz et al. 2006;
Hübner et al. 2012). Glucuronic acid conjugates (DON-3-
GlcA, ZEA-14-GlcA, ZAN-14-GlcA, α-ZEL-14-GlcA, β-
ZEL-14-GlcA, and HT-2-4-GlcA) were obtained from en-
zymatic synthesis using rat and pig liver microsomes
(Welsch and Humpf 2012). Solid analytes were dissolved
in ACN or ACN/H2O (DON-3-GlcA, FB1). Stock solutions
were prepared at a concentration of 10 μg/mL in ACN or
ACN/H2O and stored at −20 °C. A working solution was
freshly prepared at 20-fold concentration of the highest
calibration point at each day of measurement in ACN/
H2O (50/50, v/v).
Sample collection and origin
Samples from Bangladesh and Germany were collected
from 2013 to 2014 from healthy adult volunteers with
ethical permission granted by the respective Institutional
Internal Review Boards (Institute of Biological Sciences,
Rajshahi University, Bangladesh; and IfADo, Germany).
Samples from Bangladesh (n=95) were collected from res-
idents of rural and urban areas of Rajshahi District (Ali
et al. 2015c). Samples from Germany (n=50) were col-
lected in the area of the city of Dortmund. Sample collec-
tion in Haiti (n=142) took place in the areas of Port au
Prince and Quartier Morin with participation of healthy
adult and children volunteers. For sample collection in
Port-au-Prince, approval was received from the GHESKIO
internal review board, and in Quartier Morin the depart-
ment director of the North for the Ministry of Health
(MSPP, in French). Sample collection in Port-au-Prince
took place during July of 2012 and in Quartier Morin
during September and October of 2013 and January of
2014. This study was reviewed by and received approval
from the Cornell Institutional Review Board for Human
Participants (ID no. 0908000519).
Sample preparation
After collection, samples were aliquoted, transported to
Germany on dry ice, and stored at −80 °C until further
analysis. On the day of analysis, samples were allowed
to reach room temperature and centrifuged at 14,000×g
for 10 min to remove solid residues. One-hundred μL
of the supernatant were diluted with 900 μL H2O/ACN/
formic acid (FA) (0.94/0.05/0.01, v/v/v) and subjected to
LC-MS/MS analysis. All measurements were performed
in duplicate and included the measurement of a blank
urine sample pooled from German samples and a blank
urine sample spiked with analytes at medium concentra-
tion level for quality control. Runs were rejected, if
quality control samples failed to be within 15 % of their
correct value.
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LC-MS/MS conditions
Analysis was carried out on an Agilent 1260 Infinity HPLC
system coupled to an AB SCIEX QTRAP®6500 mass
spectrometer.
HPLC setup
Separation of analytes was carried out by reversed-phase chro-
matography on a NUCLEODUR® C18 Pyramid column
(3 μm, 2.0×150 mm, MACHEREY-NAGEL, Düren, Germa-
ny) equipped with a C18 EC guard column (2 mm×4 mm,
MACHEREY-NAGEL, Düren, Germany). Eluent Awas ace-
tonitrile (0.1 % formic acid) and eluent B water (0.1 % formic
acid) at a flow rate of 600 μL/min. The total runtime was
13 min. The gradient started at 5 % A for 2 min. Solvent A
was increased to 95% until 9.5 min and kept for 1 min at 95%
A. Afterwards percentage of Awas decreased to starting con-
ditions (11 min) and the column was allowed to re-equilibrate
until 13 min.
MS/MS setup
Detection of analytes of interest was carried out on an AB
SCIEXQTRAP®6500 mass spectrometer with ESI ionization
in Scheduled MRMTM (multiple reaction monitoring) detec-
tion mode. ESI-source parameters were optimized and preset
for all measurements as follows: source temperature, 500 °C;
curtain gas, 30 psi; gas 1, 35 psi; gas 2, 45 psi. Ion spray
voltage was set to −4,500 V in negative ionization mode and
5,500 V in positive ionization mode. Two characteristic MRM
transitions per analyte were monitored to ensure accurate
identification. MS/MS parameters were optimized for each
analyte in positive and negative ionization mode by direct
infusion of pure standard solutions. The final method was
built based on the best S/N ratio in positive or negative ioni-
zation mode. Scheduled MRMTM parameters were set to a
window width of 25 s and a target scan time of 0.15 s in
negative and 0.20 s in positive ionization mode. The software
used was Analyst 1.6.2. Detailed MS-Parameters are in
Table S1 in the supporting information.
Validation of the analytical method
The analytical method was subject to an in-house validation
comprising linearity, apparent recovery (RA), reproducibility,
and accuracy along with the determination of LOD and LOQ.
Quantitation was carried out with an external matrix-matched
calibration with spiked blank urine samples using a freshly
prepared working solution. Blank urine was pooled out of
samples negative for all analytes in a previous measurement.
The calibration curves covered two magnitudes in concentra-
tion of each analyte. Coefficient of determination was defined
as a measure of linearity of the calibration curves. The cali-
bration range was chosen based on the preliminary determi-
nation of LOD and LOQ of the analytes. LOD was defined at
a signal to noise (S/N) ratio of S/N=3 and LOQ at S/N=10.
All validation experiments were executed in triplicate. RAwas
calculated from the slope of the linear calibration curves of
spiked urine samples and neat standard solutions. Reproduc-
ibility was investigated at low, medium, and high spiking level
in blank urine on three different days. Intraday precision was
determined by 10-fold injection of a spiked urine sample at
second highest spiking level.
Statistical analysis
Means of biomarker concentrations detected in urines of dif-
ferent origins were subjected to a one-way analysis of variance
(ANOVA). Differences among means of populations were
further characterized using a post hoc test (Scheffe’s method).
Statistical significance was assumed at a p value≤0.05. IBM
SPSS 22 program was used for statistical analysis.
Estimation of probable daily intakes (PDI)
for a theoretical reference subject weighing 60 kg
PDI was calculated if samples from an investigated popula-
tion were tested positive for a specific biomarker and previ-
ously published data on human excretion rates were avail-
able. In cases in which no data on human excretion were
available, estimates from piglet biomarker excretion were
used for calculations. Table 4 summarizes underlying excre-
tion rates and references. Concerning the excretion of DON,
we assumed an excretion rate of 68 % where 52 % were
excreted as DON-GlcA and 16 % as unmetabolized DON
(Warth et al. 2013a). PDI was calculated using Formula 1.
Since no specific data on individual body weight and the
daily excreted amount of urine volume of the investigated
populations were available, calculations were based on an
average body weight of 60 kg. Results therefore have to
be considered as rough estimates rather than accurate expo-
sure assessments, but give valuable insights to the exposure
situation of the investigated populations. A mean body
weight of 60 kg and a mean daily urine excretion of 1.5 L
(EFSA 2010) were assumed.
PDI
μg
kg
body weight
 
¼ C  V  100
W  E ð1Þ
With:
C Biomarker concentration (in microgram per liter)
V (Mean) daily urine excretion (in liter)
W (Mean) body weight (in kilogram)
E Excretion rate (in percent)
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Results
Method development and validation
This improved LC-MS/MS method is capable of the simulta-
neous separation and sensitive detection of 23 mycotoxin-
biomarkers in one single chromatographic run of 13 min
(Gerding et al. 2014). DON-3-GlcA and DON-15-GlcA were
not chromatographically separated and the resulting signal was
assumed to be the sum of both glucuronides. LOD of OTA,
FB1, EnB, DH-CIT, and other analytes could be lowered com-
pared to the previously published method and allowed the fre-
quent detection of OTA throughout the sample pool. Obtained
LODs were in the low nanogram per milliliter scale or below.
Apparent recovery (RA) values ranged from 73 to 183 % and
indicate an acceptable suppressing or enhancing effect of the
matrix on signal intensities. Relative standard deviation (RSD)
during intraday reproducibility was lower than 15 % for all
analytes. RSD during interday reproducibility was lower than
15 % at high and medium spiking level and below 20 % at low
calibration level for themajority of analytes.With the exception
of HT-2-4-GlcA, all analytes met the criteria set during in-
house validation. A higher RSD of 36 % in the low and 20 %
at high spiking level was tolerated for HT-2-4-GlcA since a
reliable screening at low concentration levels was the major
aim during method development. Retention times were highly
reproducible and stable for all analytes, allowing the applica-
tion of Scheduled MRMTM algorithm. Detailed validation pa-
rameters are listed in Table 1.
Mycotoxin and metabolite excretion patterns of urine
samples from Germany, Haiti, and Bangladesh
Some mycotoxins and their metabolites could be detected in
the samples from all countries of origin. The detailed results
are summarized in Tables 2 and 3. Analyte occurrence differs
widely among the investigated populations. Eighty-seven per-
cent of the samples from Bangladesh were tested positive for
one or more mycotoxin biomarker, and 80 % of German urine
samples contained detectable amounts of biomarkers. The
presence of mycotoxin biomarkers was confirmed for 68 %
of the Haitian samples (Table 3). Eight different biomarkers
were detected in the samples from Haiti. OTA, DON-GlcA,
DON, and DH-CITwere the most prevalent analytes, follow-
ed by the infrequent detection of AFM1, EnB, FB1, and α-
ZEL. DON-GlcA, DON, OTA, and DH-CITwere detected in
urines of the German cohort. Samples from Bangladesh
showed an abundant occurrence of OTA and DH-CIT, where-
as AFM1, FB1, and EnB were only occasionally detected.
DON and DON-GlcA were frequently detected in samples
from Germany and Haiti at similar concentrations, but were
absent in samples from Bangladesh (Table 2). DH-CIT and
OTA occurred more frequently and at higher mean
concentrations in urine samples from Bangladesh than in
those from Germany or Haiti. α-ZEL was the sole metabolite
related to zearalenone contamination of ingested foodstuffs
and was only identified in Haitian samples. Neither T-2-toxin
nor HT-2-toxin or HT-2-4-GlcA were detected in any of the
three cohorts.
Estimation of probable daily intake rates (PDI)
The obtained biomarker concentrations of DON, DON-GlcA,
FB1, AFM1, and α-ZEL were used to estimate probable daily
intake (PDI) values for the mycotoxins DON, FB1, AFB1, and
ZEA based on published urinary excretion rates for these my-
cotoxins. The OTA data was not considered for estimation of
intakes as a robust estimate of human urinary OTA excretion
rates is not available (Duarte et al. 2011). Table 4 summarizes
the calculated PDI values and relates to the established TDI
values. Mean PDI was below the TDI for all toxins in samples
from the different geographic origins. PDI calculated for DON
exceeded the TDI of 1 μg/kg b.w. in 6 % of the samples at
maximum by the factor of two in German and four in Haitian
samples. α-ZEL was occasionally detected in urines from
Haiti. Assuming a urinary excretion rate of 8.3 %, 1 % of
the samples exceed the TDI set for ZEA at 0.2 μg/kg b.w.
with a maximum exceedance by the factor of four.
Discussion
Interregional differences in urinary mycotoxin and mycotoxin
metabolite excretion patterns exist between German, Haitian,
and Bangladeshi populations. DON and its urinary metabolite
DON-GlcA were frequently detected in urine samples from
Germany and Haiti, whereas all samples from Bangladesh
tested negative for these compounds. Presence of OTA and
DH-CIT was confirmed in samples from all geographic re-
gions, with samples from Bangladesh showing higher occur-
rence rates and mean concentrations than samples originating
from Germany or Haiti (Tables 2 and 3). AFM1 and FB1 were
exclusively found in samples from Bangladesh and Haiti. Fre-
quent detection of DON or its urinary metabolites DON-3-
GLcA and DON-15-GlcA in Europe was previously reported
in populations from Italy, Germany, and Croatia (Solfrizzo
et al. 2014; Gerding et al. 2014; Šarkanj et al. 2013). The
outcomes of these studies match the present data of mean
concentrations below the LOQ (4 ng/mL for DON) and
11.2 ng/mL for DON-GlcA in the German population. Both
Solfrizzo et al. (2014) and Gerding et al. (2014) concluded a
medium risk for the investigated populations based on PDI
calculations ranging close to the established TDI of 1 μg
DON/kg b.w. with an occasional exceedance of the TDI. Ex-
posure to DON was low in all of the three investigated loca-
tions. Whereas DON-Biomarkers were absent in samples
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from Bangladesh, the TDI for DON was only occasionally
exceeded in Germany and Haiti. The biomarker data reflect
the high occurrence rates of DON in 99 % of raw grains at
mean concentrations of 61 μg/kg (wheat) as reported in the
annual German harvest report (Bundesministerium für
Ernährung und Landwirtschaft 2013). Our data indicate that
the exposure of the investigated Haitian population to DON is
similar or higher, including peak values, compared to DON
exposure in Germany. This finding is rather interesting as no
data on the natural occurrence of DON in Haitian foodstuffs
are available. High peak concentrations of DON-GlcA of 60
and 104 ng/mL in the German and Haitian population further-
more demonstrate the advantage of biomarker-based ap-
proaches to assess the exposure of individuals and sub-popu-
lations. Since neither DON nor its metabolites were detected
in samples from Bangladesh, we conclude a low rate of expo-
sure among Bangladeshi participants. This result is consistent
with low occurrence rates reported for DON in foodstuffs of
Bangladesh (Dawlatana et al. 2002) and the outcome of a
biomarker based study on DON exposure conducted in South-
east Asia, in the area of Bangkok and Thailand (Dawlatana
et al. 2002; Warth et al. 2014).
OTAwas frequently detected in samples of all origins, with
mean values of 0.040, 0.109, and 0.203 ng/mL in urines from
Germany, Haiti, and Bangladesh. Samples from Bangladesh
showed significantly higher mean concentrations than sam-
ples from Germany and Haiti. The data of the present study
resemble ranges of OTA concentrations reported for urine
samples from Germany, Italy, and Croatia (Gerding et al.
2014; Solfrizzo et al. 2014; Klapec et al. 2012). From a mean
urinary concentration of 0.144 ng/mL in Italian urines,
Solfrizzo et al. (2014) calculated a PDI of 0.139 μg/kg b.w.,
i.e., a significant exceedance of the established TDI of
0.017 μg/kg b.w. for OTA. We did not estimate exposure to
OTA by quantitative means, since uncertainties remain
concerning urinary excretion rates of OTA due to its complex
toxicokinetics (Duarte et al. 2011). Excretion rates applied in
previous biomarker studies range from 2.6 % (Solfrizzo et al.
Table 1 Results of method validation. Limit of detection (LOD) and limit of quantitation (LOQ) are defined at a S/N ratio of 3 (LOD) and 10 (LOQ)
Analyte Calibration range [ng/mL] LOD [ng/mL] a LOQ [ng/mL]a RA [%] Intraday [%]
b Interdayc Retention times [min]
DON-GlcA 0.4–40 0.1 (1) 0.4 (4) 91 % 9 16/9/11 4.48±0.014
ZAN-14-GlcA 0.1–10 0.0125 (0.125) 0.1 (1) 73 % 8 18/13/13 6.97±0.01
ZAN 0.15–15 0.0375 (0.375) 0.15 (1.5) 82 % 10 19/5/6 8.34±0.02
ZEA 0.03–3 0.015 (0.15) 0.03 (0.3) 86 % 8 19/15/15 8.38±0.013
α-ZEL 0.025–2.5 0.0125 (0.125) 0.025 (0.25) 74 % 10 16/12/13 7.86±0.013
α-ZEL-14-GlcA 0.5–50 0.25 (2.5) 0.5 (5) 129 % 7 13/14/15 6.62±0.012
ZEA-14-GlcA 0.75–75 0.1875 (1.875) 0.75 (7.5) 183 % 7 17/12/12 6.98±0.013
OTα 0.1–10 0.05 (0.5) 0.1 (1) 86 % 7 19/11/11 8.32±0.026
β-ZEL 0.025–2.5 0.0125 (0.125) 0.025 (0.25) 79 % 8 14/11/12 7.49±0.013
β-ZEL-14-GlcA 0.5–50 0.25 (2.5) 0.5 (5) 76 % 8 19/14/11 6.29±0.012
AFB1 0.01–1 0.0025 (0.025) 0.01 (0.1) 124 % 8 20/11/11 7.02±0.015
AFB2 0.0029–0.289 0.0014 (0.014) 0.0029 (0.029) 109 % 10 16/14/14 6.77±0.027
AFG1 0.01–1 0.0025 (0.025) 0.01 (0.1) 117 % 11 18/15/15 6.77±0.014
AFG2 0.0029–0.289 0.0014 (0.014) 0.0029 (0.029) 122 % 6 15/14/14 6.53±0.01
AFM1 0.01–1 0.0025 (0.025) 0.01 (0.1) 129 % 9 13/9/12 6.26±0.01
T-2 0.02–2 0.01 (0.1) 0.02 (0.2) 86 % 8 15/14/14 8.03±0.01
HT2 0.9–90 0.45 (4.5) 0.9 (9) 63 % 5 17/14/12 7.2±0.01
HT-2-4-GlcA 0.15–15 0.0375 (0.375) 0.15 (1.5) 111 % 14 36/20/14 6.72±0.01
DH-CIT 0.02–2 0.01 (0.1) 0.02 (0.2) 76 % 9 20/15/15 11.31±0.13
FB1 0.01–1 0.00125 (0.0125) 0.01 (0.1) 170 % 12 7/6/12 6.12±0.02
EnB 0.0005–0.05 0.000125 (0.00125) 0.0005 (0.005) 144 % 15 8/10/15 10.18±0.03
OTA 0.0075–0.75 0.001 (0.01) 0.0075 (0.075) 93 % 11 7/9/9 8.37±0.01
DON 0.4–40 0.1 (1) 0.4 (4) 82 % 8 15/9/9 4.27±0.01
Retention times are means of 58 chromatographic runs on three different days of analysis
a Values in parentheses take the 10-fold dilution of urine samples into account
b Apparent recovery (RA) was calculated from the slope of the linear calibration curves of spiked urine samples and neat standard solutions. Intraday
reproducibility was determined by 10-fold injection of a blank urine sample spiked at second highest level of the calibration range
c Interday precision was determined by 3-fold injection of a spiked urine sample on three subsequent days at second lowest, medium, and second highest
calibration point
Mycotoxin Res (2015) 31:127–136 131
T
ab
le
2
Su
m
m
ar
y
of
m
yc
ot
ox
in
an
d
m
yc
ot
ox
in
m
et
ab
ol
ite
co
nt
en
td
et
ec
te
d
in
ur
in
e
sa
m
pl
es
fr
om
G
er
m
an
y,
H
ai
ti,
an
d
B
an
gl
ad
es
h
Sa
m
pl
e
or
ig
in
H
ai
ti
G
er
m
an
y
B
an
gl
ad
es
h
C
oh
or
ts
iz
e
(n
),
14
2
C
oh
or
ts
iz
e
(n
),
50
C
oh
or
ts
iz
e
(n
),
95
To
xi
n
Po
si
tiv
es
%
(n
)
M
ea
n,
ng
/m
L
±
S
D
(n
g/
m
g
cr
ea
tin
in
e)
M
ed
ia
n,
ng
/m
L
(r
an
ge
)
Po
si
tiv
es
%
(n
)
M
ea
n,
ng
/m
L
±
S
D
(n
g/
m
g
cr
ea
tin
in
e)
M
ed
ia
n,
ng
/m
L
(l
ow
es
t,
hi
gh
es
t)
Po
si
tiv
es
%
(n
)
M
ea
n,
ng
/m
L
±
S
D
(n
g/
m
g
cr
ea
tin
in
e)
M
ed
ia
n,
ng
/m
L
(r
an
ge
)
D
O
N
17
(2
4)
3.
2
±
2.
0
(3
.6
)
2.
0
(<
L
O
Q
–1
6.
9)
16
(8
)
2.
0
±
n.
a.
(2
.0
)
2.
0
(<
L
O
Q
)
n.
d.
n.
d.
n.
d.
D
O
N
-G
lc
A
21
(3
0)
17
.0
±
21
.1
(2
0.
0)
10
.8
(<
L
O
Q
–1
04
.3
)
54
(2
7)
11
.2
±
13
.0
(1
1.
7)
7.
5
(<
L
O
Q
–6
0.
9)
n.
d.
n.
d.
n.
d.
E
nB
3
(4
)
0.
03
6
±
0.
02
0
(0
.0
29
)
0.
02
8
(0
.0
21
–0
.0
65
)
14
(7
)
0.
01
2
±
0.
00
2
(0
.0
17
)
0.
01
1
(0
.0
10
–0
.0
14
)
2
(2
)
0.
01
9
±
0.
00
0
(0
.0
15
)
0.
01
9
(0
.0
11
9–
0.
01
87
)
O
TA
33
(4
7)
0.
10
9
±
0.
04
4
(0
.0
91
)
0.
09
7
(<
L
O
Q
–0
.2
25
)
30
(1
5)
0.
04
0
±
0.
01
1
(0
.0
30
)
0.
03
8
(<
L
O
Q
–0
.0
82
)
76
(7
2)
0.
20
3a
±
0.
28
2
(0
.2
07
)
0.
11
5
(<
L
O
Q
–2
.0
10
)
A
FM
1
8
(1
1)
0.
06
±
0.
03
(0
.0
6)
0.
05
(<
L
O
Q
–0
.1
4)
n.
d.
n.
d.
n.
d.
8
(8
)
0.
06
±
0.
02
(0
.0
6)
0.
05
(<
L
O
Q
–0
.1
2)
D
H
-C
IT
14
(2
0)
0.
49
±
0.
95
(0
.2
8)
0.
27
(<
L
O
Q
–4
.3
4)
28
(1
4)
0.
12
±
0.
02
(0
.0
9)
0.
10
(<
L
O
Q
–0
.3
3)
75
(7
1)
2.
75
a
±
8.
43
(3
.1
5)
0.
42
(<
L
O
Q
–5
8.
82
)
FB
1
3
(4
)
0.
44
±
0.
21
(0
.2
9)
0.
41
(0
.2
3–
0.
70
)
n.
d.
n.
d.
n.
d.
1
(1
)
–
–
α
-Z
E
L
3
(4
)
1.
46
±
1.
02
(0
.9
7)
1.
42
(0
.5
2-
2.
49
)
n.
d.
n.
d.
n.
d.
n.
d.
n.
d.
n.
d.
T
he
po
rt
io
n
of
po
si
tiv
e
fi
nd
in
gs
fo
ra
co
m
po
un
d
is
gi
ve
n
as
a
pe
rc
en
ta
ge
(i
n
pe
rc
en
t)
an
d
an
ab
so
lu
te
nu
m
be
r(
n)
.M
ea
ns
ar
e
st
at
ed
in
na
no
gr
am
pe
rm
ill
ili
te
ra
nd
no
rm
al
iz
ed
to
cr
ea
tin
in
e
(i
n
na
no
gr
am
pe
r
m
ill
ig
ra
m
of
cr
ea
tin
in
e)
.N
eg
at
iv
e
fi
nd
in
gs
ar
e
in
di
ca
te
d
as
no
td
et
ec
te
d
(n
.d
.)
.T
ox
in
co
nc
en
tr
at
io
ns
be
tw
ee
n
th
e
lim
it
of
de
te
ct
io
n
(L
O
D
)
an
d
th
e
lim
it
of
qu
an
tit
at
io
n
(L
O
Q
)
w
er
e
se
tt
o
L
O
Q
/2
of
th
e
re
sp
ec
tiv
e
co
m
po
un
d
fo
r
th
e
ca
lc
ul
at
io
n
of
m
ea
ns
.T
w
o
sa
m
pl
es
of
th
e
B
an
gl
ad
es
hi
sa
m
pl
e
po
ol
ex
ce
ed
ed
th
e
ca
lib
ra
tio
n
ra
ng
e
fo
r
D
H
-C
IT
.
a
M
ea
su
re
m
en
to
ft
he
se
sa
m
pl
es
w
as
re
pe
at
ed
w
ith
an
ad
ju
st
ed
ca
lib
ra
tio
n.
M
ea
n
co
nc
en
tr
at
io
ns
of
D
H
-C
IT
an
d
O
TA
w
er
e
si
gn
if
ic
an
tly
hi
gh
er
in
ur
in
e
sa
m
pl
es
fr
om
B
an
gl
ad
es
h
th
an
in
G
er
m
an
y
an
d
H
ai
ti
at
a
p
va
lu
e≤
0.
05
132 Mycotoxin Res (2015) 31:127–136
2014) to 50% (Abia et al. 2013), which demonstrates the need
for better and robust estimates urinary OTA excretion rates.
On the other hand good, correlations of OTA intake or dietary
habits with urinary OTA concentrations were previously re-
ported (Gilbert et al. 2001; Coronel et al. 2011; Muñoz et al.
2014). We therefore conclude a higher exposure of the Ban-
gladeshi cohort to OTA compared to Germany and Haiti. Fur-
ther investigations are warranted in light of the frequent de-
tection of OTA in plasma samples from Bangladeshi students
(Ali et al. 2014). Whereas comprehensive data on the occur-
rence of OTA in food commodities is available for Europe
(EFSA 2006), our findings support efforts to identify dietary
sources of OTA exposure in Haiti and Bangladesh.
AFM1, as a urinary biomarker of AFB1, was detected in
8 % of samples from Bangladesh and 11 % in samples from
Haiti. Since AFB1 is a potent mutagenic carcinogen, no TDI
values are established. The presence of AFM1 in urine sam-
ples from Bangladesh and Haiti support concerns about the
aflatoxin contamination of foodstuffs in these regions. Afla-
toxin exposure in Haiti was recently reviewed, revealing high
aflatoxin levels in common staple foods like peanut butter and
maize (Schwartzbord et al. 2013; Filbert and Brown 2012;
Castor 1987). Recent data from Bangladesh showed evidence
for high AFB1 levels in common foodstuffs above EU regu-
latory limits (Roy et al. 2013). Elevated aflatoxin concentra-
tions were also reported in chili samples from Sri Lanka, with
67 % of the samples exceeding EU regulatory limits
(Yogendrarajah et al. 2014). Future efforts in monitoring afla-
toxin contents in Haiti and Bangladeshi foodstuffs should
therefore also include spices to investigate their impact on
aflatoxin exposure.
Fumonisin FB1 was detected in four urine samples from
Haiti and one sample from Bangladesh at a maximum con-
centration of 0.7 ng/mL. The TDI of 2 μg/kg b.w. was never
exceeded. No data on the occurrence of FB1 in food are avail-
able for Haiti. Biomarker-based studies conducted in regions
of endemic FB1 occurrence reported more frequent detection
of FB1 in urine samples than in our Haitian cohort. Torres et al
(2014) investigated urinary mycotoxin levels in nearby Gua-
temala, reporting the abundant presence of urinary FB1
(Torres et al. 2014). Shephard et al. (2013) detected FB1 in
96 % of the investigated South African population at mean
Table 3 Occurrence and co-occurrence of investigated mycotoxins and their metabolites in urine samples from Haiti, Germany, and Bangladesh
Occurrence/co-occurrence % (n)
Toxins Haiti Germany Bangladesh Toxins Haiti Germany Bangladesh
1 Toxin 43 (61) 42 (21) 23 (22) 3 Toxins 6 (9) 20 (10) 11 (10)
AFM1 3 (4) n. d. n. d. AFM1/DH-CIT/DON-GlcA 1 (1) n. d. n. d.
α-ZEL 1 (2) n. d. n. d. AFM1/DH-CIT/OTA 1 (1) n. d. 8 (8)
DH-CIT 5 (7) 8 (4) 11 (10) DH-CIT/DON/DON-GlcA 1 (2) 4 (2) n. d.
DON 4 (5) n. d. n. d. DH-CIT/DON-GlcA/OTA n.d 6 (3) n. d.
DON-GlcA 6 (9) 22 (11) n. d. DH-CIT/FB1/OTA n.d n. d. 1 (1)
EnB 1 (1) 4 (2) n. d. DH-CIT/ENB/OTA n.d 2 (1) 1 (1)
FB1 1 (2) n. d. n. d. DON/DON-GlcA/EnB n.d 4 (2) n. d.
OTA 22 (31) 8 (4) 13 (12) DON/DON-GlcA/OTA 3 (4) 4 (2) n. d.
2 Toxins 17 (24) 16 (8) 54 (51) EnB/DON-GlcA/OTA 1 (1) n. d. n. d.
AFM1/DH-CIT 1 (2) n. d. n. d. 4 Toxins 1 (2) 2 (1) n. d.
AFM1/DON 1 (1) n. d. n. d. DH-CIT/DON/DON-GlcA/OTA 1 (1) 2 (1) n. d.
AFM1/DON-GlcA 1 (2) n. d. n. d. DH-CIT/DON/OTA/FB1 1 (1) n. d. n. d.
α-ZEL/DH-CIT 1 (1) n. d. n. d. Total positives 68 (96) 80 (40) 87 (83)
α-ZEL/DON 1 (1) n. d. n. d. Total negatives 32 (46) 20 (10) 13 (12)
DH-CIT/DON-GlcA n.d 2 (1) n. d.
DH-CIT/EnB n.d n. d. 1 (1)
DH-CIT/FB1 1 (1) n. d. n. d.
DH-CIT/OTA 2 (3) 4 (2) 53 (50)
DON/DON-GlcA 6 (8) 2 (1) n. d.
DON/OTA 1 (1) n. d. n. d.
DON-GlcA/OTA 1 (2) 4 (2) n. d.
EnB/DON-GlcA n.d 4 (2) n. d.
EnB/OTA 1 (2) n. d. n. d.
Values are given as percentage and absolute number of occurrence in each cohort (n, in brackets)
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urine concentrations of 1.52 ng/mL. Combining our results
with the outcome of the studies from Guatemala and South
Africa, we conclude a lower risk of exposure to FB1 among
the Haitian participants of our study. Moreover, the biomarker
based approach demonstrates value identifying exposure of
individuals, since occasional peak exposures to FB1 were
not detected in the German or Bangladeshi sample cohort.
DH-CIT is a metabolite of citrinin and was frequently de-
tected in samples from all geographic areas covered by this
study. Whereas DH-CIT occurrence was frequent but at low
concentrations in the German and Haitian sample pool (0.27
and 0.49 ng/mL), mean concentrations in Bangladeshi urines
were higher: DH-CITwas detected in 76 % of these samples,
with a mean concentration of 2.75 ng/mL. This is in line with
differences reported in recent studies using targeted analysis
of citrinin biomarkers in urines from Bangladeshi cohorts col-
lected during another season and in German volunteers (Ali
et al. 2015b, c). DH-CIT has not been validated as biomarker
of exposure to citrinin, but new data indicate that a correlation
of citrinin intake and DH-CIT in urine can be anticipated (Ali
et al. 2015a). Citrinin occurrence in food and feed has been
described in Europe, Asia, and the USA, frequently present
with OTA (EFSA 2012). Nguyen et al. (2007) detected citri-
nin in rice samples from Vietnam and reported co-occurrence
with OTA and AFB1. Rice is a common staple food in Ban-
gladesh, and urinary OTA and DH-CIT concentrations were
elevated in urines from Bangladesh. Rice is also the most
common grain ingested in Haiti, but DH-CIT and OTA levels
there were not as high as those found in Bangladesh. It would
therefore be of particular interest to investigate if differences
in rice contamination with OTA and citrinin lead to the ob-
served effect.
EnB was most frequently detected in German urines and
less so among urines fromHaiti and Bangladesh. To date, little
attention has been paid to the occurrence of enniatins in food-
stuffs by regulatory authorities (Jestoi 2008). Several studies
have examined the presence of enniatins in food commodities
in Europe, revealing a widespread occurrence in grain and
grain-derived products (Juan et al. 2013; Uhlig et al. 2006).
The data of this biomarker survey indicate a frequent intake of
enniatins in Germany, supporting further studies on the occur-
rence of enniatins. There is also a need for more toxicological
studies to determine the impact of enniatin contaminated food
and feed on the health of humans and animals.
Zearalenone-related biomarkers were detected occasional-
ly in samples from Haiti and calculated PDI values exceeded
the TDI of 0.2 μg/kg b.w. in 1 % of samples by a factor of six.
Solfrizzo et al. (2014) frequently detected ZEA in southern
Italy at mean concentrations below 0.1 ng/mL of α-ZEL, β-
ZEL, and ZEA after enzymatic cleavage with β-
glucuronidase (Solfrizzo et al. 2014). That study concluded
a limited risk of exposure to the Italian population since cal-
culated mean PDI values were lower than the established TDI
by the factor of 10. The low frequency of positivity for ZEA
Table 4 Calculated probable daily intake (PDI) of selected mycotoxins
Biomarker DON+DON-GlcA FB1 AFM1 α-ZEL
Mycotoxin DON FB1 AFB1 ZEA
Excretion rate % 68 1 1.5 8.3
Reference Warth et al. (2013a) Riley et al. (2012) Zhu et al. (1987) Gambacorta et al. (2013)
Species Human Human Human Piglet
TDI (μg/kg b.w.) 1 2 – 0.2
Haiti
Mean PDI (μg/kg b.w.) 0.27 0.05 0.03 0.03
Max. PDI (μg/kg b.w.) 4.38 1.74 0.23 0.75
Samples exceeding TDI % (n) 6 (8) – – 1 (2)
Germany – – – –
Mean PDI (μg/kg b.w.) 0.3 – – –
Max. PDI (μg/kg b.w.) 2.15 – – –
Samples exceeding TDI % (n) 6 (3) – – ––
Bangladesh – – – –
Mean PDI (μg/kg b.w.) – 0.03 0.03 –
Max. PDI (μg/kg b.w.) – 1.362 0.195 –
Samples exceeding TDI % (n) – – – –
Concentration was set to LOD/2, if a biomarker was not detected and to LOQ/2 when biomarker concentration was below LOQ. Excretion rates were
obtained from human excretion data and piglet excretion data, where no data on human excretion was available (α-ZEL) TDI values were obtained from
opinions of the Scientific Committee on Food (SCF) and European Food Safety Authority (EFSA) (EFSA 2006; SCF 2000, 2002, 2003). No TDI for
AFB1 is set due to its carcinogenicity
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and its metabolites in the present study may be attributed to
the high LOD of our current approach, which compromised
detection at lower ranges but achieved direct assessment of
multiple mycotoxins. This was also discussed by Warth et al.
(2013a) detecting only ZEA and no other metabolites after
enzymatic treatment of the urine samples of a human volun-
teer consuming a ZEA containing diet. Nevertheless, the pres-
ent method detects ZEA and its metabolites in concentrations
that would result in PDI values exceeding the TDI.
No T-2, HT-2, or the urinary HT-2 biomarker HT-2-4-GlcA
was detected in any of the samples. The occurrence of T-2
toxin in Europe was reviewed by EFSA in 2011, finding a
low risk of exposure to the European population but
underscoring a lack of data on suitable T-2 biomarkers in
humans (EFSA 2011). We confirm a low exposure of the
investigated populations by means of the urinary presence of
T-2 or its metabolites.
Avalidated and improvedmulti-biomarker LC-MS/MS ap-
proach was applied to samples of three different geographic
origins to investigate differences in human urinary mycotoxin
excretion, on the basis of directly comparable data. Exposure
to DONwas higher in the German and Haitian cohorts, where-
as exposure to citrinin and OTAwas elevated in Bangladeshi
persons, based on comparatively high urine concentrations of
DH-CITand OTA. This calls for further biomonitoring studies
in Bangladesh with a focus on nephrotoxic mycotoxins. At-
tention should be paid also to aflatoxin exposure in Bangla-
desh and Haiti. We report a low exposure of the investigated
populations to DON, FB1, and ZEAwith occasional exceed-
ance of tolerable daily intakes. Valuable information is gained
through the identification of peak exposures of individuals
using the multibiomarker LC-MS/MS approach. The ap-
proach of this study furthermore demonstrates its usefulness
in estimating human exposure to mycotoxins in geographic
areas with little or no data available on mycotoxin occurrence
in food commodities.
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